CN102020995A - Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element - Google Patents
Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element Download PDFInfo
- Publication number
- CN102020995A CN102020995A CN2010102811883A CN201010281188A CN102020995A CN 102020995 A CN102020995 A CN 102020995A CN 2010102811883 A CN2010102811883 A CN 2010102811883A CN 201010281188 A CN201010281188 A CN 201010281188A CN 102020995 A CN102020995 A CN 102020995A
- Authority
- CN
- China
- Prior art keywords
- formula
- liquid crystal
- crystal alignment
- represented
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004973 liquid crystal related substance Substances 0.000 title claims abstract description 327
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 125
- 229920005575 poly(amic acid) Polymers 0.000 claims abstract description 115
- 150000004985 diamines Chemical class 0.000 claims abstract description 110
- GTDPSWPPOUPBNX-UHFFFAOYSA-N ac1mqpva Chemical compound CC12C(=O)OC(=O)C1(C)C1(C)C2(C)C(=O)OC1=O GTDPSWPPOUPBNX-UHFFFAOYSA-N 0.000 claims abstract description 81
- 125000006158 tetracarboxylic acid group Chemical group 0.000 claims abstract description 71
- 238000010438 heat treatment Methods 0.000 claims abstract description 15
- 150000001875 compounds Chemical class 0.000 claims description 172
- -1 piperidine-1,4-diyl Chemical group 0.000 claims description 102
- 125000000217 alkyl group Chemical group 0.000 claims description 84
- 239000004593 Epoxy Substances 0.000 claims description 48
- 239000000758 substrate Substances 0.000 claims description 40
- 125000002947 alkylene group Chemical group 0.000 claims description 39
- 239000000203 mixture Substances 0.000 claims description 37
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 29
- 125000003342 alkenyl group Chemical group 0.000 claims description 20
- 125000004432 carbon atom Chemical group C* 0.000 claims description 20
- 238000000576 coating method Methods 0.000 claims description 17
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 14
- 229910052799 carbon Inorganic materials 0.000 claims description 14
- 125000003545 alkoxy group Chemical group 0.000 claims description 13
- 239000011248 coating agent Substances 0.000 claims description 13
- 125000001931 aliphatic group Chemical group 0.000 claims description 12
- 229910018828 PO3H2 Inorganic materials 0.000 claims description 7
- 229910006069 SO3H Inorganic materials 0.000 claims description 7
- 125000002723 alicyclic group Chemical group 0.000 claims description 7
- 150000001412 amines Chemical class 0.000 claims description 5
- 238000006467 substitution reaction Methods 0.000 claims description 5
- WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical group [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 claims description 5
- 125000004955 1,4-cyclohexylene group Chemical group [H]C1([H])C([H])([H])C([H])([*:1])C([H])([H])C([H])([H])C1([H])[*:2] 0.000 claims description 4
- 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 claims description 4
- 125000005543 phthalimide group Chemical group 0.000 claims description 4
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical group O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 claims description 4
- 125000005714 2,5- (1,3-dioxanylene) group Chemical group [H]C1([H])OC([H])([*:1])OC([H])([H])C1([H])[*:2] 0.000 claims description 3
- 150000003254 radicals Chemical class 0.000 claims 1
- 125000002345 steroid group Chemical group 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 18
- 230000014759 maintenance of location Effects 0.000 abstract description 10
- 238000012360 testing method Methods 0.000 abstract description 3
- 239000010408 film Substances 0.000 description 110
- 229910052757 nitrogen Inorganic materials 0.000 description 76
- 238000000034 method Methods 0.000 description 50
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 36
- 229920000642 polymer Polymers 0.000 description 36
- 239000000243 solution Substances 0.000 description 34
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 23
- 230000015572 biosynthetic process Effects 0.000 description 23
- 239000002904 solvent Substances 0.000 description 23
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 22
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 22
- 238000003786 synthesis reaction Methods 0.000 description 22
- 230000000052 comparative effect Effects 0.000 description 21
- 239000000126 substance Substances 0.000 description 21
- 239000000178 monomer Substances 0.000 description 20
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 19
- FVCSARBUZVPSQF-UHFFFAOYSA-N 5-(2,4-dioxooxolan-3-yl)-7-methyl-3a,4,5,7a-tetrahydro-2-benzofuran-1,3-dione Chemical compound C1C(C(OC2=O)=O)C2C(C)=CC1C1C(=O)COC1=O FVCSARBUZVPSQF-UHFFFAOYSA-N 0.000 description 17
- 229920001577 copolymer Polymers 0.000 description 17
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 16
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 16
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 15
- 229920001721 polyimide Polymers 0.000 description 15
- 125000003504 2-oxazolinyl group Chemical group O1C(=NCC1)* 0.000 description 14
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 13
- 125000003118 aryl group Chemical group 0.000 description 13
- 230000007774 longterm Effects 0.000 description 13
- 238000005259 measurement Methods 0.000 description 13
- 239000007787 solid Substances 0.000 description 13
- 229920000647 polyepoxide Polymers 0.000 description 12
- 239000004642 Polyimide Substances 0.000 description 11
- 229910052739 hydrogen Inorganic materials 0.000 description 11
- 239000001294 propane Substances 0.000 description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 10
- KMBSSXSNDSJXCG-UHFFFAOYSA-N 1-[2-(2-hydroxyundecylamino)ethylamino]undecan-2-ol Chemical compound CCCCCCCCCC(O)CNCCNCC(O)CCCCCCCCC KMBSSXSNDSJXCG-UHFFFAOYSA-N 0.000 description 9
- 0 C*c1cc(C(OCC*(C(C=C2c(cc3)ccc3N)=O)C2=O)=O)cc(*)c1 Chemical compound C*c1cc(C(OCC*(C(C=C2c(cc3)ccc3N)=O)C2=O)=O)cc(*)c1 0.000 description 9
- 238000004140 cleaning Methods 0.000 description 9
- 229920000728 polyester Polymers 0.000 description 9
- 239000000654 additive Substances 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000001257 hydrogen Substances 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 8
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 8
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 8
- 150000002500 ions Chemical class 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical group N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 6
- 238000001354 calcination Methods 0.000 description 6
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 6
- 230000018044 dehydration Effects 0.000 description 6
- 238000006297 dehydration reaction Methods 0.000 description 6
- 125000003700 epoxy group Chemical group 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 150000004893 oxazines Chemical class 0.000 description 6
- 125000000466 oxiranyl group Chemical group 0.000 description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 238000004528 spin coating Methods 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 5
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical class CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 5
- 239000004952 Polyamide Substances 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- PXKLMJQFEQBVLD-UHFFFAOYSA-N bisphenol F Chemical compound C1=CC(O)=CC=C1CC1=CC=C(O)C=C1 PXKLMJQFEQBVLD-UHFFFAOYSA-N 0.000 description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- 230000001678 irradiating effect Effects 0.000 description 5
- 239000012046 mixed solvent Substances 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 125000000962 organic group Chemical group 0.000 description 5
- AFEQENGXSMURHA-UHFFFAOYSA-N oxiran-2-ylmethanamine Chemical compound NCC1CO1 AFEQENGXSMURHA-UHFFFAOYSA-N 0.000 description 5
- 229920002647 polyamide Polymers 0.000 description 5
- 238000007639 printing Methods 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 238000007363 ring formation reaction Methods 0.000 description 5
- 150000003431 steroids Chemical group 0.000 description 5
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 4
- KUDUQBURMYMBIJ-UHFFFAOYSA-N 2-prop-2-enoyloxyethyl prop-2-enoate Chemical compound C=CC(=O)OCCOC(=O)C=C KUDUQBURMYMBIJ-UHFFFAOYSA-N 0.000 description 4
- JFUOAGBSDGCVES-UHFFFAOYSA-N 3-but-2-enyl-4-methylpyrrolidine-2,5-dione Chemical compound CC=CCC1C(C)C(=O)NC1=O JFUOAGBSDGCVES-UHFFFAOYSA-N 0.000 description 4
- 101001053401 Arabidopsis thaliana Acid beta-fructofuranosidase 3, vacuolar Proteins 0.000 description 4
- 101100132433 Arabidopsis thaliana VIII-1 gene Proteins 0.000 description 4
- 101100459319 Arabidopsis thaliana VIII-2 gene Proteins 0.000 description 4
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 4
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 4
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 4
- 150000008065 acid anhydrides Chemical group 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- 125000002993 cycloalkylene group Chemical group 0.000 description 4
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 4
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 150000002170 ethers Chemical class 0.000 description 4
- 229920001519 homopolymer Polymers 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229960003742 phenol Drugs 0.000 description 4
- 238000011907 photodimerization Methods 0.000 description 4
- 230000000704 physical effect Effects 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- OUPZKGBUJRBPGC-UHFFFAOYSA-N 1,3,5-tris(oxiran-2-ylmethyl)-1,3,5-triazinane-2,4,6-trione Chemical compound O=C1N(CC2OC2)C(=O)N(CC2OC2)C(=O)N1CC1CO1 OUPZKGBUJRBPGC-UHFFFAOYSA-N 0.000 description 3
- RWNUSVWFHDHRCJ-UHFFFAOYSA-N 1-butoxypropan-2-ol Chemical compound CCCCOCC(C)O RWNUSVWFHDHRCJ-UHFFFAOYSA-N 0.000 description 3
- AOBIOSPNXBMOAT-UHFFFAOYSA-N 2-[2-(oxiran-2-ylmethoxy)ethoxymethyl]oxirane Chemical compound C1OC1COCCOCC1CO1 AOBIOSPNXBMOAT-UHFFFAOYSA-N 0.000 description 3
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 3
- BCHZICNRHXRCHY-UHFFFAOYSA-N 2h-oxazine Chemical group N1OC=CC=C1 BCHZICNRHXRCHY-UHFFFAOYSA-N 0.000 description 3
- 229930185605 Bisphenol Natural products 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000006087 Silane Coupling Agent Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 3
- 150000001299 aldehydes Chemical class 0.000 description 3
- 229940106691 bisphenol a Drugs 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- WVIIMZNLDWSIRH-UHFFFAOYSA-N cyclohexylcyclohexane Chemical group C1CCCCC1C1CCCCC1 WVIIMZNLDWSIRH-UHFFFAOYSA-N 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000007865 diluting Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000005684 electric field Effects 0.000 description 3
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 3
- 238000005227 gel permeation chromatography Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 150000002431 hydrogen Chemical group 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 125000001624 naphthyl group Chemical group 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 150000002989 phenols Chemical class 0.000 description 3
- 238000007699 photoisomerization reaction Methods 0.000 description 3
- 229920002959 polymer blend Polymers 0.000 description 3
- 150000003141 primary amines Chemical class 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000000565 sealant Substances 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 3
- 239000010409 thin film Substances 0.000 description 3
- 239000002966 varnish Substances 0.000 description 3
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 2
- KATAXDCYPGGJNJ-UHFFFAOYSA-N 1,3-bis(oxiran-2-ylmethoxy)propan-2-ol Chemical compound C1OC1COCC(O)COCC1CO1 KATAXDCYPGGJNJ-UHFFFAOYSA-N 0.000 description 2
- XQUPVDVFXZDTLT-UHFFFAOYSA-N 1-[4-[[4-(2,5-dioxopyrrol-1-yl)phenyl]methyl]phenyl]pyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1C(C=C1)=CC=C1CC1=CC=C(N2C(C=CC2=O)=O)C=C1 XQUPVDVFXZDTLT-UHFFFAOYSA-N 0.000 description 2
- HECLRDQVFMWTQS-RGOKHQFPSA-N 1755-01-7 Chemical compound C1[C@H]2[C@@H]3CC=C[C@@H]3[C@@H]1C=C2 HECLRDQVFMWTQS-RGOKHQFPSA-N 0.000 description 2
- PHXGAJLBHUUAKB-UHFFFAOYSA-N 2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan Chemical compound O1CCC2OCCC21 PHXGAJLBHUUAKB-UHFFFAOYSA-N 0.000 description 2
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 2
- QCAHUFWKIQLBNB-UHFFFAOYSA-N 3-(3-methoxypropoxy)propan-1-ol Chemical compound COCCCOCCCO QCAHUFWKIQLBNB-UHFFFAOYSA-N 0.000 description 2
- YBRVSVVVWCFQMG-UHFFFAOYSA-N 4,4'-diaminodiphenylmethane Chemical compound C1=CC(N)=CC=C1CC1=CC=C(N)C=C1 YBRVSVVVWCFQMG-UHFFFAOYSA-N 0.000 description 2
- VPWNQTHUCYMVMZ-UHFFFAOYSA-N 4,4'-sulfonyldiphenol Chemical compound C1=CC(O)=CC=C1S(=O)(=O)C1=CC=C(O)C=C1 VPWNQTHUCYMVMZ-UHFFFAOYSA-N 0.000 description 2
- DQFMPTUTAAIXAN-UHFFFAOYSA-N 4,4-dimethyl-1h-imidazol-5-one Chemical compound CC1(C)NC=NC1=O DQFMPTUTAAIXAN-UHFFFAOYSA-N 0.000 description 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 101100055224 Anemone leveillei AL10 gene Proteins 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 239000004962 Polyamide-imide Substances 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 206010047571 Visual impairment Diseases 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N anhydrous diethylene glycol Natural products OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- 125000003710 aryl alkyl group Chemical group 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 125000000751 azo group Chemical group [*]N=N[*] 0.000 description 2
- 230000037429 base substitution Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- ZFVMWEVVKGLCIJ-UHFFFAOYSA-N bisphenol AF Chemical compound C1=CC(O)=CC=C1C(C(F)(F)F)(C(F)(F)F)C1=CC=C(O)C=C1 ZFVMWEVVKGLCIJ-UHFFFAOYSA-N 0.000 description 2
- 239000001273 butane Substances 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 229940114081 cinnamate Drugs 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 125000006159 dianhydride group Chemical group 0.000 description 2
- 150000001991 dicarboxylic acids Chemical class 0.000 description 2
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 2
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 2
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 150000002118 epoxides Chemical class 0.000 description 2
- 239000003822 epoxy resin Substances 0.000 description 2
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 125000003055 glycidyl group Chemical group C(C1CO1)* 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- HJOVHMDZYOCNQW-UHFFFAOYSA-N isophorone Chemical compound CC1=CC(=O)CC(C)(C)C1 HJOVHMDZYOCNQW-UHFFFAOYSA-N 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- RASFMBBIZLUCME-UHFFFAOYSA-N methyl 2-amino-3-[(2-amino-3-methoxycarbonylphenyl)methyl]benzoate Chemical compound COC(=O)C1=CC=CC(CC=2C(=C(C(=O)OC)C=CC=2)N)=C1N RASFMBBIZLUCME-UHFFFAOYSA-N 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- WAUMXMQJIMQTJK-UHFFFAOYSA-N n,n'-dihydroxyocta-2,6-dienediamide Chemical compound ONC(=O)C=CCCC=CC(=O)NO WAUMXMQJIMQTJK-UHFFFAOYSA-N 0.000 description 2
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 2
- JAYXSROKFZAHRQ-UHFFFAOYSA-N n,n-bis(oxiran-2-ylmethyl)aniline Chemical compound C1OC1CN(C=1C=CC=CC=1)CC1CO1 JAYXSROKFZAHRQ-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 229920003986 novolac Polymers 0.000 description 2
- 125000002971 oxazolyl group Chemical group 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 229920003192 poly(bis maleimide) Polymers 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920002312 polyamide-imide Polymers 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 2
- 150000003222 pyridines Chemical group 0.000 description 2
- 150000003248 quinolines Chemical group 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000004149 tartrazine Substances 0.000 description 2
- 235000012756 tartrazine Nutrition 0.000 description 2
- 150000000000 tetracarboxylic acids Chemical class 0.000 description 2
- 150000003852 triazoles Chemical class 0.000 description 2
- DQZNLOXENNXVAD-UHFFFAOYSA-N trimethoxy-[2-(7-oxabicyclo[4.1.0]heptan-4-yl)ethyl]silane Chemical compound C1C(CC[Si](OC)(OC)OC)CCC2OC21 DQZNLOXENNXVAD-UHFFFAOYSA-N 0.000 description 2
- BPSIOYPQMFLKFR-UHFFFAOYSA-N trimethoxy-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CO[Si](OC)(OC)CCCOCC1CO1 BPSIOYPQMFLKFR-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical group C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- PMTMAFAPLCGXGK-JMTMCXQRSA-N (15Z)-12-oxophyto-10,15-dienoic acid Chemical compound CC\C=C/C[C@H]1[C@@H](CCCCCCCC(O)=O)C=CC1=O PMTMAFAPLCGXGK-JMTMCXQRSA-N 0.000 description 1
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 1
- LTUMRKDLVGQMJU-VHSABMJYSA-N (5z,9z)-6,10,14-trimethylpentadeca-5,9,13-trien-2-one Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CCC(C)=O LTUMRKDLVGQMJU-VHSABMJYSA-N 0.000 description 1
- VDFVNEFVBPFDSB-UHFFFAOYSA-N 1,3-dioxane Chemical compound C1COCOC1 VDFVNEFVBPFDSB-UHFFFAOYSA-N 0.000 description 1
- DQVRVXRIKVWXQH-UHFFFAOYSA-N 1,8-bis(oxiran-2-yl)-4,6-bis(oxiran-2-ylmethyl)octane-3,5-diol Chemical compound C1OC1CC(C(O)C(CCC1OC1)CC1OC1)C(O)CCC1CO1 DQVRVXRIKVWXQH-UHFFFAOYSA-N 0.000 description 1
- UWFRVQVNYNPBEF-UHFFFAOYSA-N 1-(2,4-dimethylphenyl)propan-1-one Chemical compound CCC(=O)C1=CC=C(C)C=C1C UWFRVQVNYNPBEF-UHFFFAOYSA-N 0.000 description 1
- IPJGAEWUPXWFPL-UHFFFAOYSA-N 1-[3-(2,5-dioxopyrrol-1-yl)phenyl]pyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1C1=CC=CC(N2C(C=CC2=O)=O)=C1 IPJGAEWUPXWFPL-UHFFFAOYSA-N 0.000 description 1
- JEEQFCAWJUBRGE-UHFFFAOYSA-N 1-[3-[[bis(oxiran-2-ylmethyl)amino]methyl]-5-bicyclo[2.2.1]heptanyl]-n,n-bis(oxiran-2-ylmethyl)methanamine Chemical compound C1OC1CN(CC1C2C(CN(CC3OC3)CC3OC3)CC(C2)C1)CC1CO1 JEEQFCAWJUBRGE-UHFFFAOYSA-N 0.000 description 1
- HASUCEDGKYJBDC-UHFFFAOYSA-N 1-[3-[[bis(oxiran-2-ylmethyl)amino]methyl]cyclohexyl]-n,n-bis(oxiran-2-ylmethyl)methanamine Chemical compound C1OC1CN(CC1CC(CN(CC2OC2)CC2OC2)CCC1)CC1CO1 HASUCEDGKYJBDC-UHFFFAOYSA-N 0.000 description 1
- DQXFMCBYGKGRGN-UHFFFAOYSA-N 1-[4-[[bis(oxiran-2-ylmethyl)amino]methyl]cyclohexyl]-n,n-bis(oxiran-2-ylmethyl)methanamine Chemical compound C1OC1CN(CC1CCC(CN(CC2OC2)CC2OC2)CC1)CC1CO1 DQXFMCBYGKGRGN-UHFFFAOYSA-N 0.000 description 1
- BQTPKSBXMONSJI-UHFFFAOYSA-N 1-cyclohexylpyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1C1CCCCC1 BQTPKSBXMONSJI-UHFFFAOYSA-N 0.000 description 1
- BDQNKCYCTYYMAA-UHFFFAOYSA-N 1-isocyanatonaphthalene Chemical compound C1=CC=C2C(N=C=O)=CC=CC2=C1 BDQNKCYCTYYMAA-UHFFFAOYSA-N 0.000 description 1
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 1
- JNMJIXITXWBDMJ-UHFFFAOYSA-N 1-n,1-n,3-n,3-n-tetrakis(oxiran-2-ylmethyl)benzene-1,3-diamine Chemical compound C1OC1CN(C=1C=C(C=CC=1)N(CC1OC1)CC1OC1)CC1CO1 JNMJIXITXWBDMJ-UHFFFAOYSA-N 0.000 description 1
- DBXOZIGKCLFPQZ-UHFFFAOYSA-N 1-n,1-n,3-n,3-n-tetrakis(oxiran-2-ylmethyl)cyclohexane-1,3-diamine Chemical compound C1OC1CN(C1CC(CCC1)N(CC1OC1)CC1OC1)CC1CO1 DBXOZIGKCLFPQZ-UHFFFAOYSA-N 0.000 description 1
- XUUZTOCNBZMTDJ-UHFFFAOYSA-N 1-n,1-n,4-n,4-n-tetrakis(oxiran-2-ylmethyl)benzene-1,4-diamine Chemical compound C1OC1CN(C=1C=CC(=CC=1)N(CC1OC1)CC1OC1)CC1CO1 XUUZTOCNBZMTDJ-UHFFFAOYSA-N 0.000 description 1
- PZQDLBZWPGNKFH-UHFFFAOYSA-N 1-n,1-n,4-n,4-n-tetrakis(oxiran-2-ylmethyl)cyclohexane-1,4-diamine Chemical compound C1OC1CN(C1CCC(CC1)N(CC1OC1)CC1OC1)CC1CO1 PZQDLBZWPGNKFH-UHFFFAOYSA-N 0.000 description 1
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 description 1
- HIDBROSJWZYGSZ-UHFFFAOYSA-N 1-phenylpyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1C1=CC=CC=C1 HIDBROSJWZYGSZ-UHFFFAOYSA-N 0.000 description 1
- RESPXSHDJQUNTN-UHFFFAOYSA-N 1-piperidin-1-ylprop-2-en-1-one Chemical compound C=CC(=O)N1CCCCC1 RESPXSHDJQUNTN-UHFFFAOYSA-N 0.000 description 1
- DGPVNNMFVYYVDF-UHFFFAOYSA-N 1-prop-2-enoylpyrrolidin-2-one Chemical compound C=CC(=O)N1CCCC1=O DGPVNNMFVYYVDF-UHFFFAOYSA-N 0.000 description 1
- LTMRRSWNXVJMBA-UHFFFAOYSA-L 2,2-diethylpropanedioate Chemical compound CCC(CC)(C([O-])=O)C([O-])=O LTMRRSWNXVJMBA-UHFFFAOYSA-L 0.000 description 1
- MODMUHZSYIODLE-UHFFFAOYSA-N 2,4,6-tribromo-n,n-bis(oxiran-2-ylmethyl)aniline Chemical compound BrC1=CC(Br)=CC(Br)=C1N(CC1OC1)CC1OC1 MODMUHZSYIODLE-UHFFFAOYSA-N 0.000 description 1
- KKKKCPPTESQGQH-UHFFFAOYSA-N 2-(4,5-dihydro-1,3-oxazol-2-yl)-4,5-dihydro-1,3-oxazole Chemical compound O1CCN=C1C1=NCCO1 KKKKCPPTESQGQH-UHFFFAOYSA-N 0.000 description 1
- KUBDPQJOLOUJRM-UHFFFAOYSA-N 2-(chloromethyl)oxirane;4-[2-(4-hydroxyphenyl)propan-2-yl]phenol Chemical compound ClCC1CO1.C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 KUBDPQJOLOUJRM-UHFFFAOYSA-N 0.000 description 1
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 1
- HDPLHDGYGLENEI-UHFFFAOYSA-N 2-[1-(oxiran-2-ylmethoxy)propan-2-yloxymethyl]oxirane Chemical compound C1OC1COC(C)COCC1CO1 HDPLHDGYGLENEI-UHFFFAOYSA-N 0.000 description 1
- FVCHRIQAIOHAIC-UHFFFAOYSA-N 2-[1-[1-[1-(oxiran-2-ylmethoxy)propan-2-yloxy]propan-2-yloxy]propan-2-yloxymethyl]oxirane Chemical compound C1OC1COC(C)COC(C)COC(C)COCC1CO1 FVCHRIQAIOHAIC-UHFFFAOYSA-N 0.000 description 1
- SEFYJVFBMNOLBK-UHFFFAOYSA-N 2-[2-[2-(oxiran-2-ylmethoxy)ethoxy]ethoxymethyl]oxirane Chemical compound C1OC1COCCOCCOCC1CO1 SEFYJVFBMNOLBK-UHFFFAOYSA-N 0.000 description 1
- ZDNUPMSZKVCETJ-UHFFFAOYSA-N 2-[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]-4,5-dihydro-1,3-oxazole Chemical compound O1CCN=C1C1=CC=C(C=2OCCN=2)C=C1 ZDNUPMSZKVCETJ-UHFFFAOYSA-N 0.000 description 1
- SHKUUQIDMUMQQK-UHFFFAOYSA-N 2-[4-(oxiran-2-ylmethoxy)butoxymethyl]oxirane Chemical compound C1OC1COCCCCOCC1CO1 SHKUUQIDMUMQQK-UHFFFAOYSA-N 0.000 description 1
- WTYYGFLRBWMFRY-UHFFFAOYSA-N 2-[6-(oxiran-2-ylmethoxy)hexoxymethyl]oxirane Chemical compound C1OC1COCCCCCCOCC1CO1 WTYYGFLRBWMFRY-UHFFFAOYSA-N 0.000 description 1
- PRJQBLZFLQSJOM-UHFFFAOYSA-N 2-[[1,3-dibromo-2,2-dimethyl-3-(oxiran-2-ylmethoxy)propoxy]methyl]oxirane Chemical compound C(C1CO1)OC(C(C)(C(OCC1CO1)Br)C)Br PRJQBLZFLQSJOM-UHFFFAOYSA-N 0.000 description 1
- XOSCKTQMAZSFBZ-UHFFFAOYSA-N 2-[[1-[[2,7-bis(oxiran-2-ylmethoxy)naphthalen-1-yl]methyl]-7-(oxiran-2-ylmethoxy)naphthalen-2-yl]oxymethyl]oxirane Chemical compound C1OC1COC(C=C1C=2CC=3C4=CC(OCC5OC5)=CC=C4C=CC=3OCC3OC3)=CC=C1C=CC=2OCC1CO1 XOSCKTQMAZSFBZ-UHFFFAOYSA-N 0.000 description 1
- KUAUJXBLDYVELT-UHFFFAOYSA-N 2-[[2,2-dimethyl-3-(oxiran-2-ylmethoxy)propoxy]methyl]oxirane Chemical compound C1OC1COCC(C)(C)COCC1CO1 KUAUJXBLDYVELT-UHFFFAOYSA-N 0.000 description 1
- NKANYVMWDXJHLE-UHFFFAOYSA-N 2-[[2-(oxiran-2-ylmethoxy)phenoxy]methyl]oxirane Chemical compound C1OC1COC1=CC=CC=C1OCC1CO1 NKANYVMWDXJHLE-UHFFFAOYSA-N 0.000 description 1
- FSYPIGPPWAJCJG-UHFFFAOYSA-N 2-[[4-(oxiran-2-ylmethoxy)phenoxy]methyl]oxirane Chemical compound C1OC1COC(C=C1)=CC=C1OCC1CO1 FSYPIGPPWAJCJG-UHFFFAOYSA-N 0.000 description 1
- IGZBSJAMZHNHKE-UHFFFAOYSA-N 2-[[4-[bis[4-(oxiran-2-ylmethoxy)phenyl]methyl]phenoxy]methyl]oxirane Chemical compound C1OC1COC(C=C1)=CC=C1C(C=1C=CC(OCC2OC2)=CC=1)C(C=C1)=CC=C1OCC1CO1 IGZBSJAMZHNHKE-UHFFFAOYSA-N 0.000 description 1
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 1
- UUODQIKUTGWMPT-UHFFFAOYSA-N 2-fluoro-5-(trifluoromethyl)pyridine Chemical compound FC1=CC=C(C(F)(F)F)C=N1 UUODQIKUTGWMPT-UHFFFAOYSA-N 0.000 description 1
- OVEUFHOBGCSKSH-UHFFFAOYSA-N 2-methyl-n,n-bis(oxiran-2-ylmethyl)aniline Chemical compound CC1=CC=CC=C1N(CC1OC1)CC1OC1 OVEUFHOBGCSKSH-UHFFFAOYSA-N 0.000 description 1
- TWYISXLZCIVDDW-UHFFFAOYSA-N 2-methyl-n-(2-methylpropoxymethyl)prop-2-enamide Chemical compound CC(C)COCNC(=O)C(C)=C TWYISXLZCIVDDW-UHFFFAOYSA-N 0.000 description 1
- JJOYJOCWEDSDOO-UHFFFAOYSA-N 2-methyl-n-(oxolan-2-ylmethyl)prop-2-enamide Chemical compound CC(=C)C(=O)NCC1CCCO1 JJOYJOCWEDSDOO-UHFFFAOYSA-N 0.000 description 1
- TURITJIWSQEMDB-UHFFFAOYSA-N 2-methyl-n-[(2-methylprop-2-enoylamino)methyl]prop-2-enamide Chemical compound CC(=C)C(=O)NCNC(=O)C(C)=C TURITJIWSQEMDB-UHFFFAOYSA-N 0.000 description 1
- IJSVVICYGLOZHA-UHFFFAOYSA-N 2-methyl-n-phenylprop-2-enamide Chemical compound CC(=C)C(=O)NC1=CC=CC=C1 IJSVVICYGLOZHA-UHFFFAOYSA-N 0.000 description 1
- YQIGLEFUZMIVHU-UHFFFAOYSA-N 2-methyl-n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C(C)=C YQIGLEFUZMIVHU-UHFFFAOYSA-N 0.000 description 1
- CCIDRBFZPRURMU-UHFFFAOYSA-N 2-methyl-n-propylprop-2-enamide Chemical compound CCCNC(=O)C(C)=C CCIDRBFZPRURMU-UHFFFAOYSA-N 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- HHCHLHOEAKKCAB-UHFFFAOYSA-N 2-oxaspiro[3.5]nonane-1,3-dione Chemical compound O=C1OC(=O)C11CCCCC1 HHCHLHOEAKKCAB-UHFFFAOYSA-N 0.000 description 1
- CMLFRMDBDNHMRA-UHFFFAOYSA-N 2h-1,2-benzoxazine Chemical compound C1=CC=C2C=CNOC2=C1 CMLFRMDBDNHMRA-UHFFFAOYSA-N 0.000 description 1
- OLQWMCSSZKNOLQ-UHFFFAOYSA-N 3-(2,5-dioxooxolan-3-yl)oxolane-2,5-dione Chemical compound O=C1OC(=O)CC1C1C(=O)OC(=O)C1 OLQWMCSSZKNOLQ-UHFFFAOYSA-N 0.000 description 1
- VAGOJLCWTUPBKD-UHFFFAOYSA-N 3-(oxiran-2-ylmethoxy)-n,n-bis(oxiran-2-ylmethyl)aniline Chemical compound C1OC1COC(C=1)=CC=CC=1N(CC1OC1)CC1CO1 VAGOJLCWTUPBKD-UHFFFAOYSA-N 0.000 description 1
- CWLKGDAVCFYWJK-UHFFFAOYSA-N 3-aminophenol Chemical compound NC1=CC=CC(O)=C1 CWLKGDAVCFYWJK-UHFFFAOYSA-N 0.000 description 1
- IWTYTFSSTWXZFU-UHFFFAOYSA-N 3-chloroprop-1-enylbenzene Chemical compound ClCC=CC1=CC=CC=C1 IWTYTFSSTWXZFU-UHFFFAOYSA-N 0.000 description 1
- OXYZDRAJMHGSMW-UHFFFAOYSA-N 3-chloropropyl(trimethoxy)silane Chemical compound CO[Si](OC)(OC)CCCCl OXYZDRAJMHGSMW-UHFFFAOYSA-N 0.000 description 1
- KNTKCYKJRSMRMZ-UHFFFAOYSA-N 3-chloropropyl-dimethoxy-methylsilane Chemical compound CO[Si](C)(OC)CCCCl KNTKCYKJRSMRMZ-UHFFFAOYSA-N 0.000 description 1
- YOWKKGPNCDIFFB-UHFFFAOYSA-N 3-decyloxolane-2,5-dione Chemical compound CCCCCCCCCCC1CC(=O)OC1=O YOWKKGPNCDIFFB-UHFFFAOYSA-N 0.000 description 1
- YAXXOCZAXKLLCV-UHFFFAOYSA-N 3-dodecyloxolane-2,5-dione Chemical compound CCCCCCCCCCCCC1CC(=O)OC1=O YAXXOCZAXKLLCV-UHFFFAOYSA-N 0.000 description 1
- MFKRHJVUCZRDTF-UHFFFAOYSA-N 3-methoxy-3-methylbutan-1-ol Chemical compound COC(C)(C)CCO MFKRHJVUCZRDTF-UHFFFAOYSA-N 0.000 description 1
- OFNISBHGPNMTMS-UHFFFAOYSA-N 3-methylideneoxolane-2,5-dione Chemical compound C=C1CC(=O)OC1=O OFNISBHGPNMTMS-UHFFFAOYSA-N 0.000 description 1
- GRFNBEZIAWKNCO-UHFFFAOYSA-N 3-pyridinol Chemical compound OC1=CC=CN=C1 GRFNBEZIAWKNCO-UHFFFAOYSA-N 0.000 description 1
- BZECBEKZECEQRI-UHFFFAOYSA-N 3-tetradecyloxolane-2,5-dione Chemical compound CCCCCCCCCCCCCCC1CC(=O)OC1=O BZECBEKZECEQRI-UHFFFAOYSA-N 0.000 description 1
- YOABZRCMJMKPFF-UHFFFAOYSA-N 3-triethoxysilylaniline Chemical compound CCO[Si](OCC)(OCC)C1=CC=CC(N)=C1 YOABZRCMJMKPFF-UHFFFAOYSA-N 0.000 description 1
- SJECZPVISLOESU-UHFFFAOYSA-N 3-trimethoxysilylpropan-1-amine Chemical compound CO[Si](OC)(OC)CCCN SJECZPVISLOESU-UHFFFAOYSA-N 0.000 description 1
- UUEWCQRISZBELL-UHFFFAOYSA-N 3-trimethoxysilylpropane-1-thiol Chemical compound CO[Si](OC)(OC)CCCS UUEWCQRISZBELL-UHFFFAOYSA-N 0.000 description 1
- XDLMVUHYZWKMMD-UHFFFAOYSA-N 3-trimethoxysilylpropyl 2-methylprop-2-enoate Chemical compound CO[Si](OC)(OC)CCCOC(=O)C(C)=C XDLMVUHYZWKMMD-UHFFFAOYSA-N 0.000 description 1
- QEQVCPKISCKMOQ-UHFFFAOYSA-N 3h-benzo[f][1,2]benzoxazine Chemical compound C1=CC=CC2=C(C=CNO3)C3=CC=C21 QEQVCPKISCKMOQ-UHFFFAOYSA-N 0.000 description 1
- KQIKKETXZQDHGE-FOCLMDBBSA-N 4,4'-diaminoazobenzene Chemical compound C1=CC(N)=CC=C1\N=N\C1=CC=C(N)C=C1 KQIKKETXZQDHGE-FOCLMDBBSA-N 0.000 description 1
- AHIPJALLQVEEQF-UHFFFAOYSA-N 4-(oxiran-2-ylmethoxy)-n,n-bis(oxiran-2-ylmethyl)aniline Chemical compound C1OC1COC(C=C1)=CC=C1N(CC1OC1)CC1CO1 AHIPJALLQVEEQF-UHFFFAOYSA-N 0.000 description 1
- JLBJTVDPSNHSKJ-UHFFFAOYSA-N 4-Methylstyrene Chemical compound CC1=CC=C(C=C)C=C1 JLBJTVDPSNHSKJ-UHFFFAOYSA-N 0.000 description 1
- YFKPQCYLWJULME-UHFFFAOYSA-N 4-[(4-amino-2-methylphenyl)methyl]-3-methylaniline Chemical compound CC1=CC(N)=CC=C1CC1=CC=C(N)C=C1C YFKPQCYLWJULME-UHFFFAOYSA-N 0.000 description 1
- WQNBIRGALIEKLM-UHFFFAOYSA-N 4-[3,4-bis[bis(oxiran-2-ylmethyl)amino]phenyl]-1-n,1-n,2-n,2-n-tetrakis(oxiran-2-ylmethyl)benzene-1,2-diamine Chemical group C1OC1CN(C=1C(=CC(=CC=1)C=1C=C(C(N(CC2OC2)CC2OC2)=CC=1)N(CC1OC1)CC1OC1)N(CC1OC1)CC1OC1)CC1CO1 WQNBIRGALIEKLM-UHFFFAOYSA-N 0.000 description 1
- ZTJJSSVFPTXFLW-UHFFFAOYSA-N 4-[3,5-bis[4-[bis(oxiran-2-ylmethyl)amino]phenoxy]phenoxy]-n,n-bis(oxiran-2-ylmethyl)aniline Chemical compound C1OC1CN(C=1C=CC(OC=2C=C(OC=3C=CC(=CC=3)N(CC3OC3)CC3OC3)C=C(OC=3C=CC(=CC=3)N(CC3OC3)CC3OC3)C=2)=CC=1)CC1CO1 ZTJJSSVFPTXFLW-UHFFFAOYSA-N 0.000 description 1
- YXIBWOSJFHLUKT-UHFFFAOYSA-N 4-[4-[bis(oxiran-2-ylmethyl)amino]-2-methylphenyl]-3-methyl-n,n-bis(oxiran-2-ylmethyl)aniline Chemical group CC1=CC(N(CC2OC2)CC2OC2)=CC=C1C(C(=C1)C)=CC=C1N(CC1OC1)CC1CO1 YXIBWOSJFHLUKT-UHFFFAOYSA-N 0.000 description 1
- FAUAZXVRLVIARB-UHFFFAOYSA-N 4-[[4-[bis(oxiran-2-ylmethyl)amino]phenyl]methyl]-n,n-bis(oxiran-2-ylmethyl)aniline Chemical compound C1OC1CN(C=1C=CC(CC=2C=CC(=CC=2)N(CC2OC2)CC2OC2)=CC=1)CC1CO1 FAUAZXVRLVIARB-UHFFFAOYSA-N 0.000 description 1
- VFERWHVXGASKHV-UHFFFAOYSA-N 4-[bis[4-[bis(oxiran-2-ylmethyl)amino]phenyl]methyl]-n,n-bis(oxiran-2-ylmethyl)aniline Chemical compound C1OC1CN(C=1C=CC(=CC=1)C(C=1C=CC(=CC=1)N(CC1OC1)CC1OC1)C=1C=CC(=CC=1)N(CC1OC1)CC1OC1)CC1CO1 VFERWHVXGASKHV-UHFFFAOYSA-N 0.000 description 1
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical compound NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 description 1
- GCNTZFIIOFTKIY-UHFFFAOYSA-N 4-hydroxypyridine Chemical compound OC1=CC=NC=C1 GCNTZFIIOFTKIY-UHFFFAOYSA-N 0.000 description 1
- IUFHJPXOLHSJTC-UHFFFAOYSA-N 4-phenyl-2-[(4-phenyl-4,5-dihydro-1,3-oxazol-2-yl)methyl]-4,5-dihydro-1,3-oxazole Chemical compound N=1C(C=2C=CC=CC=2)COC=1CC(OC1)=NC1C1=CC=CC=C1 IUFHJPXOLHSJTC-UHFFFAOYSA-N 0.000 description 1
- JTNVCJCSECAMLD-UHFFFAOYSA-N 4-phenyl-2-[2-(4-phenyl-4,5-dihydro-1,3-oxazol-2-yl)propan-2-yl]-4,5-dihydro-1,3-oxazole Chemical compound N=1C(C=2C=CC=CC=2)COC=1C(C)(C)C(OC1)=NC1C1=CC=CC=C1 JTNVCJCSECAMLD-UHFFFAOYSA-N 0.000 description 1
- LNFGJDBAWVODMB-UHFFFAOYSA-N 4-prop-1-en-2-yl-2-[3-(4-prop-1-en-2-yl-4,5-dihydro-1,3-oxazol-2-yl)butan-2-yl]-4,5-dihydro-1,3-oxazole Chemical compound N=1C(C(C)=C)COC=1C(C)C(C)C1=NC(C(C)=C)CO1 LNFGJDBAWVODMB-UHFFFAOYSA-N 0.000 description 1
- CSGQGLBCAHGJDR-UHFFFAOYSA-N 4-propan-2-yl-2-[6-(4-propan-2-yl-4,5-dihydro-1,3-oxazol-2-yl)pyridin-2-yl]-4,5-dihydro-1,3-oxazole Chemical compound CC(C)C1COC(C=2N=C(C=CC=2)C=2OCC(N=2)C(C)C)=N1 CSGQGLBCAHGJDR-UHFFFAOYSA-N 0.000 description 1
- WCCCBUXURHZPQL-UHFFFAOYSA-N 4-tert-butyl-2-[(4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl)methyl]-4,5-dihydro-1,3-oxazole Chemical compound CC(C)(C)C1COC(CC=2OCC(N=2)C(C)(C)C)=N1 WCCCBUXURHZPQL-UHFFFAOYSA-N 0.000 description 1
- DPMGLJUMNRDNMX-UHFFFAOYSA-N 4-tert-butyl-2-[2-(4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl)propan-2-yl]-4,5-dihydro-1,3-oxazole Chemical compound CC(C)(C)C1COC(C(C)(C)C=2OCC(N=2)C(C)(C)C)=N1 DPMGLJUMNRDNMX-UHFFFAOYSA-N 0.000 description 1
- TVTRDGVFIXILMY-UHFFFAOYSA-N 4-triethoxysilylaniline Chemical compound CCO[Si](OCC)(OCC)C1=CC=C(N)C=C1 TVTRDGVFIXILMY-UHFFFAOYSA-N 0.000 description 1
- CNODSORTHKVDEM-UHFFFAOYSA-N 4-trimethoxysilylaniline Chemical compound CO[Si](OC)(OC)C1=CC=C(N)C=C1 CNODSORTHKVDEM-UHFFFAOYSA-N 0.000 description 1
- YGYCECQIOXZODZ-UHFFFAOYSA-N 4415-87-6 Chemical compound O=C1OC(=O)C2C1C1C(=O)OC(=O)C12 YGYCECQIOXZODZ-UHFFFAOYSA-N 0.000 description 1
- IMEHGXRUDNNSGQ-UHFFFAOYSA-N 6-(2,5-dioxo-3-phenylpyrrol-1-yl)hexyl 3,5-diaminobenzoate Chemical compound NC1=CC(N)=CC(C(=O)OCCCCCCN2C(C(=CC2=O)C=2C=CC=CC=2)=O)=C1 IMEHGXRUDNNSGQ-UHFFFAOYSA-N 0.000 description 1
- RBHIUNHSNSQJNG-UHFFFAOYSA-N 6-methyl-3-(2-methyloxiran-2-yl)-7-oxabicyclo[4.1.0]heptane Chemical compound C1CC2(C)OC2CC1C1(C)CO1 RBHIUNHSNSQJNG-UHFFFAOYSA-N 0.000 description 1
- FIHBHSQYSYVZQE-UHFFFAOYSA-N 6-prop-2-enoyloxyhexyl prop-2-enoate Chemical compound C=CC(=O)OCCCCCCOC(=O)C=C FIHBHSQYSYVZQE-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 239000004229 Alkannin Substances 0.000 description 1
- 101100452593 Caenorhabditis elegans ina-1 gene Proteins 0.000 description 1
- WVOLTBSCXRRQFR-SJORKVTESA-N Cannabidiolic acid Natural products OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@@H]1[C@@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-SJORKVTESA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- GDFCSMCGLZFNFY-UHFFFAOYSA-N Dimethylaminopropyl Methacrylamide Chemical compound CN(C)CCCNC(=O)C(C)=C GDFCSMCGLZFNFY-UHFFFAOYSA-N 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- 239000004214 Fast Green FCF Substances 0.000 description 1
- 239000004230 Fast Yellow AB Substances 0.000 description 1
- 239000004233 Indanthrene blue RS Substances 0.000 description 1
- FNJSWIPFHMKRAT-UHFFFAOYSA-N Monomethyl phthalate Chemical compound COC(=O)C1=CC=CC=C1C(O)=O FNJSWIPFHMKRAT-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- SUAKHGWARZSWIH-UHFFFAOYSA-N N,N‐diethylformamide Chemical compound CCN(CC)C=O SUAKHGWARZSWIH-UHFFFAOYSA-N 0.000 description 1
- ZWXPDGCFMMFNRW-UHFFFAOYSA-N N-methylcaprolactam Chemical compound CN1CCCCCC1=O ZWXPDGCFMMFNRW-UHFFFAOYSA-N 0.000 description 1
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N N-phenyl amine Natural products NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 1
- 239000004988 Nematic liquid crystal Substances 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- ARZCYQALUKFQBU-UHFFFAOYSA-N O1C(=CC=C1)C1N=C(OC1=O)C1C(C=CC=C1)=C Chemical compound O1C(=CC=C1)C1N=C(OC1=O)C1C(C=CC=C1)=C ARZCYQALUKFQBU-UHFFFAOYSA-N 0.000 description 1
- SNHKMHUMILUWSJ-UHFFFAOYSA-N O=C(C(CC1)C2CC1C(CCC1C(O3)=O)CC1C3=O)OC2=O Chemical compound O=C(C(CC1)C2CC1C(CCC1C(O3)=O)CC1C3=O)OC2=O SNHKMHUMILUWSJ-UHFFFAOYSA-N 0.000 description 1
- ANSXAPJVJOKRDJ-UHFFFAOYSA-N O=C(c(c1c2)cc(C(O3)=O)c2C3=O)OC1=O Chemical compound O=C(c(c1c2)cc(C(O3)=O)c2C3=O)OC1=O ANSXAPJVJOKRDJ-UHFFFAOYSA-N 0.000 description 1
- QQGYZOYWNCKGEK-UHFFFAOYSA-N O=C(c(c1c2)ccc2Oc(cc2)cc(C(O3)=O)c2C3=O)OC1=O Chemical compound O=C(c(c1c2)ccc2Oc(cc2)cc(C(O3)=O)c2C3=O)OC1=O QQGYZOYWNCKGEK-UHFFFAOYSA-N 0.000 description 1
- GIFXHNWKMSFJET-UHFFFAOYSA-N O=C(c(c1cc2c3)cc2cc(C(O2)=O)c3C2=O)OC1=O Chemical compound O=C(c(c1cc2c3)cc2cc(C(O2)=O)c3C2=O)OC1=O GIFXHNWKMSFJET-UHFFFAOYSA-N 0.000 description 1
- WKDNYTOXBCRNPV-UHFFFAOYSA-N O=C(c(cc1)c2cc1-c(cc1)cc(C(O3)=O)c1C3=O)OC2=O Chemical compound O=C(c(cc1)c2cc1-c(cc1)cc(C(O3)=O)c1C3=O)OC2=O WKDNYTOXBCRNPV-UHFFFAOYSA-N 0.000 description 1
- VQVIHDPBMFABCQ-UHFFFAOYSA-N O=C(c(cc1C(O2)=O)ccc1C2=O)c(cc1)cc(C(O2)=O)c1C2=O Chemical compound O=C(c(cc1C(O2)=O)ccc1C2=O)c(cc1)cc(C(O2)=O)c1C2=O VQVIHDPBMFABCQ-UHFFFAOYSA-N 0.000 description 1
- IKPDWXPKZUEPFR-UHFFFAOYSA-N O=C(c1c2cc(Cc(cc3)cc(C(O4)=O)c3C4=O)cc1)OC2=O Chemical compound O=C(c1c2cc(Cc(cc3)cc(C(O4)=O)c3C4=O)cc1)OC2=O IKPDWXPKZUEPFR-UHFFFAOYSA-N 0.000 description 1
- PMTMAFAPLCGXGK-UHFFFAOYSA-N OPDA Natural products CCC=CCC1C(CCCCCCCC(O)=O)C=CC1=O PMTMAFAPLCGXGK-UHFFFAOYSA-N 0.000 description 1
- 239000004235 Orange GGN Substances 0.000 description 1
- 101100028078 Oryza sativa subsp. japonica OPR1 gene Proteins 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002396 Polyurea Polymers 0.000 description 1
- 239000004237 Ponceau 6R Substances 0.000 description 1
- 239000004236 Ponceau SX Substances 0.000 description 1
- AEKNYBWUEYNWMJ-QWOOXDRHSA-N Pramiconazole Chemical compound O=C1N(C(C)C)CCN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(CO3)C=3C(=CC(F)=CC=3)F)=CC=2)C=C1 AEKNYBWUEYNWMJ-QWOOXDRHSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 239000004231 Riboflavin-5-Sodium Phosphate Substances 0.000 description 1
- 229920001079 Thiokol (polymer) Polymers 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- DAKWPKUUDNSNPN-UHFFFAOYSA-N Trimethylolpropane triacrylate Chemical compound C=CC(=O)OCC(CC)(COC(=O)C=C)COC(=O)C=C DAKWPKUUDNSNPN-UHFFFAOYSA-N 0.000 description 1
- 239000004234 Yellow 2G Substances 0.000 description 1
- VCFFZAQQHCLMNH-UHFFFAOYSA-N [3-(6-prop-2-enoyloxyhexanoyloxy)-2-[[3-(6-prop-2-enoyloxyhexanoyloxy)-2,2-bis(6-prop-2-enoyloxyhexanoyloxymethyl)propoxy]methyl]-2-(6-prop-2-enoyloxyhexanoyloxymethyl)propyl] 6-prop-2-enoyloxyhexanoate Chemical compound C=CC(=O)OCCCCCC(=O)OCC(COC(=O)CCCCCOC(=O)C=C)(COC(=O)CCCCCOC(=O)C=C)COCC(COC(=O)CCCCCOC(=O)C=C)(COC(=O)CCCCCOC(=O)C=C)COC(=O)CCCCCOC(=O)C=C VCFFZAQQHCLMNH-UHFFFAOYSA-N 0.000 description 1
- HTMMMSIQFWMMIJ-UHFFFAOYSA-N [3-[2,2-dimethyl-3-(6-prop-2-enoyloxyhexanoyloxy)propanoyl]oxy-2,2-dimethylpropyl] 6-prop-2-enoyloxyhexanoate Chemical compound C=CC(=O)OCCCCCC(=O)OCC(C)(C)COC(=O)C(C)(C)COC(=O)CCCCCOC(=O)C=C HTMMMSIQFWMMIJ-UHFFFAOYSA-N 0.000 description 1
- YNTQTLGBCMXNFX-UHFFFAOYSA-N [5-ethyl-2-(2-methyl-1-prop-2-enoyloxypropan-2-yl)-1,3-dioxan-5-yl]methyl prop-2-enoate Chemical compound C=CC(=O)OCC1(CC)COC(C(C)(C)COC(=O)C=C)OC1 YNTQTLGBCMXNFX-UHFFFAOYSA-N 0.000 description 1
- ZVQSOAFYLJKZPH-UHFFFAOYSA-N [SiH4].NC=1C=C(C=CC1)[Si](OC)(OC)OC Chemical compound [SiH4].NC=1C=C(C=CC1)[Si](OC)(OC)OC ZVQSOAFYLJKZPH-UHFFFAOYSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- BAPJBEWLBFYGME-UHFFFAOYSA-N acrylic acid methyl ester Natural products COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001334 alicyclic compounds Chemical group 0.000 description 1
- 150000007824 aliphatic compounds Chemical group 0.000 description 1
- 235000019232 alkannin Nutrition 0.000 description 1
- 150000001346 alkyl aryl ethers Chemical class 0.000 description 1
- 239000004191 allura red AC Substances 0.000 description 1
- 235000012741 allura red AC Nutrition 0.000 description 1
- NIXXEONCZZIYKV-UHFFFAOYSA-N allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboximide Chemical compound O=C1NC(=O)C2C1C1(CCC=C)C=CC2C1 NIXXEONCZZIYKV-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- YJXGADCZMLHGLV-UHFFFAOYSA-N aniline;pyridine Chemical group C1=CC=NC=C1.NC1=CC=CC=C1 YJXGADCZMLHGLV-UHFFFAOYSA-N 0.000 description 1
- 150000001448 anilines Chemical group 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 150000001491 aromatic compounds Chemical group 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 125000000732 arylene group Chemical group 0.000 description 1
- 239000004176 azorubin Substances 0.000 description 1
- 235000012733 azorubine Nutrition 0.000 description 1
- GPRLTFBKWDERLU-UHFFFAOYSA-N bicyclo[2.2.2]octane Chemical group C1CC2CCC1CC2 GPRLTFBKWDERLU-UHFFFAOYSA-N 0.000 description 1
- JRPRCOLKIYRSNH-UHFFFAOYSA-N bis(oxiran-2-ylmethyl) benzene-1,2-dicarboxylate Chemical compound C=1C=CC=C(C(=O)OCC2OC2)C=1C(=O)OCC1CO1 JRPRCOLKIYRSNH-UHFFFAOYSA-N 0.000 description 1
- NEPKLUNSRVEBIX-UHFFFAOYSA-N bis(oxiran-2-ylmethyl) benzene-1,4-dicarboxylate Chemical compound C=1C=C(C(=O)OCC2OC2)C=CC=1C(=O)OCC1CO1 NEPKLUNSRVEBIX-UHFFFAOYSA-N 0.000 description 1
- 239000004126 brilliant black BN Substances 0.000 description 1
- 235000012709 brilliant black BN Nutrition 0.000 description 1
- 239000004161 brilliant blue FCF Substances 0.000 description 1
- 235000012745 brilliant blue FCF Nutrition 0.000 description 1
- 239000004109 brown FK Substances 0.000 description 1
- 235000012713 brown FK Nutrition 0.000 description 1
- 239000001678 brown HT Substances 0.000 description 1
- 235000012670 brown HT Nutrition 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- WVOLTBSCXRRQFR-DLBZAZTESA-M cannabidiolate Chemical compound OC1=C(C([O-])=O)C(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-DLBZAZTESA-M 0.000 description 1
- 239000001752 chlorophylls and chlorophyllins Substances 0.000 description 1
- 235000012698 chlorophylls and chlorophyllins Nutrition 0.000 description 1
- 239000001679 citrus red 2 Substances 0.000 description 1
- 235000013986 citrus red 2 Nutrition 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000004121 copper complexes of chlorophylls and chlorophyllins Substances 0.000 description 1
- 235000012700 copper complexes of chlorophylls and chlorophyllins Nutrition 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000011353 cycloaliphatic epoxy resin Substances 0.000 description 1
- 150000001925 cycloalkenes Chemical class 0.000 description 1
- RZIPTXDCNDIINL-UHFFFAOYSA-N cyclohexane-1,1,2,2-tetracarboxylic acid Chemical compound OC(=O)C1(C(O)=O)CCCCC1(C(O)=O)C(O)=O RZIPTXDCNDIINL-UHFFFAOYSA-N 0.000 description 1
- 125000004956 cyclohexylene group Chemical group 0.000 description 1
- MAWOHFOSAIXURX-UHFFFAOYSA-N cyclopentylcyclopentane Chemical group C1CCCC1C1CCCC1 MAWOHFOSAIXURX-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 125000004427 diamine group Chemical group 0.000 description 1
- WHGNXNCOTZPEEK-UHFFFAOYSA-N dimethoxy-methyl-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CO[Si](C)(OC)CCCOCC1CO1 WHGNXNCOTZPEEK-UHFFFAOYSA-N 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000008393 encapsulating agent Substances 0.000 description 1
- 239000004174 erythrosine Substances 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- FWDBOZPQNFPOLF-UHFFFAOYSA-N ethenyl(triethoxy)silane Chemical compound CCO[Si](OCC)(OCC)C=C FWDBOZPQNFPOLF-UHFFFAOYSA-N 0.000 description 1
- NKSJNEHGWDZZQF-UHFFFAOYSA-N ethenyl(trimethoxy)silane Chemical compound CO[Si](OC)(OC)C=C NKSJNEHGWDZZQF-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 235000019240 fast green FCF Nutrition 0.000 description 1
- 235000019233 fast yellow AB Nutrition 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 239000004120 green S Substances 0.000 description 1
- 235000012701 green S Nutrition 0.000 description 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Substances CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000006358 imidation reaction Methods 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 235000019239 indanthrene blue RS Nutrition 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 239000004179 indigotine Substances 0.000 description 1
- 235000012738 indigotine Nutrition 0.000 description 1
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- ZFSLODLOARCGLH-UHFFFAOYSA-N isocyanuric acid Chemical compound OC1=NC(O)=NC(O)=N1 ZFSLODLOARCGLH-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 150000002690 malonic acid derivatives Chemical class 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 125000005394 methallyl group Chemical group 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- MQWFLKHKWJMCEN-UHFFFAOYSA-N n'-[3-[dimethoxy(methyl)silyl]propyl]ethane-1,2-diamine Chemical compound CO[Si](C)(OC)CCCNCCN MQWFLKHKWJMCEN-UHFFFAOYSA-N 0.000 description 1
- IFZUFHWISBKFJP-UHFFFAOYSA-N n'-[4-[dimethoxy(methyl)silyl]oxybutyl]ethane-1,2-diamine Chemical compound CO[Si](C)(OC)OCCCCNCCN IFZUFHWISBKFJP-UHFFFAOYSA-N 0.000 description 1
- HZGIOLNCNORPKR-UHFFFAOYSA-N n,n'-bis(3-trimethoxysilylpropyl)ethane-1,2-diamine Chemical compound CO[Si](OC)(OC)CCCNCCNCCC[Si](OC)(OC)OC HZGIOLNCNORPKR-UHFFFAOYSA-N 0.000 description 1
- QRWZCJXEAOZAAW-UHFFFAOYSA-N n,n,2-trimethylprop-2-enamide Chemical compound CN(C)C(=O)C(C)=C QRWZCJXEAOZAAW-UHFFFAOYSA-N 0.000 description 1
- AJFDBNQQDYLMJN-UHFFFAOYSA-N n,n-diethylacetamide Chemical compound CCN(CC)C(C)=O AJFDBNQQDYLMJN-UHFFFAOYSA-N 0.000 description 1
- OVHHHVAVHBHXAK-UHFFFAOYSA-N n,n-diethylprop-2-enamide Chemical compound CCN(CC)C(=O)C=C OVHHHVAVHBHXAK-UHFFFAOYSA-N 0.000 description 1
- KAKALCZDCFZYRN-UHFFFAOYSA-N n-(2-ethoxyethyl)-2-methylprop-2-enamide Chemical compound CCOCCNC(=O)C(C)=C KAKALCZDCFZYRN-UHFFFAOYSA-N 0.000 description 1
- YLQHOUDDHYMERA-UHFFFAOYSA-N n-(2-ethoxyethyl)prop-2-enamide Chemical compound CCOCCNC(=O)C=C YLQHOUDDHYMERA-UHFFFAOYSA-N 0.000 description 1
- XZSZONUJSGDIFI-UHFFFAOYSA-N n-(4-hydroxyphenyl)-2-methylprop-2-enamide Chemical compound CC(=C)C(=O)NC1=CC=C(O)C=C1 XZSZONUJSGDIFI-UHFFFAOYSA-N 0.000 description 1
- YOZHLACIXDCHPV-UHFFFAOYSA-N n-(methoxymethyl)-2-methylprop-2-enamide Chemical compound COCNC(=O)C(C)=C YOZHLACIXDCHPV-UHFFFAOYSA-N 0.000 description 1
- KPEKHIHQXHOSRM-UHFFFAOYSA-N n-(oxolan-2-ylmethyl)prop-2-enamide Chemical compound C=CC(=O)NCC1CCCO1 KPEKHIHQXHOSRM-UHFFFAOYSA-N 0.000 description 1
- DCBBWYIVFRLKCD-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]-2-methylprop-2-enamide Chemical compound CN(C)CCNC(=O)C(C)=C DCBBWYIVFRLKCD-UHFFFAOYSA-N 0.000 description 1
- AYGYHGXUJBFUJU-UHFFFAOYSA-N n-[2-(prop-2-enoylamino)ethyl]prop-2-enamide Chemical compound C=CC(=O)NCCNC(=O)C=C AYGYHGXUJBFUJU-UHFFFAOYSA-N 0.000 description 1
- SJPFBRJHYRBAGV-UHFFFAOYSA-N n-[[3-[[bis(oxiran-2-ylmethyl)amino]methyl]phenyl]methyl]-1-(oxiran-2-yl)-n-(oxiran-2-ylmethyl)methanamine Chemical compound C1OC1CN(CC=1C=C(CN(CC2OC2)CC2OC2)C=CC=1)CC1CO1 SJPFBRJHYRBAGV-UHFFFAOYSA-N 0.000 description 1
- VQGWOOIHSXNRPW-UHFFFAOYSA-N n-butyl-2-methylprop-2-enamide Chemical compound CCCCNC(=O)C(C)=C VQGWOOIHSXNRPW-UHFFFAOYSA-N 0.000 description 1
- FIBUWQFQYAAXHD-UHFFFAOYSA-N n-cyclopropyl-2-methylprop-2-enamide Chemical compound CC(=C)C(=O)NC1CC1 FIBUWQFQYAAXHD-UHFFFAOYSA-N 0.000 description 1
- LCXIFAOALNZGDO-UHFFFAOYSA-N n-cyclopropylprop-2-enamide Chemical compound C=CC(=O)NC1CC1 LCXIFAOALNZGDO-UHFFFAOYSA-N 0.000 description 1
- SWPMNMYLORDLJE-UHFFFAOYSA-N n-ethylprop-2-enamide Chemical compound CCNC(=O)C=C SWPMNMYLORDLJE-UHFFFAOYSA-N 0.000 description 1
- COYVWKMZTCAFHO-UHFFFAOYSA-N n-methyl-n-propan-2-ylprop-2-enamide Chemical compound CC(C)N(C)C(=O)C=C COYVWKMZTCAFHO-UHFFFAOYSA-N 0.000 description 1
- RGNKVBUBMHKKJP-UHFFFAOYSA-N n-methyl-n-propylprop-2-enamide Chemical compound CCCN(C)C(=O)C=C RGNKVBUBMHKKJP-UHFFFAOYSA-N 0.000 description 1
- QNILTEGFHQSKFF-UHFFFAOYSA-N n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C=C QNILTEGFHQSKFF-UHFFFAOYSA-N 0.000 description 1
- WDFKEEALECCKTJ-UHFFFAOYSA-N n-propylprop-2-enamide Chemical compound CCCNC(=O)C=C WDFKEEALECCKTJ-UHFFFAOYSA-N 0.000 description 1
- UMRZSTCPUPJPOJ-KNVOCYPGSA-N norbornane Chemical group C1C[C@H]2CC[C@@H]1C2 UMRZSTCPUPJPOJ-KNVOCYPGSA-N 0.000 description 1
- ZDHCZVWCTKTBRY-UHFFFAOYSA-N omega-Hydroxydodecanoic acid Natural products OCCCCCCCCCCCC(O)=O ZDHCZVWCTKTBRY-UHFFFAOYSA-N 0.000 description 1
- 230000005693 optoelectronics Effects 0.000 description 1
- 235000019236 orange GGN Nutrition 0.000 description 1
- 150000002918 oxazolines Chemical class 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- DGTNSSLYPYDJGL-UHFFFAOYSA-N phenyl isocyanate Chemical compound O=C=NC1=CC=CC=C1 DGTNSSLYPYDJGL-UHFFFAOYSA-N 0.000 description 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-M phenylacetate Chemical compound [O-]C(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-M 0.000 description 1
- 229940049953 phenylacetate Drugs 0.000 description 1
- 238000006303 photolysis reaction Methods 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 229920002454 poly(glycidyl methacrylate) polymer Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920005906 polyester polyol Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001021 polysulfide Polymers 0.000 description 1
- 239000005077 polysulfide Substances 0.000 description 1
- 150000008117 polysulfides Polymers 0.000 description 1
- 239000004175 ponceau 4R Substances 0.000 description 1
- 235000012731 ponceau 4R Nutrition 0.000 description 1
- 235000019238 ponceau 6R Nutrition 0.000 description 1
- 235000019237 ponceau SX Nutrition 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 1
- 229940080818 propionamide Drugs 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical compound OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 239000004180 red 2G Substances 0.000 description 1
- 235000012739 red 2G Nutrition 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 235000019234 riboflavin-5-sodium phosphate Nutrition 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000013020 steam cleaning Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004173 sunset yellow FCF Substances 0.000 description 1
- 235000012751 sunset yellow FCF Nutrition 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 125000005628 tolylene group Chemical group 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- HQYALQRYBUJWDH-UHFFFAOYSA-N trimethoxy(propyl)silane Chemical compound CCC[Si](OC)(OC)OC HQYALQRYBUJWDH-UHFFFAOYSA-N 0.000 description 1
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 1
- 238000004506 ultrasonic cleaning Methods 0.000 description 1
- 239000004108 vegetable carbon Substances 0.000 description 1
- 235000012712 vegetable carbon Nutrition 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 125000006839 xylylene group Chemical group 0.000 description 1
- 235000019235 yellow 2G Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/52—Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
- C09K19/54—Additives having no specific mesophase characterised by their chemical composition
- C09K19/56—Aligning agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L79/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
- C08L79/04—Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
- C08L79/08—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
- G02F1/133711—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
- G02F1/133723—Polyimide, polyamide-imide
Landscapes
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Nonlinear Science (AREA)
- Health & Medical Sciences (AREA)
- Mathematical Physics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Liquid Crystal (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
本发明是一种液晶配向剂,其含有使式(Q)所表示的四羧酸二酐与特定的侧链型二胺反应而所得的聚酰胺酸或其衍生物。该液晶配向剂可形成垂直配向用液晶配向膜。使用该液晶配向膜的液晶显示元件在加热试验中可长时间保持高的电压保持率,且具有减低残留DC的效果。This invention is a liquid crystal aligning agent containing the polyamic acid obtained by making tetracarboxylic dianhydride represented by formula (Q) react with specific side chain type diamine, or its derivative|guide_body. The liquid crystal alignment agent can form a liquid crystal alignment film for vertical alignment. The liquid crystal display element using the liquid crystal alignment film can maintain a high voltage retention rate for a long time in a heating test, and has the effect of reducing residual DC.
Description
技术领域technical field
本发明涉及一种含有使四羧酸二酐与二胺反应而所得的聚酰胺酸或其衍生物的液晶配向剂、由该液晶配向剂而所得的液晶配向膜、以及具有该液晶配向膜的液晶显示元件,特别是涉及一种可适宜地用于不进行物理摩擦处理的液晶显示元件中的液晶配向剂、由该液晶配向剂而所得的液晶配向膜、及具有该液晶配向膜的液晶显示元件。The present invention relates to a liquid crystal alignment agent containing polyamic acid or its derivatives obtained by reacting tetracarboxylic dianhydride with diamine, a liquid crystal alignment film obtained from the liquid crystal alignment agent, and a liquid crystal alignment film with the liquid crystal alignment film Liquid crystal display element, in particular to a liquid crystal alignment agent that can be suitably used in liquid crystal display elements without physical rubbing treatment, a liquid crystal alignment film obtained from the liquid crystal alignment agent, and a liquid crystal display with the liquid crystal alignment film element.
背景技术Background technique
液晶显示元件用于以笔记本电脑(note personal computer)或台式电脑(desktop computer)的显示器(monitor)为首的摄像机(video camera)的取景器(view finder)、投影显示器(projection display)等各种液晶显示装置中,于最近也开始用作电视。另外,还可以用作光打印头(optical printer head)、光学傅里叶变换(optical Fourier transform)元件、光阀(light valve)等光电子相关元件。先前的液晶显示元件的主流是使用向列型液晶的显示元件,且1)扭曲了90度的TN(Twisted Nematic,扭曲向列)型液晶显示元件、2)通常扭曲了180度以上的STN(Super Twisted Nematic,超扭曲向列)型液晶显示元件、3)使用了薄膜晶体管的所谓TFT(Thin Film Transistor,薄膜晶体管)型液晶显示元件已经得到了实用化。Liquid crystal display components are used in various liquid crystals such as viewfinders of video cameras and projection displays, including monitors of note personal computers and desktop computers. Among display devices, it has recently begun to be used as a television. In addition, it can also be used as an optoelectronic related element such as an optical printer head, an optical Fourier transform element, and a light valve. The mainstream of previous liquid crystal display elements is the display element using nematic liquid crystal, and 1) TN (Twisted Nematic, twisted nematic) type liquid crystal display element twisted by 90 degrees, 2) STN ( Super Twisted Nematic (Super Twisted Nematic) type liquid crystal display elements, 3) So-called TFT (Thin Film Transistor, thin film transistor) type liquid crystal display elements using thin film transistors have been put into practical use.
这些液晶显示元件具有如下缺点:可适当地辨视影像的视角窄,且当自斜方向观看时,产生亮度或对比度降低以及半色调的亮度反转。近年来,关于这个视角的问题,利用如下技术进行改良:1)使用了光学补偿膜的TN-TFT型液晶显示元件、2)使用了垂直配向和光学补偿膜的VA(Vertical Alignment,垂直配向)型液晶显示元件、3)并用了垂直配向和突起结构物的技术的MVA(Multi Domain Vertical Alignment,多象限垂直配向)型液晶显示元件、或4)横向电场方式的IPS(In-Plane Switching,共面切换)型液晶显示元件、5)ECB(Electrically Controlled Birefringence,电控双折射)型液晶显示元件、6)光学补偿弯曲(Optically Compensated Bend或Optically self-Compensated Birefringence:OCB)型液晶显示元件等,将这些显示元件实用化,或者正在研究实用化。These liquid crystal display elements have disadvantages in that the viewing angle at which an image can be viewed appropriately is narrow, and when viewed from an oblique direction, a reduction in brightness or contrast and brightness inversion of halftones occur. In recent years, the problem of viewing angle has been improved by using the following technologies: 1) TN-TFT liquid crystal display element using optical compensation film, 2) VA (Vertical Alignment, vertical alignment) using vertical alignment and optical compensation film 3) MVA (Multi Domain Vertical Alignment, multi-quadrant vertical alignment) liquid crystal display element using vertical alignment and protrusion structure technology, or 4) IPS (In-Plane Switching, total Surface switching) type liquid crystal display element, 5) ECB (Electrically Controlled Birefringence, electronically controlled birefringence) type liquid crystal display element, 6) Optically Compensated Bend (Optically Compensated Bend or Optically self-Compensated Birefringence: OCB) type liquid crystal display element, etc., These display elements are being put into practical use, or are being studied for practical use.
液晶显示元件技术的发展,不仅仅是它们的驱动方式和元件结构的改良,而且还可以通过显示元件中所使用的构成部件的改良来达成。在显示元件中所使用的构成部件中,特别是液晶配向膜是关系到液晶显示元件的显示品质的重要因素之一,随着显示元件的高品质化,液晶配向膜的作用逐年变得重要起来。The development of liquid crystal display element technology is not only the improvement of their driving method and element structure, but also can be achieved through the improvement of the components used in the display element. Among the components used in the display element, especially the liquid crystal alignment film is one of the important factors related to the display quality of the liquid crystal display element. With the high quality of the display element, the role of the liquid crystal alignment film becomes more and more important year by year. .
液晶配向膜可由液晶配向剂而制备。现在主要使用的液晶配向剂是使聚酰胺酸或可溶性聚酰亚胺溶解于有机溶剂而成的溶液。将此种溶液涂布于基板上后,利用加热等手段进行成膜而形成聚酰亚胺系配向膜。虽然还研究了聚酰胺酸或可溶性聚酰亚胺以外的各种液晶配向剂,但自耐热性、耐化学品性(耐液晶性)、涂布性、液晶配向性、电气特性、光学特性、显示特性等方面考虑,基本未得到实用化。A liquid crystal alignment film can be prepared from a liquid crystal alignment agent. The liquid crystal alignment agent mainly used at present is a solution obtained by dissolving polyamic acid or soluble polyimide in an organic solvent. After coating such a solution on a substrate, a film is formed by means such as heating to form a polyimide-based alignment film. Although various liquid crystal alignment agents other than polyamic acid and soluble polyimide have been studied, self-heat resistance, chemical resistance (liquid crystal resistance), coatability, liquid crystal alignment, electrical characteristics, optical characteristics Considering aspects such as display characteristics, etc., it has not been practically used.
为了提高液晶显示元件的显示品质而对液晶配向膜所要求的重要特性,可列举电压保持率及残留DC。如果电压保持率低,则在帧时间内对液晶所施加的电压降低,结果导致亮度降低而对正常的谐调显示带来障碍。另一方面,若残留DC大,则即使在施加电压后关闭(OFF)电压,亦产生所谓的“残像(residual image)”即残留了消去的图像。In order to improve the display quality of a liquid crystal display element, the important characteristic requested|required of a liquid crystal alignment film is a voltage retention rate and residual DC. If the voltage retention rate is low, the voltage applied to the liquid crystal during the frame time decreases, resulting in a decrease in luminance, which hinders normal harmonious display. On the other hand, if the residual DC is large, even if the voltage is turned OFF after the voltage is applied, a so-called "residual image" in which an erased image remains remains.
作为解决所述问题的尝试,最近提出了数种方法。As an attempt to solve the problem, several methods have recently been proposed.
(1)已知用以形成液晶配向膜的、将物性不同的两种以上聚酰胺酸组合而使用的聚酰胺酸组成物(参照日本专利特开平11-193345号公报、日本专利特开平11-193347号公报)。(1) Known polyamic acid compositions used in combination of two or more polyamic acids having different physical properties for forming a liquid crystal alignment film (refer to Japanese Patent Laid-Open Publication No. 11-193345, Japanese Patent Laid-Open Publication No. 11- 193347).
(2)已知使用了聚合物成分和溶剂的清漆组成物,其中所述聚合物成分使用了聚酰胺酸和聚酰胺(参照国际公开第00/061684号说明书)。(2) A varnish composition using a polyamic acid and a polyamide as the polymer component and a solvent is known (see WO 00/061684 specification).
(3)已知使用了物性不同的两种以上的聚酰胺酸及聚酰胺、以及溶剂的清漆组成物(参照国际公开第01/000733号说明书)。(3) A varnish composition using two or more types of polyamic acid and polyamide having different physical properties, and a solvent is known (see WO 01/000733 specification).
(4)已知使用了高分子材料的清漆组成物,其中所述高分子材料使用了:使用具有特定结构的胺成分而合成的聚酰胺酸等(日本专利特开2002-162630号公报参照)。(4) A varnish composition using a polymer material using polyamic acid synthesized using an amine component having a specific structure is known (refer to Japanese Patent Application Laid-Open No. 2002-162630 ) .
然而,由于并未对与二胺反应的四羧酸二酐所造成的残留DC的减低进行充分研究,尚存在进一步改善的余地。However, since reduction of residual DC by tetracarboxylic dianhydride reacted with diamine has not been sufficiently studied, there is room for further improvement.
作为四羧酸二酐的发明例,例如,已知使用了二环己烷四羧酸二酐的液晶配向膜,且揭示了使配向膜水平配向且改善低电压驱动面板中的由于密封剂(sealing agents)或封装剂(encapsulant)所造成的液晶污染(参照日本专利特开2000-214467号公报)。As an invention example of tetracarboxylic dianhydride, for example, a liquid crystal alignment film using dicyclohexanetetracarboxylic dianhydride is known, and it is disclosed that the alignment film is horizontally aligned and the sealant ( liquid crystal contamination caused by sealing agents) or encapsulant (refer to Japanese Patent Laid-Open No. 2000-214467).
由此可见,上述现有的液晶配向剂在结构与使用上,显然仍存在有不便与缺陷,而亟待加以进一步改进。为了解决上述存在的问题,相关厂商莫不费尽心思来谋求解决之道,但长久以来一直未见适用的设计被发展完成,而一般产品又没有适切结构能够解决上述问题,此显然是相关业者急欲解决的问题。因此如何能创设一种新型的液晶配向剂、液晶配向膜以及液晶显示元件,实属当前重要研发课题之一,亦成为当前业界极需改进的目标。It can be seen that the above-mentioned existing liquid crystal alignment agents obviously still have inconveniences and defects in structure and use, and need to be further improved. In order to solve the above-mentioned problems, the relevant manufacturers have tried their best to find a solution, but no suitable design has been developed for a long time, and the general products do not have a suitable structure to solve the above-mentioned problems. This is obviously the relevant industry. urgent problem to be solved. Therefore, how to create a new type of liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element is one of the current important research and development topics, and has also become a goal that the industry needs to improve.
发明内容Contents of the invention
本发明的目的在于,克服现有的液晶配向剂存在的缺陷,而提供一种新型的液晶配向剂、液晶配向膜以及液晶显示元件,所要解决的技术问题是提供一种液晶配向剂,所述液晶配向剂可形成液晶显示元件的长期热可靠性优异,即在元件的加热试验中可长时间保持高的电压保持率,且减低液晶显示元件的残留DC的垂直配向用液晶配向膜;另外提供一种使用所述液晶配向剂而形成的液晶配向膜、及使用了该液晶配向膜的液晶显示元件,非常适于实用。The purpose of the present invention is to overcome the defects existing in the existing liquid crystal alignment agent, and provide a new type of liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element, the technical problem to be solved is to provide a kind of liquid crystal alignment agent, said The liquid crystal alignment agent can form a liquid crystal alignment film with excellent long-term thermal reliability of the liquid crystal display element, that is, it can maintain a high voltage retention rate for a long time in the heating test of the element, and reduce the residual DC of the liquid crystal display element. A liquid crystal alignment film formed by using the liquid crystal alignment agent and a liquid crystal display element using the liquid crystal alignment film are very suitable for practical use.
本发明的目的及解决其技术问题是采用以下技术方案来实现的。为达到上述目的,依据本发明提供一种液晶配向剂,所述液晶配向剂可形成液晶显示元件的长期热可靠性优异,即在元件的加热试验中可长时间保持高的电压保持率,且减低液晶显示元件的残留DC的垂直配向用液晶配向膜;另外提供一种使用所述液晶配向剂而形成的液晶配向膜、及使用了该液晶配向膜的液晶显示元件。The purpose of the present invention and the solution to its technical problems are achieved by adopting the following technical solutions. In order to achieve the above object, according to the present invention, a liquid crystal alignment agent is provided, which can form a liquid crystal display element with excellent long-term thermal reliability, that is, it can maintain a high voltage retention rate for a long time in the heating test of the element, and A liquid crystal alignment film for vertical alignment that reduces the residual DC of a liquid crystal display element; and a liquid crystal alignment film formed using the liquid crystal alignment agent, and a liquid crystal display element using the liquid crystal alignment film.
本发明者等人发现:将含有以特定的四羧酸二酐和具有垂直配向侧链的二胺为原料的聚酰胺酸或其衍生物的组成物用于垂直配向用液晶配向剂中,具有由此而形成的液晶配向膜的液晶显示元件的长期热可靠性优异、且残留DC低,从而完成本发明。The inventors of the present invention found that the composition of polyamic acid or its derivatives containing specific tetracarboxylic dianhydride and diamine with vertical alignment side chains as raw materials is used in the liquid crystal alignment agent for vertical alignment, which has the following advantages: The long-term thermal reliability of the liquid crystal display element of the liquid crystal alignment film formed in this way is excellent, and residual DC is low, and this invention was completed.
另外,在发明的详细说明中,将左右不对称的基定义为左右朝向任意方向均可(例如,-COCH=CH-表示“-COCH=CH-”或“-CH=CHCO-”的任一者)。In addition, in the detailed description of the invention, the left-right asymmetric base is defined as left-right orientation in any direction (for example, -COCH=CH- means any of "-COCH=CH-" or "-CH=CHCO-") By).
烷基或亚烷基中的-CH2-被-O-取代时,-O-并不连续。When -CH 2 - in the alkyl or alkylene group is replaced by -O-, -O- is not continuous.
烷基或亚烷基可以为直链或分枝的任一种。An alkyl group or an alkylene group may be either linear or branched.
本发明包括如下的构成。The present invention includes the following configurations.
[1]一种垂直配向用液晶配向剂,其含有式(Q)所表示的四羧酸二酐、与式(V-2)所表示的具有侧链结构的二胺或者与式(V-2)所表示的具有侧链结构的二胺与其他二胺的混合物进行反应而获得的聚酰胺酸或其衍生物,[1] A liquid crystal alignment agent for vertical alignment, which contains a tetracarboxylic dianhydride represented by formula (Q), a diamine with a side chain structure represented by formula (V-2) or a compound with formula (V- 2) the polyamic acid or derivative thereof obtained by reacting the diamine with side chain structure and other diamine mixtures,
在式(V-2)中,In formula (V-2),
X10是单键、-O-、-COO-、-OCO-、-CO-、-CONH-、或-(CH2)m-,m是1~6的整数;X 10 is a single bond, -O-, -COO-, -OCO-, -CO-, -CONH-, or -(CH 2 ) m -, m is an integer of 1 to 6;
Y11是具有类固醇骨架、琥珀酰亚胺(succinimide)骨架、邻苯二甲酰亚胺(phthalimide)骨架或肉桂酸酯(cinnamate)骨架的基或者下述式(XXIII)所表示的基。 Y11 is a group having a steroid skeleton, a succinimide skeleton, a phthalimide skeleton or a cinnamate skeleton, or a group represented by the following formula (XXIII).
在式(XXIII)中,In formula (XXIII),
A4独立为单键、或碳数为1~12的亚烷基,亚烷基的-CH2-也可以被-O-、-NH-或-CO-取代,-CH2CH2-也可以被-CH=CH-、-C≡C-或-N=N-取代,亚烷基的-H也可以被-F、-Cl、-C≡N、-OH、-COOH、-SO3H或-PO3H2取代;A 4 is independently a single bond, or an alkylene group with 1 to 12 carbons, the -CH 2 - of the alkylene group can also be substituted by -O-, -NH- or -CO-, and -CH 2 CH 2 - can also be Can be substituted by -CH=CH-, -C≡C- or -N=N-, the -H of the alkylene group can also be substituted by -F, -Cl, -C≡N, -OH, -COOH, -SO 3 H or -PO 3 H 2 substitution;
Y12独立为-F或-CH3;Y 12 is independently -F or -CH 3 ;
环S独立为1,4-亚苯基、1,4-亚环己基、1,3-二噁烷-2,5-二基、哌啶-1,4-二基、嘧啶-2,5-二基、吡啶-2,5-二基、萘-1,5-二基、萘-2,7-二基、或蒽-9,10-二基;Ring S is independently 1,4-phenylene, 1,4-cyclohexylene, 1,3-dioxane-2,5-diyl, piperidine-1,4-diyl, pyrimidine-2,5 -diyl, pyridine-2,5-diyl, naphthalene-1,5-diyl, naphthalene-2,7-diyl, or anthracene-9,10-diyl;
Y13是-H、-F、-Cl、-C≡N、-OH、-COOH、-SO3H、-PO3H2或碳数为1~30的烷基,烷基的-CH2-也可以被-O-、-NH-或-CO-取代,-CH2CH2-也可以被-CH=CH-、-C≡C-或-N=N-取代,烷基的-H也可以被-F、-Cl、-C≡N、-OH、-COOH、-SO3H或-PO3H2取代;而且,Y 13 is -H, -F, -Cl, -C≡N, -OH, -COOH, -SO 3 H, -PO 3 H 2 or an alkyl group with a carbon number of 1 to 30, and -CH 2 of an alkyl group - can also be substituted by -O-, -NH- or -CO-, -CH 2 CH 2 - can also be substituted by -CH=CH-, -C≡C- or -N=N-, the -H of the alkyl may also be substituted by -F , -Cl, -C≡N, -OH, -COOH, -SO3H , or -PO3H2 ; and,
b独立为0~4的整数,c、d及e独立为0~3的整数,f独立为0~2的整数,且c+d+e≥1。b is independently an integer of 0-4, c, d, and e are independently integers of 0-3, f is independently an integer of 0-2, and c+d+e≥1.
[2]根据第[1]项所述的垂直配向用液晶配向剂,其中,式(V-2)中的Y11是选自下述式(Y11-1)~式(Y11-8)所表示的基的群组的一个。[2] The liquid crystal alignment agent for vertical alignment according to item [1], wherein Y 11 in formula (V-2) is selected from the following formula (Y 11 -1) to formula (Y 11 -8 ) is one of the groups of bases represented by .
在式(Y11-1)~(Y11-8)中,In the formulas (Y 11 -1) to (Y 11 -8),
Y2是-H、-F、碳数为1~30的烷基、碳数为1~30的经氟取代的烷基、碳数为1~30的烷氧基、碳数为2~30的烯基、-C≡N、-OCH2F、-OCHF2或-OCF3; Y2 is -H, -F, alkyl with 1 to 30 carbons, fluorine-substituted alkyl with 1 to 30 carbons, alkoxy with 1 to 30 carbons, 2 to 30 carbons Alkenyl, -C≡N, -OCH 2 F, -OCHF 2 or -OCF 3 ;
A1是-O-或碳数为1~6的亚烷基;而且,A 1 is -O- or an alkylene group with 1 to 6 carbons; and,
A2是-OCO-、-COO-、-O-或碳数为1~6的亚烷基。A 2 is -OCO-, -COO-, -O- or an alkylene group having 1 to 6 carbon atoms.
[3]根据第[1]项所述的垂直配向用液晶配向剂,其中,具有侧链基的二胺是选自下述式(V-2-1)~式(V-2-8)及式(V-2-53)所表示的化合物的群组的至少一种。[3] The liquid crystal alignment agent for vertical alignment according to item [1], wherein the diamine having a side chain group is selected from the following formula (V-2-1) to formula (V-2-8) and at least one of the group of compounds represented by formula (V-2-53).
在式(V-2-2)中,Y2是碳数为6~30的烷基;In formula (V-2-2), Y 2 is an alkyl group with 6 to 30 carbons;
在式(V-2-3)~式(V-2-6)中,Y2是碳数为3~30的烷基;In formula (V-2-3) ~ formula (V-2-6), Y 2 is an alkyl group with a carbon number of 3 to 30;
在式(V-2-7)中,Y2是碳数为2~30的烷基;In formula (V-2-7), Y 2 is an alkyl group with 2 to 30 carbons;
在式(V-2-8)中,Y2是碳数为2~30的烷基;且In formula (V-2-8), Y 2 is an alkyl group with 2 to 30 carbons; and
在式(V-2-53)中,Y18是-F、-CF3或-OCF3。In formula (V-2-53), Y 18 is -F, -CF 3 or -OCF 3 .
[4]根据第[1]项所述的垂直配向用液晶配向剂,其中,二胺是式(V-2)所表示的二胺的至少一种与选自下述式(V-1-1)~式(V-1-5)、式(V-1-14)、式(V-1-15)、式(VI-1-1)~式(VI-1-12)、式(VI-1-28)~式(VI-1-30)、式(VI-1-35)~式(VI-1-39)、式(VII-2-1)、及式(VII-2-2)所表示的二胺的群组的至少一种的混合物。[4] The liquid crystal alignment agent for vertical alignment according to item [1], wherein the diamine is at least one of the diamines represented by the formula (V-2) and selected from the following formula (V-1- 1)~Formula (V-1-5), Formula (V-1-14), Formula (V-1-15), Formula (VI-1-1)~Formula (VI-1-12), Formula ( VI-1-28) ~ formula (VI-1-30), formula (VI-1-35) ~ formula (VI-1-39), formula (VII-2-1), and formula (VII-2- 2) A mixture of at least one of the indicated diamine groups.
[5]根据第[1]项所述的垂直配向用液晶配向剂,其中,使用使式(Q)所表示的四羧酸二酐以及选自下述式(1)、式(2)、式(5)~式(7)及式(12)所表示的芳香族四羧酸的群组的至少一种与二胺反应而获得的聚酰胺酸或其衍生物。[5] The liquid crystal alignment agent for vertical alignment according to item [1], wherein tetracarboxylic dianhydride represented by formula (Q) and a compound selected from the following formula (1), formula (2), Polyamic acid obtained by reacting at least one of the group of aromatic tetracarboxylic acids represented by formula (5) to formula (7) and formula (12) with diamine, or a derivative thereof.
[6]根据第[1]项所述的垂直配向用液晶配向剂,其中,使用使式(Q)所表示的四羧酸二酐以及选自下述式(19)、式(23)、式(25)、式(35)~式(39)、式(44)及式(49)所表示的脂环族四羧酸二酐和脂肪族四羧酸二酐的群组的至少一种与二胺反应而获得的聚酰胺酸或其衍生物。[6] The liquid crystal alignment agent for vertical alignment according to item [1], wherein the tetracarboxylic dianhydride represented by the formula (Q) and the group selected from the following formula (19), formula (23), At least one of the group of alicyclic tetracarboxylic dianhydride and aliphatic tetracarboxylic dianhydride represented by formula (25), formula (35) to formula (39), formula (44) and formula (49) Polyamic acid or its derivatives obtained by reacting with diamine.
[7]根据第[1]项所述的垂直配向用液晶配向剂,其中,二胺是式(V-2)所表示的二胺的至少一种、与选自下述式(VI-11-4)~式(VI-11-16)、式(V-11-2)及式(V-11-17)~式(V-11-19)所表示的具有感光性结构的二胺的群组的至少一种的混合物,且具有光配向性。[7] The liquid crystal alignment agent for vertical alignment according to item [1], wherein the diamine is at least one of the diamines represented by the formula (V-2), and selected from the following formula (VI-11 -4) Diamine having a photosensitive structure represented by formula (VI-11-16), formula (V-11-2) and formula (V-11-17) to formula (V-11-19) A mixture of at least one of the group, and has photoalignment.
[8]根据第[1]项所述的垂直配向用液晶配向剂,其中,二胺是式(V-2)所表示的二胺的至少一种、与选自下述式(VI-11-7)、式(VI-11-11)、式(V-11-2)及式(V-11-17)~式(V-11-19)所表示的具有感光性结构的二胺的群组的至少一种的混合物,且具有光配向性。[8] The liquid crystal alignment agent for vertical alignment according to item [1], wherein the diamine is at least one of the diamines represented by the formula (V-2), and selected from the following formula (VI-11 -7), formula (VI-11-11), formula (V-11-2) and formula (V-11-17) ~ formula (V-11-19) represented by the diamine having a photosensitive structure A mixture of at least one of the group, and has photoalignment.
[9]根据第[1]项~第[8]项中任一项所述的垂直配向用液晶配向剂,其还含有选自经烯基取代的耐地酰亚胺化合物(alkenyl-substituted nadiimide compound)、具有自由基聚合性不饱和双键的化合物、噁嗪化合物、噁唑啉化合物、及环氧化合物的至少一种。[9] The liquid crystal alignment agent for vertical alignment according to any one of items [1] to [8], which further contains alkenyl-substituted nadiimide compound), a compound having a radically polymerizable unsaturated double bond, an oxazine compound, an oxazoline compound, and an epoxy compound.
[10]一种垂直配向用液晶配向膜,其是对根据第[1]项~第[9]项中任一项所述的垂直配向用液晶配向剂的涂膜进行加热而形成的。[10] A liquid crystal alignment film for vertical alignment, which is formed by heating the coating film of the liquid crystal alignment agent for vertical alignment according to any one of items [1] to [9].
[11]一种液晶显示元件,其是包括一对基板、形成于该基板之间的液晶层、对液晶层施加电压的电极、以及使所述液晶分子配向为预定方向的液晶配向膜的液晶显示元件,所述液晶配向膜是根据第[10]项所述的垂直配向用液晶配向膜。[11] A liquid crystal display element, which is a liquid crystal comprising a pair of substrates, a liquid crystal layer formed between the substrates, electrodes for applying a voltage to the liquid crystal layer, and a liquid crystal alignment film for aligning the liquid crystal molecules in a predetermined direction In a display element, the liquid crystal alignment film is the liquid crystal alignment film for vertical alignment according to item [10].
本发明与现有技术相比具有明显的优点和有益效果。借由上述技术方案,本发明(液晶配向剂、液晶配向膜以及液晶显示元件)至少具有下列优点及有益效果:根据本发明,可提供电压保持率的长期热可靠性优异、残留DC低的液晶显示元件。Compared with the prior art, the present invention has obvious advantages and beneficial effects. By means of the above-mentioned technical solution, the present invention (liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element) has at least the following advantages and beneficial effects: According to the present invention, liquid crystals with excellent long-term thermal reliability of voltage retention and low residual DC can be provided. Display components.
上述说明仅是本发明技术方案的概述,为了能够更清楚了解本发明的技术手段,而可依照说明书的内容予以实施,并且为了让本发明的上述和其他目的、特征和优点能够更明显易懂,以下特举较佳实施例,详细说明如下。The above description is only an overview of the technical solution of the present invention. In order to better understand the technical means of the present invention, it can be implemented according to the contents of the description, and in order to make the above and other purposes, features and advantages of the present invention more obvious and understandable , the following special preferred embodiments are described in detail as follows.
具体实施方式Detailed ways
为更进一步阐述本发明为达成预定发明目的所采取的技术手段及功效,以下结合较佳实施例,对依据本发明提出的液晶配向剂、液晶配向膜以及液晶显示元件其具体实施方式、特征及其功效,详细说明如后。In order to further explain the technical means and effects of the present invention to achieve the intended purpose of the invention, the specific implementation methods, characteristics and characteristics of the liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element proposed according to the present invention will be described below in conjunction with preferred embodiments. Its effect is described in detail below.
本发明的液晶配向剂含有四羧酸二酐和二胺的反应生成物聚酰胺酸或其衍生物。所谓聚酰胺酸的衍生物,是在制成含有溶剂的液晶配向剂时溶解于溶剂的成分,且是在将该液晶配向剂制成液晶配向膜时可形成以聚酰亚胺为主成分的液晶配向膜的成分。此种聚酰胺酸的衍生物例如可列举可溶性聚酰亚胺、聚酰胺酸酯、及聚酰胺酸酰胺等。更具体而言,可列举:1)聚酰胺酸的所有胺基与羧基进行脱水闭环反应而成的聚酰亚胺、2)进行部分脱水闭环反应而成的部分聚酰亚胺、3)将聚酰胺酸的羧基转换为酯而成的聚酰胺酸酯、4)将四羧酸二酐化合物中所含的酸二酐的一部分替换为有机二羧酸进行反应而所得的聚酰胺酸-聚酰胺共聚物、另外5)使该聚酰胺酸-聚酰胺共聚物的一部分或全部进行脱水闭环反应而成的聚酰胺酰亚胺。所述聚酰胺酸或其衍生物可单独用于液晶配向剂中,也可以并用多种化合物。The liquid crystal alignment agent of this invention contains the reaction product polyamic acid of tetracarboxylic dianhydride and diamine, or its derivative|guide_body. The so-called derivatives of polyamic acid are components that dissolve in solvents when making liquid crystal alignment agents containing solvents, and can form polyimide-based components when the liquid crystal alignment agents are made into liquid crystal alignment films. Components of liquid crystal alignment film. As for the derivative of such polyamic acid, a soluble polyimide, polyamic acid ester, polyamic acid amide, etc. are mentioned, for example. More specifically, 1) a polyimide in which all amine groups and carboxyl groups of a polyamic acid undergo a dehydration ring-closure reaction, 2) a partial polyimide in which a part of the amine groups and carboxyl groups undergo a dehydration ring-closure reaction, 3) a polyimide in which Polyamic acid ester in which the carboxyl group of polyamic acid is converted to ester, 4) Polyamic acid-polyamic acid obtained by replacing part of the acid dianhydride contained in tetracarboxylic dianhydride compound with organic dicarboxylic acid and reacting An amide copolymer, and 5) a polyamideimide obtained by subjecting part or all of the polyamic acid-polyamide copolymer to a dehydration ring-closure reaction. The polyamic acid or its derivatives may be used alone in a liquid crystal alignment agent, or multiple compounds may be used in combination.
本发明中所使用的四羧酸二酐包含式(Q)所表示的四羧酸二酐。The tetracarboxylic dianhydride used by this invention contains the tetracarboxylic dianhydride represented by formula (Q).
自于液晶显示元件中表现出所期望的电压保持率、且实现其长期热可靠性的观点考虑,优选于构成本发明的液晶配向剂中的聚酰胺酸的酸二酐中含有10mol%~100mol%的式(Q)所表示的四羧酸二酐,更优选含有20mol%~100mol%的式(Q)所表示的四羧酸二酐。From the viewpoint of exhibiting the desired voltage retention rate in the liquid crystal display element and realizing its long-term thermal reliability, it is preferable to contain 10 mol% to 100 mol% of It is more preferable that the tetracarboxylic dianhydride represented by the formula (Q) contains 20 mol% - 100 mol% of the tetracarboxylic dianhydride represented by the formula (Q).
构成本发明的液晶配向剂中的聚酰胺酸的四羧酸二酐除了式(Q)所表示的四羧酸二酐以外,还可以含有芳香族四羧酸二酐。所谓芳香族四羧酸二酐,是两个-CO-O-CO-的至少一个键结在芳香族化合物上的化合物。芳香族四羧酸二酐可例示下述式(1)~式(13)所表示的化合物。The tetracarboxylic dianhydride which comprises the polyamic acid in the liquid crystal aligning agent of this invention may contain aromatic tetracarboxylic dianhydride other than the tetracarboxylic dianhydride represented by formula (Q). The so-called aromatic tetracarboxylic dianhydride is a compound in which at least one of two -CO-O-CO- is bonded to an aromatic compound. As aromatic tetracarboxylic dianhydride, the compound represented by following formula (1) - a formula (13) can be illustrated.
与式(Q)所表示的四羧酸二酐所述一同使用的芳香族四羧酸二酐优选式(1)、式(2)、式(5)~式(7)及式(12)所表示的化合物,更优选式(1)及式(12)所表示的化合物。若并用芳香族四羧酸二酐,则具有提高液晶显示元件的耐光性的效果以及减低残留DC的效果。于构成本发明的液晶配向剂中的聚酰胺酸的所有酸二酐中,优选含有1mol%~90mol%的芳香族四羧酸二酐,更优选含有2mol%~60mol%的芳香族四羧酸二酐。The aromatic tetracarboxylic dianhydride used together with the tetracarboxylic dianhydride represented by formula (Q) is preferably formula (1), formula (2), formula (5) to formula (7) and formula (12) The compounds represented are more preferably compounds represented by formula (1) and formula (12). When an aromatic tetracarboxylic dianhydride is used together, it has the effect of improving the light resistance of a liquid crystal display element, and the effect of reducing residual DC. Among all the acid dianhydrides constituting the polyamic acid in the liquid crystal alignment agent of the present invention, it is preferred to contain 1 mol% to 90 mol% of aromatic tetracarboxylic dianhydride, more preferably 2 mol% to 60 mol% of aromatic tetracarboxylic acid Dianhydride.
构成本发明的液晶配向剂中的聚酰胺酸的四羧酸二酐除了式(Q)所表示的四羧酸二酐以外,还可以含有脂环族四羧酸二酐及/或脂肪族四羧酸二酐。脂环族四羧酸二酐是2个-CO-O-CO-的至少一个键结于脂环族化合物上的化合物。脂肪族四羧酸二酐是2个-CO-O-CO-的至少一个键结于脂肪族化合物上的化合物。脂环族四羧酸二酐可例示下述式(19)~式(22)、式(24)、式(25)、式(27)~式(44)、式(49)~式(58)、及式(62)~式(64)所表示的化合物。The tetracarboxylic dianhydride constituting the polyamic acid in the liquid crystal alignment agent of the present invention may contain alicyclic tetracarboxylic dianhydride and/or aliphatic tetracarboxylic dianhydride in addition to the tetracarboxylic dianhydride represented by formula (Q). Carboxylic dianhydride. The alicyclic tetracarboxylic dianhydride is a compound in which at least one of two -CO-O-CO- is bonded to an alicyclic compound. The aliphatic tetracarboxylic dianhydride is a compound in which at least one of two -CO-O-CO- is bonded to an aliphatic compound. Alicyclic tetracarboxylic dianhydrides can be exemplified by the following formula (19) to formula (22), formula (24), formula (25), formula (27) to formula (44), formula (49) to formula (58) ), and compounds represented by formula (62) to formula (64).
脂肪族四羧酸二酐可例示下述式(23)、式(45)~式(48)、式(66)及式(67)所表示的化合物。As an aliphatic tetracarboxylic dianhydride, the compound represented by following formula (23), formula (45) - formula (48), formula (66), and formula (67) can be illustrated.
脂环族四羧酸二酐及所述脂肪族四羧酸二酐优选式(19)、式(23)、式(25)、式(35)~式(39)、式(44)及式(49)所表示的化合物,更优选式(19)及式(23)所表示的化合物。若并用脂环族四羧酸二酐及/或脂肪族四羧酸二酐,则具有提高液晶显示元件的耐热性的效果以及改善透明性的效果。于构成本发明的液晶配向剂中的聚酰胺酸的所有四羧酸二酐中,优选含有1mol%~90mol%的脂环族四羧酸二酐及/或脂肪族四羧酸二酐,更优选含有10mol%~80mol%的脂环族四羧酸二酐及/或脂肪族四羧酸二酐。Alicyclic tetracarboxylic dianhydride and the preferred formula (19), formula (23), formula (25), formula (35) ~ formula (39), formula (44) and formula The compound represented by (49) is more preferably a compound represented by formula (19) and formula (23). When alicyclic tetracarboxylic dianhydride and/or aliphatic tetracarboxylic dianhydride are used in combination, there is an effect of improving the heat resistance of a liquid crystal display element and an effect of improving transparency. In all tetracarboxylic dianhydrides constituting the polyamic acid in the liquid crystal alignment agent of the present invention, it is preferable to contain 1 mol% to 90 mol% of alicyclic tetracarboxylic dianhydride and/or aliphatic tetracarboxylic dianhydride, more It is preferable to contain 10 mol% - 80 mol% of alicyclic tetracarboxylic dianhydrides and/or aliphatic tetracarboxylic dianhydrides.
本发明中所使用的四羧酸二酐优选含有倍半硅氧烷(silsesquioxane)二酐衍生物。倍半硅氧烷是高度的交联体且不会水解,因此可通过含有倍半硅氧烷而使作为液晶配向剂的保存稳定性优异。而且,即使在成膜后也不水解,因此可形成热可靠性高的液晶配向膜。The tetracarboxylic dianhydride used in the present invention preferably contains a silsesquioxane (silsesquioxane) dianhydride derivative. Since silsesquioxane is a highly cross-linked body and does not hydrolyze, the storage stability as a liquid crystal aligning agent can be made excellent by containing silsesquioxane. Moreover, since it does not hydrolyze even after film formation, the liquid crystal alignment film with high thermal reliability can be formed.
本发明中所使用的倍半硅氧烷二酐例如可使用国际公开第03/024870号说明书中记载的化合物,如下述式所表示。As the silsesquioxane dianhydride used in the present invention, for example, a compound described in International Publication No. 03/024870 can be used, and it is represented by the following formula.
在式(S)中,R分别独立地选自氢、碳数为1~45的烷基、经取代或未经取代的芳基和经取代或未经取代的芳基烷基,Y以下述式(a)或(b)所表示。In formula (S), R is independently selected from hydrogen, alkyl groups with 1 to 45 carbons, substituted or unsubstituted aryl groups and substituted or unsubstituted arylalkyl groups, and Y is represented by the following represented by formula (a) or (b).
式(a)和式(b)中的X分别独立为氢、卤素、羟基或具有酸酐结构(-CO-O-CO-)的1价有机基,X的至少两个是具有酸酐结构(-CO-O-CO-)的1价有机基,Z是-O-、-CH2-或单键。其中,在碳数为1~45的烷基中,任意的氢也可以被氟取代,任意的-CH2-也可以被-O-、-CH=CH-、环亚烷基或环亚烯基取代。经取代或未经取代的芳基烷基中的亚烷基中,任意的氢也可以被氟取代,任意的-CH2-的也可以被-O-、-CH=CH-或环亚烷基取代。X in formula (a) and formula (b) is independently hydrogen, halogen, hydroxyl or monovalent organic group with acid anhydride structure (-CO-O-CO-), at least two of X are with acid anhydride structure (- CO-O-CO-), a monovalent organic group, Z is -O-, -CH 2 - or a single bond. Among them, in the alkyl group with a carbon number of 1 to 45, any hydrogen can also be replaced by fluorine, and any -CH 2 - can also be replaced by -O-, -CH=CH-, cycloalkylene or cycloalkene base substitution. In the alkylene group in the substituted or unsubstituted arylalkyl group, any hydrogen can also be replaced by fluorine, and any -CH 2 - can also be replaced by -O-, -CH=CH- or cycloalkylene base substitution.
在式(S)所表示的倍半硅氧烷二酐中,优选的是下述式(S-1)所表示的化合物。Among the silsesquioxane dianhydrides represented by the formula (S), a compound represented by the following formula (S-1) is preferable.
在式(S-1)中,R与上述式(S)中的R相同。In formula (S-1), R is the same as R in the above formula (S).
若并用倍半硅氧烷二酐,则具有提高液晶显示元件的电压保持率、提高耐光性及耐热性、且减低离子密度的效果。在构成本发明的液晶配向剂中的聚酰胺酸的所有四羧酸二酐中,优选含有1mol%~60mol%的倍半硅氧烷二酐,更优选含有10mol%~40mol%的倍半硅氧烷二酐。When silsesquioxane dianhydride is used together, it has the effect of improving the voltage retention of a liquid crystal display element, improving light resistance and heat resistance, and reducing an ion density. Among all the tetracarboxylic dianhydrides constituting the polyamic acid in the liquid crystal alignment agent of the present invention, it is preferable to contain 1 mol% to 60 mol% of silsesquioxane dianhydride, more preferably 10 mol% to 40 mol% of silsesquioxane Oxyalkylene dianhydride.
与式(Q)所表示的四羧酸二酐并用的四羧酸二酐,在达成本发明的效果的范围内,关于其种类或调配量可任意使用。在本发明中,使用与式(Q)所表示的四羧酸二酐一同使用至少一种其他四羧酸二酐、与二胺反应而成的共聚物,可提高配向剂的保存稳定性而优选。The tetracarboxylic dianhydride used together with the tetracarboxylic dianhydride represented by a formula (Q) can be used arbitrarily about the kind or compounding quantity as long as the effect of this invention is obtained. In the present invention, the use of tetracarboxylic dianhydrides represented by formula (Q) together with at least one other tetracarboxylic dianhydrides and copolymers formed by reacting with diamines can improve the storage stability of the alignment agent. preferred.
与式(Q)所表示的四羧酸二酐并用的四羧酸二酐,也可以将其一部分替换为羧酸酐。通过此种替换,可以产生生成聚酰胺酸时的聚合反应的终止(termination),可以抑制聚合反应的进行。因此,可以容易地控制所得聚合物(聚酰胺酸或其衍生物)的分子量,例如可以不损及本发明的效果地改善液晶配向剂的涂布特性。羧酸酐相对于四羧酸二酐的比率只要在不损及本发明的效果的范围内即可,然而标准优选为总四羧酸二酐量的10mol%以下。羧酸酐只要不损及本发明的效果,则可仅使用一种化合物,也可以使用两种以上。羧酸酐可例示顺丁烯二酸酐、邻苯二甲酸酐、衣康酸酐、正癸基琥珀酸酐、正十二烷基琥珀酸酐、正十四烷基琥珀酸酐、正十六烷基琥珀酸酐、及环己二羧酸酐。The tetracarboxylic dianhydride used together with the tetracarboxylic dianhydride represented by formula (Q) may replace a part with carboxylic anhydride. By such substitution, the termination (termination) of the polymerization reaction at the time of producing a polyamic acid can arise, and progress of a polymerization reaction can be suppressed. Therefore, the molecular weight of the obtained polymer (polyamic acid or its derivative) can be controlled easily, for example, the coating characteristic of a liquid crystal alignment agent can be improved without impairing the effect of this invention. The ratio of carboxylic acid anhydride to tetracarboxylic dianhydride should just be in the range which does not impair the effect of this invention, However, It is preferable that it is 10 mol% or less of the total tetracarboxylic dianhydride amount as a standard. As long as the effect of the present invention is not impaired, only one kind of compound may be used for the carboxylic anhydride, or two or more kinds may be used. Examples of the carboxylic acid anhydride include maleic anhydride, phthalic anhydride, itaconic anhydride, n-decyl succinic anhydride, n-dodecyl succinic anhydride, n-tetradecyl succinic anhydride, n-hexadecyl succinic anhydride, and cyclohexanedicarboxylic anhydride.
所述与式(Q)所表示的四羧酸二酐并用的四羧酸二酐,也可以在二羧酸相对于四羧酸二酐的比率为10mol%以下的范围内,将其一部分替换为二羧酸。二羧酸只要不损及本发明的效果,可以是一种,也可以使用两种以上。The tetracarboxylic dianhydride used together with the tetracarboxylic dianhydride represented by the formula (Q) may be partially replaced within the range where the ratio of the dicarboxylic acid to the tetracarboxylic dianhydride is 10 mol% or less. For dicarboxylic acids. As long as the effects of the present invention are not impaired, dicarboxylic acids may be used alone or in combination of two or more.
构成本发明的液晶配向剂中的聚酰胺酸或其衍生物的、与式(Q)所表示的四羧酸二酐反应的二胺是下述式(V-2)所表示的具有侧链结构的化合物。The diamine reacted with the tetracarboxylic dianhydride represented by the formula (Q) that constitutes the polyamic acid or its derivatives in the liquid crystal alignment agent of the present invention has a side chain represented by the following formula (V-2): Structured compounds.
在式(V-2)中,In formula (V-2),
X10是单键、-O-、-COO-、-OCO-、-CO-、-CONH-或-(CH2)m-,m是1~6的整数,X 10 is a single bond, -O-, -COO-, -OCO-, -CO-, -CONH- or -(CH 2 ) m -, m is an integer of 1 to 6,
Y11是具有类固醇骨架、琥珀酰亚胺骨架、邻苯二甲酰亚胺骨架、或肉桂酸酯骨架的基或者下述式(XXIII)所表示的基, Y11 is a group having a steroid skeleton, a succinimide skeleton, a phthalimide skeleton, or a cinnamate skeleton or a group represented by the following formula (XXIII),
在式(XXIII)中,A4独立为单键、或碳数为1~12的亚烷基,亚烷基的-CH2-也可以被-O-、-NH-或-CO-取代,-CH2CH2-也可以被-CH=CH-、-C≡C-或-N=N-取代,亚烷基的-H也可以被-F、-Cl、-C≡N、-OH、-COOH、-SO3H或-PO3H2取代,In formula (XXIII), A 4 is independently a single bond, or an alkylene group with 1 to 12 carbons, and -CH 2 - of the alkylene group can also be substituted by -O-, -NH- or -CO-, -CH 2 CH 2 - can also be substituted by -CH=CH-, -C≡C- or -N=N-, and the -H of the alkylene group can also be substituted by -F, -Cl, -C≡N, -OH , -COOH, -SO 3 H or -PO 3 H 2 substitution,
Y12独立为-F或-CH3,Y 12 is independently -F or -CH 3 ,
环S独立为1,4-亚苯基、1,4-亚环己基、1,3-二噁烷-2,5-二基、哌啶-1,4-二基、嘧啶-2,5-二基、吡啶-2,5-二基、萘-1,5-二基、萘-2,7-二基、或蒽-9,10-二基,Ring S is independently 1,4-phenylene, 1,4-cyclohexylene, 1,3-dioxane-2,5-diyl, piperidine-1,4-diyl, pyrimidine-2,5 -diyl, pyridine-2,5-diyl, naphthalene-1,5-diyl, naphthalene-2,7-diyl, or anthracene-9,10-diyl,
Y13是-H、-F、-Cl、-C≡N、-OH、-COOH、-SO3H、-PO3H2或碳数为1~30的烷基,烷基的-CH2-也可以被-O-、-NH-或-CO-取代,-CH2CH2-也可以被-CH=CH-、-C≡C-或-N=N-取代,烷基的-H也可以被-F、-Cl、-C≡N、-OH、-COOH、-SO3H或-PO3H2取代,Y 13 is -H, -F, -Cl, -C≡N, -OH, -COOH, -SO 3 H, -PO 3 H 2 or an alkyl group with a carbon number of 1 to 30, and -CH 2 of an alkyl group - can also be substituted by -O-, -NH- or -CO-, -CH 2 CH 2 - can also be substituted by -CH=CH-, -C≡C- or -N=N-, the -H of the alkyl Can also be substituted by -F, -Cl, -C≡N, -OH, -COOH, -SO 3 H or -PO 3 H 2 ,
b独立为0~4的整数,c、d及e独立为0~3的整数,f独立为0~2的整数,且c+d+e≥1。b is independently an integer of 0-4, c, d, and e are independently integers of 0-3, f is independently an integer of 0-2, and c+d+e≥1.
式(V-2)所表示的二胺优选为Y11是选自下述式(Y11-1)~式(Y11-8)所表示的基的群组的一个的化合物。The diamine represented by formula (V-2) is preferably a compound in which Y 11 is one compound selected from the group represented by the following formula (Y 11 -1) to formula (Y 11 -8).
在式(Y11-1)~式(Y11-8)中,In formula (Y 11 -1) ~ formula (Y 11 -8),
Y2是-H、-F、碳数为1~30的烷基、碳数为1~30的经氟取代的烷基、碳数为1~30的烷氧基、碳数为2~30的烯基、-C≡N、-OCH2F、-OCHF2、或-OCF3, Y2 is -H, -F, alkyl with 1 to 30 carbons, fluorine-substituted alkyl with 1 to 30 carbons, alkoxy with 1 to 30 carbons, 2 to 30 carbons Alkenyl, -C≡N, -OCH 2 F, -OCHF 2 , or -OCF 3 ,
A1是-O-或碳数为1~6的亚烷基,而且,A 1 is -O- or an alkylene group having 1 to 6 carbon atoms, and,
A2是-OCO-、-COO-、-O-或碳数为1~6的亚烷基。A 2 is -OCO-, -COO-, -O- or an alkylene group having 1 to 6 carbon atoms.
式(V-2)所表示的二胺的例子是以下的式(V-2-1)~式(V-2-54)所表示的化合物。Examples of the diamine represented by formula (V-2) are compounds represented by the following formula (V-2-1) to formula (V-2-54).
在式(V-2-1)~(V-2-54)中,In the formulas (V-2-1) to (V-2-54),
Y2独立为-H、-F、碳数为1~30的烷基、碳数为1~30的经氟取代的烷基、碳数为1~30的烷氧基、碳数为2~30的烯基、-C≡N、-OCH2F、-OCHF2或-OCF3,优选独立为-H、碳数为1~20的烷基或碳数为2~20的烯基, Y2 is independently -H, -F, alkyl with 1 to 30 carbons, fluorine-substituted alkyl with 1 to 30 carbons, alkoxy with 1 to 30 carbons, and 2 to 30 carbons 30 alkenyl, -C≡N, -OCH 2 F, -OCHF 2 or -OCF 3 , preferably independently -H, alkyl with 1 to 20 carbons or alkenyl with 2 to 20 carbons,
Y5独立为碳数为1~30的烷基、或碳数为2~30的烯基, Y5 is independently an alkyl group with 1 to 30 carbons, or an alkenyl group with 2 to 30 carbons,
Y16独立为-H、碳数为1~30的烷基、碳数为1~29的烷氧基、或碳数为2~30的烯基,而且, Y16 is independently -H, an alkyl group with 1 to 30 carbons, an alkoxy group with 1 to 29 carbons, or an alkenyl group with 2 to 30 carbons, and,
Y18是-F、-CF3或-OCF3。Y 18 is -F, -CF 3 or -OCF 3 .
式(V-2)所表示的二胺优选为选自上述式(V-2-2)~式(V-2-8)及式(V-2-53)所表示的化合物的群组的至少一种。The diamine represented by formula (V-2) is preferably selected from the group of compounds represented by the above-mentioned formula (V-2-2) to formula (V-2-8) and formula (V-2-53). at least one.
在式(V-2-2)中,Y2优选为碳数为6~30的烷基,更优选为碳数为9~20的烷基。In formula (V-2-2), Y 2 is preferably an alkyl group having 6 to 30 carbon atoms, more preferably an alkyl group having 9 to 20 carbon atoms.
在式(V-2-3)~(V-2-6)中,Y2优选为碳数为3~30的烷基,更优选为碳数为5~20的烷基。In formulas (V-2-3) to (V-2-6), Y 2 is preferably an alkyl group having 3 to 30 carbon atoms, more preferably an alkyl group having 5 to 20 carbon atoms.
在式(V-2-7)中,Y2优选为碳数为2~30的烷基,更优选为碳数为4~25的烷基。In formula (V-2-7), Y 2 is preferably an alkyl group having 2 to 30 carbon atoms, more preferably an alkyl group having 4 to 25 carbon atoms.
在式(V-2-8)中,Y2优选为碳数为2~30的烷基,更优选为碳数为2~12的烷基。而且,In the formula (V-2-8), Y 2 is preferably an alkyl group having 2 to 30 carbon atoms, more preferably an alkyl group having 2 to 12 carbon atoms. and,
式(V-2-53)中的Y18是-F、-CF3或-OCF3。Y 18 in formula (V-2-53) is -F, -CF 3 or -OCF 3 .
与式(V-2)所表示的二胺并用,与式(Q)所表示的四羧酸二酐反应的其他二胺可根据要求的特性而适宜使用。于用于本发明的垂直配向用液晶配向剂的情况下,优选使用与式(V-2)所表示的二胺同样地具有配向性侧链结构的二胺。所谓具有配向性侧链结构的二胺,是在将连结2个胺基的取代基作为主链时,具有自主链分枝的取代基(侧链),且具有对液晶表现出垂直配向性或预倾角的性质的二胺。侧链可根据所要求的配向性而适宜选择。并用的二胺中,也可以在不损及本发明的效果的范围内,选择不具有配向性侧链结构的化合物。本发明的液晶配向剂可根据并用而使用的二胺的结构,而应用于TN或IPS液晶显示元件中。The diamine represented by formula (V-2) can be used in combination, and other diamines reacted with tetracarboxylic dianhydride represented by formula (Q) can be used suitably according to the required characteristic. When using the liquid crystal aligning agent for vertical alignment of this invention, it is preferable to use the diamine which has an alignment side chain structure similarly to the diamine represented by formula (V-2). The so-called diamine having an alignment side chain structure refers to a substituent (side chain) branching from the main chain when the substituent linking two amine groups is used as the main chain, and has a vertical alignment or Pretilt properties of diamines. The side chain can be appropriately selected according to the required alignment. Among the diamines used in combination, a compound not having an aligning side chain structure may be selected within the range not impairing the effect of the present invention. The liquid crystal alignment agent of the present invention can be applied to a TN or IPS liquid crystal display element depending on the structure of the diamine used in combination.
可于本发明中使用的其他二胺,可根据所要求的特性而适宜选择,可列举式(II-1)、式(III-1)、式(IV-1)、式(V-1)、式(V-11)、式(VI-1)、式(VI-2)、式(VI-3)、式(VI-11)、式(VI-12)、式(VII-1)、式(VII-2)、式(VII-3)、式(VII-11)、式(VII-12)、式(VIII-1)、式(VIII-2)、式(VIII-3)、式(VIII-4)、式(VIII-11)或式(IX-1)所表示的化合物。Other diamines that can be used in the present invention can be appropriately selected according to the required properties, and examples include formula (II-1), formula (III-1), formula (IV-1), and formula (V-1) , formula (V-11), formula (VI-1), formula (VI-2), formula (VI-3), formula (VI-11), formula (VI-12), formula (VII-1), Formula (VII-2), Formula (VII-3), Formula (VII-11), Formula (VII-12), Formula (VIII-1), Formula (VIII-2), Formula (VIII-3), Formula (VIII-4), a compound represented by formula (VIII-11) or formula (IX-1).
在这些二胺中,在2个胺基键结于相同的六员环的碳上的情况下,优选相互间位或对位键结。Among these diamines, when two amine groups are bonded to the same carbon of the six-membered ring, they are preferably bonded to each other at the meta-position or para-position.
于式(II-1)、式(III-1)、式(IV-1)、式(V-1)、式(V-11)、式(VI-1)、式(VI-2)、式(VI-3)、式(VI-11)、式(VI-12)、式(VII-1)、式(VII-2)、式(VII-12)、式(VII-3)、式(VII-11)、式(VIII-1)、式(VIII-2)、式(VIII-3)、式(VIII-4)、式(VIII-11)及式(IX-1)中,In formula (II-1), formula (III-1), formula (IV-1), formula (V-1), formula (V-11), formula (VI-1), formula (VI-2), Formula (VI-3), Formula (VI-11), Formula (VI-12), Formula (VII-1), Formula (VII-2), Formula (VII-12), Formula (VII-3), Formula In (VII-11), formula (VIII-1), formula (VIII-2), formula (VIII-3), formula (VIII-4), formula (VIII-11) and formula (IX-1),
X11独立为碳数为1~12的亚烷基,亚烷基上的-H也可以被碳数为1~10的烷基取代,X 11 is independently an alkylene group with 1 to 12 carbons, and -H on the alkylene group can also be substituted by an alkyl group with 1 to 10 carbons,
X5独立为-COCH=CH-、-N=N-或-C≡C-,X is independently -COCH=CH-, -N=N- or -C≡C-,
X6独立为单键、-O-、-S-、-S-S-、-SO2-、-CO-、-CONH-、-COO-、-NH-、-N(CH3)-(CH2)m-N(CH3)-、-C(CH3)2-、-C(CF3)2-、-(CH2)m-、-O-(CH2)m-O-、-S-(CH2)m-S-、-COCH=CH-、-N=N-或-C≡C-,而且,X 6 is independently a single bond, -O-, -S-, -SS-, -SO 2 -, -CO-, -CONH-, -COO-, -NH-, -N(CH 3 )-(CH 2 ) m -N(CH 3 )-, -C(CH 3 ) 2 -, -C(CF 3 ) 2 -, -(CH 2 ) m -, -O-(CH 2 ) m -O-, -S -(CH 2 ) m -S-, -COCH=CH-, -N=N- or -C≡C-, and,
m是1~6的整数,m is an integer of 1 to 6,
X7独立为亚甲基、亚苯基,亚苯基的-H也可以被碳数为1~30的烷基取代, X7 is independently methylene or phenylene, and the -H of phenylene can also be substituted by an alkyl group with 1 to 30 carbons,
X8独立为单键或碳数为1~3的亚烷基, X8 is independently a single bond or an alkylene group with 1 to 3 carbons,
X9独立为单键、1,4-亚苯基或1,4-亚环己基, X is independently a single bond, 1,4-phenylene or 1,4-cyclohexylene,
X10为单键、-O-、-COO-、-CO-、-CONH-、-(CH2)m-、-CHY2-、-C(Y2)2-或-NY2-,而且,X 10 is a single bond, -O-, -COO-, -CO-, -CONH-, -(CH 2 ) m -, -CHY 2 -, -C(Y 2 ) 2 - or -NY 2 -, and ,
m是1~6的整数,m is an integer of 1 to 6,
a对应于Y2、Y3、Y4、Y7及Y14键结的原子或环结构而为0~4的整数,a is an integer of 0 to 4 corresponding to the atoms or ring structures to which Y 2 , Y 3 , Y 4 , Y 7 and Y 14 are bonded,
1为1~10的整数,1 is an integer from 1 to 10,
Y2独立为-H、碳数为1~20的烷基、或碳数为2~20的烯基, Y2 is independently -H, an alkyl group with a carbon number of 1 to 20, or an alkenyl group with a carbon number of 2 to 20,
Y3独立为-H、-F、-Cl、-Br、-C≡N、-OH、-COOH、-SO3H、或-PO3H2或碳数为1~2的烷基, Y3 is independently -H, -F, -Cl, -Br, -C≡N, -OH, -COOH, -SO 3 H, or -PO 3 H 2 or an alkyl group with 1 to 2 carbons,
Y3为多个存在时,亦可相互键结而形成环,When Y3 exists in plural, they may be bonded to each other to form a ring,
Y4独立为苄基、-H、-F、-Cl、-OH、-COOH、-SO3H、-PO3H2、-NHY5、或-N(Y5)2,Y 4 is independently benzyl, -H, -F, -Cl, -OH, -COOH, -SO 3 H, -PO 3 H 2 , -NHY 5 , or -N(Y 5 ) 2 ,
Y5独立为碳数为1~20的烷基、或碳数为2~20的烯基, Y5 is independently an alkyl group with 1 to 20 carbons, or an alkenyl group with 2 to 20 carbons,
Y6独立为碳数为1~3的烷基或苯基, Y6 is independently an alkyl or phenyl group with 1 to 3 carbons,
Y7独立为碳数为1~30的烷基、环己基、或联环己基,环己基或联环己基的-H也可以被碳数为1~30的烷基取代。Y 7 is independently an alkyl group with 1 to 30 carbons, cyclohexyl, or bicyclohexyl, and -H of the cyclohexyl or bicyclohexyl may be substituted with an alkyl group with 1 to 30 carbons.
Y8为-H或碳数为1~30的烷基, Y8 is -H or an alkyl group with 1 to 30 carbons,
烷基的-CH2-也可以被-O-、-NH-或-CO-取代,The -CH 2 - of the alkyl group can also be substituted by -O-, -NH- or -CO-,
烷基的-CH2CH2-也可以被-CH=CH-、-C≡C-或-N=N-取代,The -CH 2 CH 2 - of the alkyl group may also be substituted by -CH=CH-, -C≡C- or -N=N-,
烷基的-H也可以被-F、-Cl、-Br、-C≡N、-OH、-COOH、-SO3H或-PO3H2取代。The -H of the alkyl group may also be substituted by -F, -Cl, -Br, -C≡N, -OH, -COOH, -SO3H or -PO3H2 .
Y9为碳数为6~30的烷基, Y9 is an alkyl group with a carbon number of 6 to 30,
Y10为碳数为1~30的烷基。Y 10 is an alkyl group having 1 to 30 carbon atoms.
Y17为-H、-F、-Cl、-Br、-C≡N、-OH、-COOH、-SO3H、-PO3H2或碳数为1~20的烷基,Y 17 is -H, -F, -Cl, -Br, -C≡N, -OH, -COOH, -SO 3 H, -PO 3 H 2 or an alkyl group with 1 to 20 carbons,
烷基的-CH2-也可以被-O-、-NH-或-CO-取代,The -CH 2 - of the alkyl group can also be substituted by -O-, -NH- or -CO-,
烷基的-CH2CH2-也可以被-CH=CH-、-C≡C-或-N=N-取代,The -CH 2 CH 2 - of the alkyl group may also be substituted by -CH=CH-, -C≡C- or -N=N-,
烷基的-H也可以被-F、-Cl、-Br、-C≡N、-OH、-COOH、-SO3H或-PO3H2取代。The -H of the alkyl group may also be substituted by -F, -Cl, -Br, -C≡N, -OH, -COOH, -SO3H or -PO3H2 .
Y11为:具有类固醇骨架、琥珀酰亚胺骨架或邻苯二甲酰亚胺骨架的基或者下述式(XXIII)所表示的基, Y11 is: a group having a steroid skeleton, a succinimide skeleton or a phthalimide skeleton or a group represented by the following formula (XXIII),
在式(XXIII)中,In formula (XXIII),
环上的-H也可以被-F、-Cl、-OH、-COOH、-SO3H、-PO3H2、碳数为1~30的烷基、或苯基取代,-H on the ring can also be substituted by -F, -Cl, -OH, -COOH, -SO 3 H, -PO 3 H 2 , alkyl with 1 to 30 carbons, or phenyl,
烷基的-CH2-也可以被-O-、-NH-或-CO-取代,The -CH 2 - of the alkyl group can also be substituted by -O-, -NH- or -CO-,
烷基的-CH2CH2-也可以被-CH=CH-、-C≡C-或-N=N-取代,The -CH 2 CH 2 - of the alkyl group may also be substituted by -CH=CH-, -C≡C- or -N=N-,
烷基的-H也可以被-F、-Cl、-Br、-C≡N、-OH、-COOH、-SO3H或-PO3H2取代,The -H of the alkyl group may also be substituted by -F, -Cl, -Br, -C≡N, -OH, -COOH, -SO3H or -PO3H2 ,
苯基的-H也可以独立地被-F、-Cl、-Br、-C≡N、-CH3、-OCH3、-OCH2F、-OCHF2、-OCF3、-OH、-COOH、-SO3H或-PO3H2取代。The -H of phenyl can also be independently replaced by -F, -Cl, -Br, -C≡N, -CH 3 , -OCH 3 , -OCH 2 F, -OCHF 2 , -OCF 3 , -OH, -COOH , -SO 3 H or -PO 3 H 2 substitution.
A4独立为单键、或碳数为1~12的亚烷基, A4 is independently a single bond or an alkylene group with 1 to 12 carbons,
亚烷基的-CH2-也可以被-O-、-NH-或-CO-取代,The -CH 2 - of the alkylene group can also be substituted by -O-, -NH- or -CO-,
亚烷基的-CH2CH2-也可以被-CH=CH-、-C≡C-或-N=N-取代,The -CH 2 CH 2 - of the alkylene group may also be substituted by -CH=CH-, -C≡C- or -N=N-,
亚烷基的-H也可以被-F、-Cl、-Br、-C≡N、-OH、-COOH、-SO3H或-PO3H2取代。-H of the alkylene group may also be substituted by -F, -Cl, -Br, -C≡N, -OH, -COOH, -SO 3 H or -PO 3 H 2 .
Y12独立为-F或CH3,Y 12 is independently -F or CH 3 ,
环S独立为环己烷、1,3-二噁烷、哌啶、哌嗪、吡咯啶、亚苯基、吡啶、吡嗪、哒嗪、嘧啶、三嗪、吡咯、呋喃、噻吩、咪唑、噁唑、噻唑、三唑、萘、蒽、吲哚、类固醇、或六氢呋喃并[3.2-b]呋喃,Ring S is independently cyclohexane, 1,3-dioxane, piperidine, piperazine, pyrrolidine, phenylene, pyridine, pyrazine, pyridazine, pyrimidine, triazine, pyrrole, furan, thiophene, imidazole, Oxazole, thiazole, triazole, naphthalene, anthracene, indole, steroid, or hexahydrofuro[3.2-b]furan,
b独立为0~1的整数,c、d及e独立为0~3的整数,f独立为0~4的整数,c+d+e≥1且6≥b+c+d+e。b is independently an integer of 0 to 1, c, d and e are independently an integer of 0 to 3, f is independently an integer of 0 to 4, c+d+e≥1 and 6≥b+c+d+e.
Y13为-H、-F、-Cl、-Br、-C≡N、-OH、-COOH、-SO3H、-PO3H2或碳数为1~30的烷基,Y 13 is -H, -F, -Cl, -Br, -C≡N, -OH, -COOH, -SO 3 H, -PO 3 H 2 or an alkyl group with 1 to 30 carbons,
烷基的-CH2-也可以被-O-、-NH-或-CO-取代,The -CH 2 - of the alkyl group can also be substituted by -O-, -NH- or -CO-,
烷基的-CH2CH2-也可以被-CH=CH-、-C≡C-或-N=N-取代,The -CH 2 CH 2 - of the alkyl group may also be substituted by -CH=CH-, -C≡C- or -N=N-,
烷基的-H也可以被-F、-Cl、-Br、-C≡N、-OH、-COOH、-SO3H或-PO3H2取代。The -H of the alkyl group may also be substituted by -F, -Cl, -Br, -C≡N, -OH, -COOH, -SO3H or -PO3H2 .
Y14独立地表示下述通式(XXI),Y 14 independently represents the following general formula (XXI),
~A1-A1-A1-A1-A1-A1-A2 (XXI)~A 1 -A 1 -A 1 -A 1 -A 1 -A 1 -A 2 (XXI)
A1独立地表示单键、碳数为1~12的亚烷基、或构成骨架的碳、氮、及氧各自的原子数的和为3~30的环, A1 independently represents a single bond, an alkylene group having 1 to 12 carbons, or a ring in which the sum of the respective atomic numbers of carbon, nitrogen, and oxygen constituting the skeleton is 3 to 30,
亚烷基中的-CH2-也可以被-O-、-NH-、-CO-、-CHY2-、-C(Y2)2-或NY2-取代,-CH 2 - in the alkylene group can also be substituted by -O-, -NH-, -CO-, -CHY 2 -, -C(Y 2 ) 2 - or NY 2 -,
Y2独立地表示-H、碳数为1~30的烷基、碳数为1~29的烷氧基、或碳数为2~30的烯基, Y2 independently represents -H, an alkyl group with 1 to 30 carbons, an alkoxy group with 1 to 29 carbons, or an alkenyl group with 2 to 30 carbons,
-CH2CH2-也可以被-CH=CH-、-C≡C-或N=N-取代,-CH 2 CH 2 - may also be substituted by -CH=CH-, -C≡C- or N=N-,
亚烷基的-H也可以被-F、-Cl、-C≡N、-OH、-COOH、-SO3H或PO3H2取代,The -H of the alkylene group can also be substituted by -F, -Cl, -C≡N, -OH, -COOH, -SO 3 H or PO 3 H 2 ,
环的-H也可以被-F、-Cl、-C≡N、-OH、-COOH、-SO3H、-PO3H2或下述通式(XXII)取代,The -H of the ring can also be substituted by -F, -Cl, -C≡N, -OH, -COOH, -SO 3 H, -PO 3 H 2 or the following general formula (XXII),
~A3-A3-A3-A2 (XXI)~A 3 -A 3 -A 3 -A 2 (XXI)
A3独立地表示单键、直链或分枝的碳数为1~12的亚烷基、或构成骨架的碳、氮、及氧各自的原子数的和为3~30的环, A3 independently represents a single bond, a linear or branched alkylene group having 1 to 12 carbon atoms, or a ring in which the total number of atoms of carbon, nitrogen, and oxygen constituting the skeleton is 3 to 30,
亚烷基的-CH2-也可以被-O-、-NH-、-CO-、-CHY2-、-C(Y2)2-或NY2-取代,The -CH 2 - of the alkylene group can also be substituted by -O-, -NH-, -CO-, -CHY 2 -, -C(Y 2 ) 2 - or NY 2 -,
Y2独立地表示-H、碳数为1~20的烷基、碳数为1~19的烷氧基、或碳数为2~20的烯基, Y2 independently represents -H, an alkyl group with 1 to 20 carbons, an alkoxy group with 1 to 19 carbons, or an alkenyl group with 2 to 20 carbons,
-CH2CH2-也可以被-CH=CH-、-C≡C-或N=N-取代,-CH 2 CH 2 - may also be substituted by -CH=CH-, -C≡C- or N=N-,
亚烷基的-H也可以被-F、-Cl、-C≡N、-OH、-COOH、-SO3H或PO3H2取代,The -H of the alkylene group can also be substituted by -F, -Cl, -C≡N, -OH, -COOH, -SO 3 H or PO 3 H 2 ,
环的-H也可以被-F、-Cl、-C≡N、-OH、-COOH、-SO3H或PO3H2取代, The -H of the ring may also be substituted by -F, -Cl, -C≡N, -OH, -COOH, -SO3H or PO3H2 ,
A2独立地表示-H、-F、-Cl、-C≡N、-OH、-COOH、-SO3H、-PO3H2、或直链或分枝的碳数为1~40的烷基,A 2 independently represents -H, -F, -Cl, -C≡N, -OH, -COOH, -SO 3 H, -PO 3 H 2 , or straight or branched carbon number of 1 to 40 alkyl,
烷基中的-CH2-也可以被-O-、-NH-或CO-取代,-CH 2 - in the alkyl group can also be substituted by -O-, -NH- or CO-,
-CH2CH2-也可以被-CH=CH-、-C≡C-或N=N-取代,-CH 2 CH 2 - may also be substituted by -CH=CH-, -C≡C- or N=N-,
烷基的-H也可以被-F、-Cl、-OH、-COOH、-SO3H或PO3H2取代,The -H of the alkyl group can also be substituted by -F, -Cl, -OH, -COOH, -SO 3 H or PO 3 H 2 ,
其中,Y14的至少一个是包含-COCH=CH-、-N=N-或C≡C-的基,而且,wherein at least one of Y 14 is a group comprising -COCH=CH-, -N=N- or C≡C-, and,
在式(II-1)、式(III-1)、式(IV-1)、式(V-1)、式(V-11)、式(VI-1)、式(VI-2)、式(VI-3)、式(VI-11)、式(VI-12)、式(VII-1)、式(VII-2)、式(VII-12)、式(VII-3)、式(VII-11)、式(VIII-1)、式(VIII-2)、式(VIII-3)、式(VIII-4)、式(VIII-11)、及式(IX-1)中,苯环也可以被哌嗪环、哌啶环、吡咯啶环、吡咯环、呋喃环、噻吩环、咪唑环、噁唑环、噻唑环、三唑环、吡啶环、吡嗪环、哒嗪环、嘧啶环、三嗪环、吲哚环、类固醇环、双环[2.2.1]庚烷环、双环[2.2.2]辛烷环、或六氢呋喃并[3.2-b]呋喃环取代。In formula (II-1), formula (III-1), formula (IV-1), formula (V-1), formula (V-11), formula (VI-1), formula (VI-2), Formula (VI-3), Formula (VI-11), Formula (VI-12), Formula (VII-1), Formula (VII-2), Formula (VII-12), Formula (VII-3), Formula In (VII-11), formula (VIII-1), formula (VIII-2), formula (VIII-3), formula (VIII-4), formula (VIII-11), and formula (IX-1), The benzene ring can also be replaced by a piperazine ring, piperidine ring, pyrrolidine ring, pyrrole ring, furan ring, thiophene ring, imidazole ring, oxazole ring, thiazole ring, triazole ring, pyridine ring, pyrazine ring, pyridazine ring , pyrimidine ring, triazine ring, indole ring, steroid ring, bicyclo[2.2.1]heptane ring, bicyclo[2.2.2]octane ring, or hexahydrofuro[3.2-b]furan ring.
其他二胺更具体而言可列举下述式所表示的化合物。As other diamine, the compound represented by the following formula is mentioned more specifically.
式(II-1)所表示的二胺可例示下述式(II-1-1)~式(II-1-4)所表示的化合物。The diamine represented by a formula (II-1) can illustrate the compound represented by following formula (II-1-1) - a formula (II-1-4).
H2N-(CH2)2-NH2 H2N-(CH2)4-NH2 H2N-(CH2)4-NH2 H2N-(CH2)12-NH2 H 2 N-(CH 2 ) 2 -NH 2 H 2 N-(CH 2 ) 4 -NH 2 H 2 N-(CH 2 ) 4 -NH 2 H 2 N-(CH 2 ) 12 -NH 2
(II-1-1) (II-1-2) (II-1-3) (II-1-4)(II-1-1) (II-1-2) (II-1-3) (II-1-4)
式(III-1)所表示的二胺可例示下述式(III-1-1)及式(III-1-2)所表示的化合物。Examples of the diamine represented by formula (III-1) include compounds represented by the following formula (III-1-1) and formula (III-1-2).
式(IV-1)所表示的二胺可例示式(IV-1-1)~式(IV-1-3)所表示的化合物。The diamine represented by formula (IV-1) can illustrate the compound represented by formula (IV-1-1) - a formula (IV-1-3).
式(V-1)所表示的二胺可例示下述式(V-1-1)~式(V-1-19)所表示的化合物。The diamine represented by a formula (V-1) can illustrate the compound represented by following formula (V-1-1) - a formula (V-1-19).
式(V-11)所表示的二胺可例示下述式(V-11-1)~式(V-11-19)所表示的化合物。The diamine represented by a formula (V-11) can illustrate the compound represented by following formula (V-11-1) - a formula (V-11-19).
式(VI-1)所表示的二胺可例示下述式(VI-1-1)~式(VI-1-39)所表示的化合物。The diamine represented by a formula (VI-1) can illustrate the compound represented by following formula (VI-1-1) - a formula (VI-1-39).
式(VI-2)所表示的二胺可例示下述式(VI-2-1)~(VI-2-8)所表示的化合物。The diamine represented by a formula (VI-2) can illustrate the compound represented by following formula (VI-2-1) - (VI-2-8).
在式(VI-2-1)~式(VI-2-8)中,In formula (VI-2-1) ~ formula (VI-2-8),
Y15独立为碳数为3~30的烷基、碳数为3~29的烷氧基、或碳数为3~30的烯基。Y 15 is independently an alkyl group having 3 to 30 carbons, an alkoxy group having 3 to 29 carbons, or an alkenyl group having 3 to 30 carbons.
Y16独立为-H、碳数为1~30的烷基、碳数为1~29的烷氧基、或碳数为2~30的烯基。Y 16 is independently -H, alkyl having 1 to 30 carbons, alkoxy having 1 to 29 carbons, or alkenyl having 2 to 30 carbons.
式(VI-3)所表示的二胺可例示下述式(VI-3-1)及式(VI-3-2)所表示的化合物。The diamine represented by a formula (VI-3) can illustrate the compound represented by following formula (VI-3-1) and a formula (VI-3-2).
在式(VI-3-1)~(VI-3-2)中,In formula (VI-3-1)~(VI-3-2),
Y15独立为碳数为3~30的烷基、碳数为3~29的烷氧基、或碳数为3~30的烯基。Y 15 is independently an alkyl group having 3 to 30 carbons, an alkoxy group having 3 to 29 carbons, or an alkenyl group having 3 to 30 carbons.
Y16独立为-H、碳数为1~30的烷基、碳数为1~29的烷氧基、或碳数为2~30的烯基。Y 16 is independently -H, alkyl having 1 to 30 carbons, alkoxy having 1 to 29 carbons, or alkenyl having 2 to 30 carbons.
式(VI-11)所表示的二胺可例示下述式(VI-11-1)~式(VI-11-16)所表示的化合物。The diamine represented by a formula (VI-11) can illustrate the compound represented by following formula (VI-11-1) - a formula (VI-11-16).
式(VI-12)所表示的二胺可例示下述式(VI-12-1)所表示的化合物。The diamine represented by formula (VI-12) can illustrate the compound represented by following formula (VI-12-1).
式(VII-1)所表示的二胺可例示下述式(VII-1-1)~式(VII-1-6)所表示的化合物。The diamine represented by a formula (VII-1) can illustrate the compound represented by following formula (VII-1-1) - a formula (VII-1-6).
式(VII-2)所表示的二胺可例示下述式(VII-2-1)~式(VII-2-15)所表示的化合物。The diamine represented by a formula (VII-2) can illustrate the compound represented by following formula (VII-2-1) - a formula (VII-2-15).
式(VII-3)所表示的二胺可例示下述式(VII-3-1)~式(VII-3-4)所表示的化合物。The diamine represented by a formula (VII-3) can illustrate the compound represented by following formula (VII-3-1) - a formula (VII-3-4).
式(VII-11)所表示的二胺可例示下述式(VII-11-1)~式(VII-11-6)所表示的化合物。The diamine represented by a formula (VII-11) can illustrate the compound represented by following formula (VII-11-1) - a formula (VII-11-6).
式(VII-12)所表示的二胺可例示下述式(VII-12-1)所表示的化合物。The diamine represented by formula (VII-12) can illustrate the compound represented by following formula (VII-12-1).
式(VIII-1)所表示的二胺可例示下述式(VIII-1-1)~式(VIII-1-16)所表示的化合物。Examples of the diamine represented by the formula (VIII-1) include compounds represented by the following formula (VIII-1-1) to formula (VIII-1-16).
式(VIII-2)所表示的二胺可例示下述式(VIII-2-1)~式(VIII-2-8)所表示的化合物。Examples of the diamine represented by the formula (VIII-2) include compounds represented by the following formula (VIII-2-1) to formula (VIII-2-8).
在式(VIII-2-1)~式(VIII-2-8)中,In formula (VIII-2-1) ~ formula (VIII-2-8),
Y16独立为-H、碳数为1~30的烷基、碳数为1~29的烷氧基、或碳数为2~30的烯基。Y 16 is independently -H, alkyl having 1 to 30 carbons, alkoxy having 1 to 29 carbons, or alkenyl having 2 to 30 carbons.
式(VIII-3)所表示的二胺可例示下述式(VIII-3-1)~式(VIII-3-3)所表示的化合物。Examples of the diamine represented by the formula (VIII-3) include compounds represented by the following formula (VIII-3-1) to the formula (VIII-3-3).
在式(VIII-3-1)~式(VIII-3-3)中,In formula (VIII-3-1) ~ formula (VIII-3-3),
Y16独立为-H、碳数为1~30的烷基、碳数为1~29的烷氧基、或碳数为2~30的烯基, Y16 is independently -H, alkyl with 1 to 30 carbons, alkoxy with 1 to 29 carbons, or alkenyl with 2 to 30 carbons,
Y9为碳数为6~30的烷基。Y 9 is an alkyl group having 6 to 30 carbon atoms.
式(VIII-4)所表示的二胺可例示下述式(VIII-4-1)~式(VIII-4-8)所表示的化合物。Examples of the diamine represented by the formula (VIII-4) include compounds represented by the following formula (VIII-4-1) to formula (VIII-4-8).
式(VIII-11)所表示的二胺可例示下述式(VIII-11-1)所表示的化合物。As the diamine represented by the formula (VIII-11), a compound represented by the following formula (VIII-11-1) can be exemplified.
式(IX-1)所表示的二胺可例示下述式(IX-1-1)所表示的化合物。The diamine represented by formula (IX-1) can illustrate the compound represented by following formula (IX-1-1).
除到此为止所例示的化合物以外的二胺可列举具有萘结构的萘系二胺、及具有芴结构的芴系二胺等。As diamines other than the compounds exemplified so far, naphthalene-based diamines having a naphthalene structure, fluorene-based diamines having a fluorene structure, and the like are exemplified.
在构成本发明的液晶配向剂中的聚酰胺酸的二胺中,可以在不损及本发明的效果的程度的范围内使用可用于本发明的其他二胺。Among the diamines constituting the polyamic acid in the liquid crystal aligning agent of the present invention, other diamines that can be used in the present invention can be used within the range that does not impair the effects of the present invention.
本发明的聚酰胺酸或其衍生物可以在其单体中进一步含有单异氰酸酯化合物。通过在单体中含有单异氰酸酯化合物,可修饰所得的聚酰胺酸或其衍生物的末端,调节分子量。通过使用该末端修饰型聚酰胺酸或其衍生物,例如可以不损及本发明的效果地改善液晶配向剂的涂布特性。自所述观点考虑,优选单体中的单异氰酸酯化合物的含量相对于单体中的二胺及四羧酸二酐的总量为1mol%~10mol%。所述单异氰酸酯化合物例如可列举异氰酸苯酯及异氰酸萘酯。The polyamic acid of this invention or its derivative(s) may contain a monoisocyanate compound further in the monomer. By containing a monoisocyanate compound in a monomer, the terminal of the obtained polyamic acid or its derivative can be modified and molecular weight can be adjusted. By using this terminal-modified polyamic acid or its derivative, the application|coating characteristic of a liquid crystal aligning agent can be improved, for example without impairing the effect of this invention. From such a viewpoint, it is preferable that content of the monoisocyanate compound in a monomer is 1 mol% - 10 mol% with respect to the total amount of the diamine and tetracarboxylic dianhydride in a monomer. Examples of the monoisocyanate compound include phenyl isocyanate and naphthyl isocyanate.
本发明的聚酰胺酸或其衍生物分子量是聚苯乙烯换算重均分子量(Mw),优选为10,000~500,000,更优选为20,000~200,000。所述聚酰胺酸或其衍生物的分子量可利用凝胶渗透色谱(GPC)法进行测定而求出。The polyamic acid or its derivative molecular weight of this invention is polystyrene conversion weight average molecular weight (Mw), Preferably it is 10,000-500,000, More preferably, it is 20,000-200,000. The molecular weight of the said polyamic acid or its derivative can be measured and calculated|required by the gel permeation chromatography (GPC) method.
本发明的聚酰胺酸或其衍生物可通过用IR、NMR对以大量贫溶剂使其沉淀而所得的固形物进行分析而确认其存在。而且,用KOH或NaOH等强碱的水溶液将本发明的聚酰胺酸或其衍生物分解后,用GC、HPLC或GC-MS对利用有机溶剂自所述分解物中萃取而得的成分进行分析,由此可确认所使用的单体。The presence of the polyamic acid of the present invention or its derivative can be confirmed by analyzing the solid matter obtained by precipitating with a large amount of poor solvent by IR or NMR. Furthermore, after decomposing the polyamic acid or derivatives thereof of the present invention with an aqueous solution of a strong base such as KOH or NaOH, the components extracted from the decomposed product with an organic solvent are analyzed by GC, HPLC or GC-MS , so that the monomer used can be confirmed.
本发明的液晶配向剂还可以含有所述的聚酰胺酸或其衍生物以外的其他成分。其他成分可以是一种也可以是两种以上。The liquid crystal alignment agent of the present invention may also contain other components than the polyamic acid or its derivatives. The other components may be one kind or two or more kinds.
例如,自使液晶显示元件的电气特性长期稳定的观点考虑,本发明的液晶配向剂还可以进一步含有经烯基取代的耐地酰亚胺化合物。所述经烯基取代的耐地酰亚胺化合物可以单独使用一种化合物,也可以并用两种以上的化合物。经烯基取代的耐地酰亚胺化合物的含量,以相对于液晶配向剂中聚酰胺酸或其衍生物的总量的重量比计,优选为0.01~1.00,更优选为0.01~0.70,进一步更优选为0.01~0.50。For example, from the viewpoint of stabilizing the electrical characteristics of a liquid crystal display element over a long period of time, the liquid crystal aligning agent of the present invention may further contain an alkenyl-substituted terimide compound. The above-mentioned alkenyl-substituted nadilimide compound may be used alone or in combination of two or more compounds. The content of alkenyl-substituted nadiimide compound is preferably 0.01-1.00, more preferably 0.01-0.70, and further More preferably, it is 0.01-0.50.
经烯基取代的耐地酰亚胺化合物优选为可溶解于本发明中所使用的溶解聚酰胺酸或其衍生物的溶剂中的化合物。此种经烯基取代的耐地酰亚胺化合物的例子可列举下述式(Ina)所表示的化合物。The alkenyl-substituted nadilimide compound is preferably a compound that is soluble in the solvent for dissolving polyamic acid or its derivative used in the present invention. Examples of such an alkenyl-substituted nadilimide compound include compounds represented by the following formula (Ina).
在式(Ina)中,L1及L2分别独立为氢、碳数为1~12的烷基、碳数为3~6的烯基、碳数为5~8的环烷基、芳基或苄基,n为1或2。In formula (Ina), L 1 and L 2 are independently hydrogen, alkyl with 1 to 12 carbons, alkenyl with 3 to 6 carbons, cycloalkyl with 5 to 8 carbons, aryl Or benzyl, n is 1 or 2.
当n=1时,When n=1,
W为碳数为1~12的烷基、碳数为2~6的烯基、碳数为5~8の环烷基、碳数为6~12的芳基、苄基、-Z1-(O)q-(Z2O)r-Z3-H所表示的基、-(Z4)s-B-Z5-H所表示的基、-B-T-B-H所表示的基、或这些基的1~3个氢被羟基取代的基。W is an alkyl group with 1 to 12 carbons, an alkenyl group with 2 to 6 carbons, a cycloalkyl group with 5 to 8 carbons, an aryl group with 6 to 12 carbons, benzyl, -Z 1 - (O) q -(Z 2 O) r -Z 3 -H, -(Z 4 ) s -BZ 5 -H, -BTBH, or 1 to 1 of these groups A group in which 3 hydrogens are replaced by hydroxyl groups.
此处,Z1、Z2及Z3独立为碳数为2~6的亚烷基,q为0或1,且r为1~30的整数,Here, Z 1 , Z 2 and Z 3 are independently an alkylene group with 2 to 6 carbons, q is 0 or 1, and r is an integer of 1 to 30,
Z4及Z5独立为碳数为1~4的亚烷基或碳数为5~8的环亚烷基,B为亚苯基,s为0或1,而且,Z 4 and Z 5 are independently an alkylene group with 1 to 4 carbons or a cycloalkylene group with 5 to 8 carbons, B is phenylene, s is 0 or 1, and,
T为-CH2-、-C(CH3)2-、-O-、-CO-、-S-或-SO2-。T is -CH 2 -, -C(CH 3 ) 2 -, -O-, -CO-, -S- or -SO 2 -.
此时,优选的W为碳数为1~8的烷基、碳数为3~4的烯基、环己基、苯基、苄基、碳数为4~10的聚(亚乙基氧基)乙基、苯基氧基苯基、苯基甲基苯基、苯基异亚丙基苯基、及这些基的1个或2个氢被羟基取代而成的基。At this time, preferred W is an alkyl group with 1 to 8 carbons, alkenyl with 3 to 4 carbons, cyclohexyl, phenyl, benzyl, poly(ethyleneoxy) with 4 to 10 carbons ) ethyl group, phenyloxyphenyl group, phenylmethylphenyl group, phenylisopropylidenephenyl group, and groups in which one or two hydrogens of these groups are replaced by hydroxyl groups.
当n=2时,When n=2,
W为碳数为2~20的亚烷基、碳数为5~8的环亚烷基、碳数为6~12的亚芳基、-Z1-O-(Z2O)r-Z3-所表示的基、-Z4-B-Z5-所表示的基、-B-(O-B)s-T-(B-O)s-B-所表示的基、或这些基的1~3个氢被羟基取代而成的基。W is an alkylene group with 2 to 20 carbons, a cycloalkylene group with 5 to 8 carbons, an arylene group with 6 to 12 carbons, -Z 1 -O-(Z 2 O) r -Z The group represented by 3- , the group represented by -Z 4 -BZ 5 -, the group represented by -B-(OB) s -T-(BO) s -B-, or 1 to 3 hydrogens of these groups A group substituted by a hydroxyl group.
此处,Z1~Z3、r、Z4、Z5及B的含义如上所述,Here, the meanings of Z 1 to Z 3 , r, Z 4 , Z 5 and B are as described above,
T为碳数为1~3的亚烷基、-O-或-SO2-,s为0或1。T is an alkylene group having 1 to 3 carbon atoms, -O- or -SO 2 -, and s is 0 or 1.
此时,优选的W为碳数为2~12的亚烷基、亚环己基、亚苯基、甲代亚苯基(tolylene)、苯二甲基(xylylene)、-C3H6-O-(Z2-O)r-O-C3H6-(Z2为碳数为2~6的亚烷基,r表示1或2)所表示的基、-B-T-B-(B为亚苯基,且T为-CH2-、-O-或SO2-)所表示的基、-B-O-B-C3H6-B-O-B-(B为亚苯基)所表示的基、及这些基的1个或2个氢被羟基取代而成的基。In this case, W is preferably an alkylene group having 2 to 12 carbon atoms, a cyclohexylene group, a phenylene group, a tolylene group, a xylylene group, or -C 3 H 6 -O -(Z 2 -O) r -OC 3 H 6 -(Z 2 is an alkylene group having 2 to 6 carbon atoms, r represents 1 or 2), -BTB-(B is phenylene, And T is a group represented by -CH 2 -, -O- or SO 2 -), a group represented by -BOBC 3 H 6 -BOB- (B is a phenylene group), and one or two of these groups A group in which hydrogen is replaced by a hydroxyl group.
此种经烯基取代的耐地酰亚胺化合物例如可如日本专利第2729565号公报中所记载那样,使用使经烯基取代的耐地酸酐衍生物与二胺在80℃~220℃的温度下保持0.5小时~20小时进行合成而所得的化合物或者市售的化合物。经烯基取代的耐地酰亚胺化合物的具体例是如下所示的化合物。Such an alkenyl-substituted resilicate imide compound can be used, for example, as described in Japanese Patent No. 2729565, by making an alkenyl-substituted resilicate anhydride derivative and a diamine at a temperature of 80° C. to 220° C. The synthetic compound or the commercially available compound is kept at the lower temperature for 0.5 hours to 20 hours. Specific examples of the alkenyl-substituted nadilimide compound are the compounds shown below.
N-甲基-烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-甲基-烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-甲基-甲基烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-甲基-甲基烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-(2-乙基己基)-烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-methyl-allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide, N-methyl-allylmethylbicyclo[2.2.1]hept-5- ene-2,3-dicarboxyimide, N-methyl-methallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide, N-methyl-methyl N-(2-ethylhexyl)-allylbicyclo[2.2.1]hept-5 -ene-2,3-dicarboxyimide,
N-(2-乙基己基)-烯丙基(甲基)双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-烯丙基-烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-烯丙基-烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-烯丙基-甲基烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-异丙烯基-烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-异丙烯基-烯丙基(甲基)双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-异丙烯基-甲基烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-环己基-烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-环己基-烯丙基(甲基)双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-环己基-甲基烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-苯基-烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-(2-ethylhexyl)-allyl(methyl)bicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide, N-allyl-allylbicyclo[ 2.2.1] Hept-5-ene-2,3-dicarboxyimide, N-allyl-allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide imine, N-allyl-methallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide, N-isopropenyl-allylbicyclo[2.2.1 ]hept-5-ene-2,3-dicarboxyimide, N-isopropenyl-allyl (methyl)bicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide Amine, N-isopropenyl-methallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide, N-cyclohexyl-allylbicyclo[2.2.1]heptane -5-ene-2,3-dicarboxyimide, N-cyclohexyl-allyl (methyl)bicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide, N -Cyclohexyl-methallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide, N-phenyl-allylbicyclo[2.2.1]hept-5-ene -2,3-Dicarboxyimide,
N-苯基-烯丙基(甲基)双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-苄基-烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-苄基-烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-苄基-甲基烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-(2-羟乙基)-烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-(2-羟乙基)-烯丙基(甲基)双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-(2-羟乙基)-甲基烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-phenyl-allyl(methyl)bicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide, N-benzyl-allylbicyclo[2.2.1]hept- 5-ene-2,3-dicarboxyimide, N-benzyl-allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide, N-benzyl -Methallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide, N-(2-hydroxyethyl)-allylbicyclo[2.2.1]hept-5 -ene-2,3-dicarboxyimide, N-(2-hydroxyethyl)-allyl(methyl)bicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide Amine, N-(2-hydroxyethyl)-methallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide,
N-(2,2-二甲基-3-羟丙基)-烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-(2,2-二甲基-3-羟丙基)-烯丙基(甲基)双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-(2,3-二羟丙基)-烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-(2,3-二羟丙基)-烯丙基(甲基)双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-(3-羟基-1-丙烯基)-烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-(4-羟基环己基)-烯丙基(甲基)双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-(2,2-dimethyl-3-hydroxypropyl)-allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide, N-(2,2- Dimethyl-3-hydroxypropyl)-allyl(methyl)bicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide, N-(2,3-dihydroxypropyl Base)-allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide, N-(2,3-dihydroxypropyl)-allyl(methyl)bicyclo[ 2.2.1] Hept-5-ene-2,3-dicarboxyimide, N-(3-hydroxy-1-propenyl)-allylbicyclo[2.2.1]hept-5-ene-2, 3-Dicarboxyimide, N-(4-hydroxycyclohexyl)-allyl(methyl)bicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide,
N-(4-羟基苯基)-烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-(4-羟基苯基)-烯丙基(甲基)双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-(4-羟基苯基)-甲基烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-(4-羟基苯基)-甲基烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-(3-羟基苯基)-烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-(3-羟基苯基)-烯丙基(甲基)双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-(对羟基苄基)-烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-{2-(2-羟基乙氧基)乙基}-烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-(4-hydroxyphenyl)-allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide, N-(4-hydroxyphenyl)-allyl(methyl base) bicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide, N-(4-hydroxyphenyl)-methallylbicyclo[2.2.1]hept-5-ene -2,3-dicarboxyimide, N-(4-hydroxyphenyl)-methallylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide, N-(3-hydroxyphenyl)-allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide, N-(3-hydroxyphenyl)-allyl(methyl Base) bicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide, N-(p-hydroxybenzyl)-allylbicyclo[2.2.1]hept-5-ene-2, 3-Dicarboxyimide, N-{2-(2-hydroxyethoxy)ethyl}-allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide,
N-{2-(2-羟基乙氧基)乙基}-烯丙基(甲基)双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-{2-(2-羟基乙氧基)乙基}-甲基烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-{2-(2-羟基乙氧基)乙基}-甲基烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-[2-{2-(2-羟基乙氧基)乙氧基}乙基]-烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-[2-{2-(2-羟基乙氧基)乙氧基}乙基]-烯丙基(甲基)双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-[2-{2-(2-羟基乙氧基)乙氧基}乙基]-甲基烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-{4-(4-羟基苯基异亚丙基)苯基}-烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-{4-(4-羟基苯基异亚丙基)苯基}-烯丙基(甲基)双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、N-{4-(4-羟基苯基异亚丙基)苯基}-甲基烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺、及它们的寡聚物、N-{2-(2-hydroxyethoxy)ethyl}-allyl(methyl)bicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide, N-{2 -(2-hydroxyethoxy)ethyl}-methallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide, N-{2-(2-hydroxyethyl Oxy)ethyl}-methallylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide, N-[2-{2-(2-hydroxyethoxy Base) ethoxy} ethyl]-allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide, N-[2-{2-(2-hydroxyethoxy )ethoxy}ethyl]-allyl(methyl)bicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide, N-[2-{2-(2-hydroxy Ethoxy)ethoxy}ethyl]-methallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide, N-{4-(4-hydroxyphenyl Isopropylidene)phenyl}-allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide, N-{4-(4-hydroxyphenylisopropylidene) Phenyl}-allyl(methyl)bicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide, N-{4-(4-hydroxyphenylisopropylidene)benzene Base}-methallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboximide, and their oligomers,
N,N′-亚乙基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-亚乙基-双(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-亚乙基-双(甲基烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-三亚甲基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-六亚甲基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-六亚甲基-双(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-十二亚甲基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-十二亚甲基-双(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-亚环己基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-亚环己基-双(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N, N'-ethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide), N,N'-ethylene-bis(allyl Methylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide), N,N'-ethylene-bis(methallylbicyclo[2.2.1]hept- 5-ene-2,3-dicarboxyimide), N,N'-trimethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide ), N, N'-hexamethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide), N,N'-hexamethylene- Bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide), N,N'-dodecamethylene-bis(allylbicyclo[2.2. 1] Hept-5-ene-2,3-dicarboxyimide), N,N'-dodecamethylene-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2 , 3-dicarboxyimide), N, N'-cyclohexylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide), N,N '-cyclohexylene-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide),
1,2-双{3′-(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)丙氧基}乙烷、1,2-双{3′-(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)丙氧基}乙烷、1,2-双{3′-(甲基烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)丙氧基}乙烷、双[2′-{3′-(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)丙氧基}乙基]醚、双[2′-{3′-(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)丙氧基}乙基]醚、1,4-双{3′-(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)丙氧基}丁烷、1,4-双{3′-(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)丙氧基}丁烷、1,2-bis{3′-(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)propoxy}ethane, 1,2-bis{3′ -(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)propoxy}ethane, 1,2-bis{3′-(methallyl Bicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)propoxy}ethane, bis[2'-{3'-(allylbicyclo[2.2.1]heptane -5-ene-2,3-dicarboxyimide)propoxy}ethyl]ether, bis[2′-{3′-(allylmethylbicyclo[2.2.1]hept-5-ene -2,3-dicarboxyimide)propoxy}ethyl]ether, 1,4-bis{3'-(allylbicyclo[2.2.1]hept-5-ene-2,3-di Carboxylimide)propoxy}butane, 1,4-bis{3′-(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)propane Oxygen}butane,
N,N′-对亚苯基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-对亚苯基-双(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-m-亚苯基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-m-亚苯基-双(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-{(1-甲基)-2,4-亚苯基}-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-对苯二甲基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-对苯二甲基-双(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-间苯二甲基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-间苯二甲基-双(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N, N'-p-phenylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboximide), N,N'-p-phenylene-bis( Allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide), N,N′-m-phenylene-bis(allylbicyclo[2.2.1] Hept-5-ene-2,3-dicarboxyimide), N,N'-m-phenylene-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3 -dicarboxyimide), N,N'-{(1-methyl)-2,4-phenylene}-bis(allylbicyclo[2.2.1]hept-5-ene-2,3 -dicarboxyimide), N,N'-p-xylylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide), N,N '-P-xylylene-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboximide), N,N'-m-xylylene-bis (Allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide), N,N'-m-xylylene-bis(allylmethylbicyclo[2.2.1 ]hept-5-ene-2,3-dicarboxyimide),
2,2-双[4-{4-(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯氧基}苯基]丙烷、2,2-双[4-{4-(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯氧基}苯基]丙烷、2,2-双[4-{4-(甲基烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯氧基}苯基]丙烷、双{4-(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯基}甲烷、双{4-(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯基}甲烷、2,2-bis[4-{4-(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)phenoxy}phenyl]propane, 2,2- Bis[4-{4-(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)phenoxy}phenyl]propane, 2,2-bis[ 4-{4-(Methallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)phenoxy}phenyl]propane, bis{4-(allyl Bicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)phenyl}methane, bis{4-(allylmethylbicyclo[2.2.1]hept-5-ene-2 , 3-dicarboxyimide) phenyl} methane,
双{4-(甲基烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯基}甲烷、双{4-(甲基烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯基}甲烷、双{4-(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯基}醚、双{4-(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯基}醚、双{4-(甲基烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯基}醚、双{4-(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯基}碸、双{4-(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯基}碸、Bis{4-(methallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)phenyl}methane, bis{4-(methallylmethylbicyclo [2.2.1]hept-5-ene-2,3-dicarboxyimide)phenyl}methane, bis{4-(allylbicyclo[2.2.1]hept-5-ene-2,3- Dicarboxyimide) phenyl} ether, bis{4-(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)phenyl} ether, bis{ 4-(Methallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)phenyl}ether, bis{4-(allylbicyclo[2.2.1]heptan -5-ene-2,3-dicarboxyimide)phenyl}pyridine, bis{4-(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide Amine) phenyl} phenyl,
双{4-(甲基烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯基}砜、1,6-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)-3-羟基-己烷、1,12-双(甲基烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)-3,6-二羟基-十二烷、1,3-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)-5-羟基-环己烷、1,5-双{3′-(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)丙氧基}-3-羟基-戊烷、1,4-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)-2-羟基-苯、Bis{4-(methallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)phenyl}sulfone, 1,6-bis(allylbicyclo[2.2. 1] Hept-5-ene-2,3-dicarboxyimide)-3-hydroxyl-hexane, 1,12-bis(methallylbicyclo[2.2.1]hept-5-ene-2 , 3-dicarboxyimide)-3,6-dihydroxy-dodecane, 1,3-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide Amine)-5-hydroxy-cyclohexane, 1,5-bis{3′-(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)propoxy} -3-Hydroxy-pentane, 1,4-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)-2-hydroxy-benzene,
1,4-双(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)-2,5-二羟基-苯、N,N′-对(2-羟基)苯二甲基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-对(2-羟基)苯二甲基-双(烯丙基甲基环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-间(2-羟基)苯二甲基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-间(2-羟基)苯二甲基-双(甲基烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-对(2,3-二羟基)苯二甲基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、1,4-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)-2,5-dihydroxyl-benzene, N,N'-p-( 2-Hydroxy)xylylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide), N,N'-p-(2-hydroxy)benzenedi Methyl-bis(allylmethylcyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide), N,N'-m-(2-hydroxy)xylylene-bis (Allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide), N,N'-m-(2-hydroxy)xylylene-bis(methallyl Bicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide), N,N'-p-(2,3-dihydroxy)xylylene-bis(allylbicyclo[2.2 .1] hept-5-ene-2,3-dicarboxyimide),
2,2-双[4-{4-(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)-2-羟基-苯氧基}苯基]丙烷、双{4-(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)-2-羟基-苯基}甲烷、双{3-(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)-4-羟基-苯基}醚、双{3-(甲基烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)-5-羟基-苯基}砜、1,1,1-三{4-(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)}苯氧甲基丙烷、N,N′,N″-三(亚乙基甲基烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)异三聚氰酸酯、及它们的寡聚物等。2,2-bis[4-{4-(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)-2-hydroxy-phenoxy}phenyl]propane , bis{4-(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)-2-hydroxy-phenyl}methane, bis{3-(allyl Bicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)-4-hydroxyl-phenyl}ether, bis{3-(methallylbicyclo[2.2.1]heptane -5-ene-2,3-dicarboxyimide)-5-hydroxy-phenyl}sulfone, 1,1,1-tri{4-(allylmethylbicyclo[2.2.1]hept-5 -ene-2,3-dicarboxyimide)}phenoxymethylpropane, N,N′,N″-tris(ethylenemethylallylbicyclo[2.2.1]hept-5-ene- 2,3-Dicarboxyimide) isocyanurate, and their oligomers, etc.
另外,本发明中所使用的经烯基取代的耐地酰亚胺化合物也可以是包含不对称的亚烷基·亚苯基的下述结构式所表示的化合物。In addition, the alkenyl-substituted imide compound used in the present invention may be a compound represented by the following structural formula including an asymmetric alkylene/phenylene group.
经烯基取代的耐地酰亚胺化合物优选使用以下化合物。As the alkenyl-substituted nadilimide compound, the following compounds are preferably used.
N,N′-亚乙基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-亚乙基-双(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-亚乙基-双(甲基烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-三亚甲基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-六亚甲基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-六亚甲基-双(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-十二亚甲基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-十二亚甲基-双(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-亚环己基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-亚环己基-双(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N, N'-ethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide), N,N'-ethylene-bis(allyl Methylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide), N,N'-ethylene-bis(methallylbicyclo[2.2.1]hept- 5-ene-2,3-dicarboxyimide), N,N'-trimethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide ), N, N'-hexamethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide), N,N'-hexamethylene- Bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide), N,N'-dodecamethylene-bis(allylbicyclo[2.2. 1] Hept-5-ene-2,3-dicarboxyimide), N,N'-dodecamethylene-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2 , 3-dicarboxyimide), N, N'-cyclohexylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide), N,N '-cyclohexylene-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide),
N,N′-对亚苯基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-对亚苯基-双(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-间亚苯基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-间亚苯基-双(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-{(1-甲基)-2,4-亚苯基}-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-对苯二甲基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-对苯二甲基-双(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-间苯二甲基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-间苯二甲基-双(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、2,2-双[4-{4-(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯氧基}苯基]丙烷、2,2-双[4-{4-(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯氧基}苯基]丙烷、2,2-双[4-{4-(甲基烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯氧基}苯基]丙烷、双{4-(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯基}甲烷、双{4-(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯基}甲烷、N, N'-p-phenylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboximide), N,N'-p-phenylene-bis( Allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide), N,N′-m-phenylene-bis(allylbicyclo[2.2.1]heptane -5-ene-2,3-dicarboxyimide), N,N'-m-phenylene-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-di Carboxylimide), N,N'-{(1-methyl)-2,4-phenylene}-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-di Carboxylimide), N,N'-p-xylylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide), N,N'- p-xylylene-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide), N,N'-m-xylylene-bis(ene Propylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide), N,N'-m-xylylene-bis(allylmethylbicyclo[2.2.1]heptane -5-ene-2,3-dicarboxyimide), 2,2-bis[4-{4-(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyacyl imine)phenoxy}phenyl]propane, 2,2-bis[4-{4-(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide )phenoxy}phenyl]propane, 2,2-bis[4-{4-(methallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)benzene Oxy}phenyl]propane, bis{4-(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)phenyl}methane, bis{4-(allyl Methylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)phenyl}methane,
双{4-(甲基烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯基}甲烷、双{4-(甲基烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯基}甲烷、双{4-(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯基}醚、双{4-(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯基}醚、双{4-(甲基烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯基}醚、双{4-(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯基}砜、双{4-(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯基}砜、双{4-(甲基烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯基}砜。Bis{4-(methallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)phenyl}methane, bis{4-(methallylmethylbicyclo [2.2.1]hept-5-ene-2,3-dicarboxyimide)phenyl}methane, bis{4-(allylbicyclo[2.2.1]hept-5-ene-2,3- Dicarboxyimide) phenyl} ether, bis{4-(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)phenyl} ether, bis{ 4-(Methallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)phenyl}ether, bis{4-(allylbicyclo[2.2.1]heptan -5-ene-2,3-dicarboxyimide)phenyl}sulfone, bis{4-(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide amine)phenyl}sulfone, bis{4-(methallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)phenyl}sulfone.
更优选使用的经烯基取代的耐地酰亚胺化合物如下所述。More preferably used alkenyl-substituted nandiimide compounds are as follows.
N,N′-亚乙基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-亚乙基-双(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-亚乙基-双(甲基烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-三亚甲基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-六亚甲基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-六亚甲基-双(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-十二亚甲基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-十二亚甲基-双(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-亚环己基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-亚环己基-双(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N, N'-ethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide), N,N'-ethylene-bis(allyl Methylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide), N,N'-ethylene-bis(methallylbicyclo[2.2.1]hept- 5-ene-2,3-dicarboxyimide), N,N'-trimethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide ), N, N'-hexamethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide), N,N'-hexamethylene- Bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide), N,N'-dodecamethylene-bis(allylbicyclo[2.2. 1] Hept-5-ene-2,3-dicarboxyimide), N,N'-dodecamethylene-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2 , 3-dicarboxyimide), N, N'-cyclohexylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide), N,N '-cyclohexylene-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide),
N,N′-对亚苯基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-对亚苯基-双(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-间亚苯基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-间亚苯基-双(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-{(1-甲基)-2,4-亚苯基}-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-对苯二甲基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-对苯二甲基-双(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-间苯二甲基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N,N′-间苯二甲基-双(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、N, N'-p-phenylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboximide), N,N'-p-phenylene-bis( Allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide), N,N′-m-phenylene-bis(allylbicyclo[2.2.1]heptane -5-ene-2,3-dicarboxyimide), N,N'-m-phenylene-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-di Carboxylimide), N,N'-{(1-methyl)-2,4-phenylene}-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-di Carboxylimide), N,N'-p-xylylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide), N,N'- p-xylylene-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide), N,N'-m-xylylene-bis(ene Propylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide), N,N'-m-xylylene-bis(allylmethylbicyclo[2.2.1]heptane -5-ene-2,3-dicarboxyimide),
2,2-双[4-{4-(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯氧基}苯基]丙烷、2,2-双[4-{4-(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯氧基}苯基]丙烷、2,2-双[4-{4-(甲基烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯氧基}苯基]丙烷、双{4-(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯基}甲烷、双{4-(烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯基}甲烷、双{4-(甲基烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯基}甲烷、双{4-(甲基烯丙基甲基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯基}甲烷。2,2-bis[4-{4-(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)phenoxy}phenyl]propane, 2,2- Bis[4-{4-(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)phenoxy}phenyl]propane, 2,2-bis[ 4-{4-(Methallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)phenoxy}phenyl]propane, bis{4-(allyl Bicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)phenyl}methane, bis{4-(allylmethylbicyclo[2.2.1]hept-5-ene-2 , 3-dicarboxyimide)phenyl}methane, bis{4-(methallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)phenyl}methane , bis{4-(methallylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)phenyl}methane.
而且,尤其优选的经烯基取代的耐地酰亚胺化合物是下述式(Ina-1)所表示的双{4-(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯基}甲烷、式(Ina-2)所表示的N,N′-间苯二甲基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)、及式(Ina-3)所表示的N,N′-六亚甲基-双(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)。Moreover, a particularly preferred alkenyl-substituted nadiimide compound is bis{4-(allylbicyclo[2.2.1]hept-5-ene-2 represented by the following formula (Ina-1), 3-Dicarboxyimide) phenyl} methane, N, N'-m-xylylene-bis(allylbicyclo[2.2.1]hept-5-ene- represented by formula (Ina-2) 2,3-dicarboxyimide), and N,N'-hexamethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2 represented by formula (Ina-3), 3-dicarboxyimide).
而且,例如自使液晶显示元件的电气特性长期稳定的观点考虑,本发明的液晶配向剂还可以进一步含有具有自由基聚合性不饱和双键的化合物。所述具有自由基聚合性不饱和双键的化合物可单独使用1种化合物,也可以并用两种以上的化合物。另外,所述具有自由基聚合性不饱和双键的化合物中并不包括所述的经烯基取代的耐地酰亚胺化合物。自所述观点考虑,具有自由基聚合性不饱和双键的化合物的含量以相对于聚酰胺酸或其衍生物的总量的重量比计,优选为0.01~1.00,更优选为0.01~0.70,进一步更优选为0.01~0.50。Moreover, the liquid crystal alignment agent of this invention may further contain the compound which has a radically polymerizable unsaturated double bond from a viewpoint of stabilizing the electric characteristic of a liquid crystal display element for a long period of time, for example. The compound having a radically polymerizable unsaturated double bond may be used alone or in combination of two or more compounds. In addition, the compound having a radically polymerizable unsaturated double bond does not include the above-mentioned alkenyl-substituted endimide compound. From this point of view, the content of the compound having a radically polymerizable unsaturated double bond is preferably 0.01 to 1.00, more preferably 0.01 to 0.70, by weight ratio relative to the total amount of polyamic acid or its derivatives, Still more preferably, it is 0.01 to 0.50.
另外,具有自由基聚合性不饱和双键的化合物相对于经烯基取代的耐地酰亚胺化合物的比率,自减低液晶显示元件的离子密度、抑制离子密度随时间经过增加、另外抑制残像的观点考虑,以重量比计优选为0.1~10,更优选为0.5~5。In addition, the ratio of the compound having a radically polymerizable unsaturated double bond to the alkenyl-substituted imide compound can reduce the ion density of the liquid crystal display device, suppress the increase of the ion density over time, and also suppress the afterimage. From a viewpoint, it is preferable that it is 0.1-10 by weight ratio, and it is more preferable that it is 0.5-5.
具有自由基聚合性不饱和双键的化合物可例示(甲基)丙烯酸酯、(甲基)丙烯酸酰胺等(甲基)丙烯酸衍生物、及双马来酰亚胺。具有自由基聚合性不饱和双键的化合物更优选具有2个以上自由基聚合性不饱和双键的(甲基)丙烯酸衍生物。As a compound which has a radically polymerizable unsaturated double bond, (meth)acrylic acid derivatives, such as (meth)acrylate and (meth)acrylamide, and bismaleimide are illustrated. The compound having a radically polymerizable unsaturated double bond is more preferably a (meth)acrylic acid derivative having two or more radically polymerizable unsaturated double bonds.
(甲基)丙烯酸酯的具体例是(甲基)丙烯酸环己酯、(甲基)丙烯酸-2-甲基环己酯、(甲基)丙烯酸二环戊酯、(甲基)丙烯酸二环戊基氧基乙酯、(甲基)丙烯酸异冰片基酯、(甲基)丙烯酸苯酯、(甲基)丙烯酸苄酯、(甲基)丙烯酸2-羟乙酯、及(甲基)丙烯酸2-羟丙酯。Specific examples of (meth)acrylates are cyclohexyl (meth)acrylate, 2-methylcyclohexyl (meth)acrylate, dicyclopentyl (meth)acrylate, bicyclohexyl (meth)acrylate Amyloxyethyl ester, isobornyl (meth)acrylate, phenyl (meth)acrylate, benzyl (meth)acrylate, 2-hydroxyethyl (meth)acrylate, and (meth)acrylic acid 2-Hydroxypropyl ester.
2官能(甲基)丙烯酸酯的具体例是例如二丙烯酸乙二酯、东亚合成化学工业株式会社的产品ARONIX M-210、ARONIX M-240及ARONIX M-6200、日本化药株式会社的产品KAYARAD HDDA、KAYARAD HX-220、KAYARAD R-604及KAYARAD R-684、大阪有机化学工业株式会社的产品V260、V312及V335HP、以及共荣社油脂化学工业株式会社的产品Light Acrylate BA-4EA、Light Acrylate BP-4PA及Light Acrylate BP-2PA。Specific examples of 2-functional (meth)acrylates are, for example, ethylene glycol diacrylate, ARONIX M-210, ARONIX M-240, and ARONIX M-6200 produced by Toagosei Chemical Industry Co., Ltd., and KAYARAD produced by Nippon Kayaku Co., Ltd. HDDA, KAYARAD HX-220, KAYARAD R-604 and KAYARAD R-684, products V260, V312 and V335HP of Osaka Organic Chemical Industry Co., Ltd., and products of Kyoeisha Oleochemical Industry Co., Ltd. Light Acrylate BA-4EA, Light Acrylate BP-4PA and Light Acrylate BP-2PA.
3官能以上的多官能(甲基)丙烯酸酯的具体例例如可列举4,4′-亚甲基双(N,N-二羟基亚乙基丙烯酸酯苯胺)、ARONIX M-400、ARONIX M-405、ARONIX M-450、ARONIX M-7100、ARONIX M-8030、ARONIX M-8060、KAYARAD TMPTA、KAYARAD DPCA-20、KAYARAD DPCA-30、KAYARAD DPCA-60、KAYARAD DPCA-120、及大阪有机化学工业株式会社的产品VGPT。Specific examples of trifunctional or more polyfunctional (meth)acrylates include 4,4'-methylene bis(N,N-dihydroxyethylene acrylate aniline), ARONIX M-400, ARONIX M- 405, ARONIX M-450, ARONIX M-7100, ARONIX M-8030, ARONIX M-8060, KAYARAD TMPTA, KAYARAD DPCA-20, KAYARAD DPCA-30, KAYARAD DPCA-60, KAYARAD DPCA-120, and Osaka Organic Chemical Industry Co., Ltd. product VGPT.
(甲基)丙烯酸酰胺衍生物的具体例是例如N-异丙基丙烯酰胺、N-异丙基甲基丙烯酰胺、N-正丙基丙烯酰胺、N-正丙基甲基丙烯酰胺、N-环丙基丙烯酰胺、N-环丙基甲基丙烯酰胺、N-乙氧基乙基丙烯酰胺、N-乙氧基乙基甲基丙烯酰胺、N-四氢糠基丙烯酰胺、N-四氢糠基甲基丙烯酰胺、N-乙基丙烯酰胺、N-乙基-N-甲基丙烯酰胺、N,N-二乙基丙烯酰胺、N-甲基-N-正丙基丙烯酰胺、N-甲基-N-异丙基丙烯酰胺、N-丙烯酰基哌啶、N-丙烯酰基吡咯烷酮、N,N′-亚甲基双丙烯酰胺、N,N′-亚乙基双丙烯酰胺、N,N′-二羟基亚乙基双丙烯酰胺、N-(4-羟基苯基)甲基丙烯酰胺、N-苯基甲基丙烯酰胺、N-丁基甲基丙烯酰胺、N-(异丁氧基甲基)甲基丙烯酰胺、N-[2-(N,N-二甲基胺基)乙基]甲基丙烯酰胺、N,N-二甲基甲基丙烯酰胺、N-[3-(二甲基胺基)丙基]甲基丙烯酰胺、N-(甲氧基甲基)甲基丙烯酰胺、N-(羟基甲基)-2-甲基丙烯酰胺、N-苄基-2-甲基丙烯酰胺、及N,N′-亚甲基双甲基丙烯酰胺。Specific examples of (meth)acrylamide derivatives are, for example, N-isopropylacrylamide, N-isopropylmethacrylamide, N-n-propylacrylamide, N-n-propylmethacrylamide, N -Cyclopropylacrylamide, N-cyclopropylmethacrylamide, N-ethoxyethylacrylamide, N-ethoxyethylmethacrylamide, N-tetrahydrofurfurylacrylamide, N- Tetrahydrofurfurylmethacrylamide, N-ethylacrylamide, N-ethyl-N-methacrylamide, N,N-diethylacrylamide, N-methyl-N-n-propylacrylamide , N-methyl-N-isopropylacrylamide, N-acryloylpiperidine, N-acryloylpyrrolidone, N,N'-methylenebisacrylamide, N,N'-ethylenebisacrylamide , N, N'-dihydroxyethylene bisacrylamide, N-(4-hydroxyphenyl) methacrylamide, N-phenyl methacrylamide, N-butyl methacrylamide, N-(isobutyl Oxymethyl)methacrylamide, N-[2-(N,N-dimethylamino)ethyl]methacrylamide, N,N-dimethylmethacrylamide, N-[3 -(Dimethylamino)propyl]methacrylamide, N-(methoxymethyl)methacrylamide, N-(hydroxymethyl)-2-methacrylamide, N-benzyl- 2-methacrylamide, and N,N'-methylenebismethacrylamide.
上述(甲基)丙烯酸衍生物中特别优选的化合物是N,N′-亚甲基双丙烯酰胺、N,N′-二羟基亚乙基-双丙烯酰胺、二丙烯酸乙二酯、及4,4′-亚甲基双(N,N-二羟基亚乙基丙烯酸酯苯胺)。Particularly preferred compounds among the above-mentioned (meth)acrylic acid derivatives are N,N'-methylenebisacrylamide, N,N'-dihydroxyethylene-bisacrylamide, ethylene glycol diacrylate, and 4, 4'-methylene bis(N,N-dihydroxyethylene acrylate aniline).
双马来酰亚胺的具体例是日本KI Chemical Industry Co.,Ltd.制造的BMI-70及BMI-80、以及大和化成工业株式会社制造的BMI-1000、BMI-3000、BMI-4000、BMI-5000及BMI-7000。Specific examples of bismaleimides are BMI-70 and BMI-80 manufactured by Japan KI Chemical Industry Co., Ltd., and BMI-1000, BMI-3000, BMI-4000, BMI manufactured by Daiwa Chemical Industry Co., Ltd. -5000 and BMI-7000.
而且,例如自液晶显示元件的电气特性的长期稳定性的观点考虑,本发明的液晶配向剂还可以进一步含有噁嗪化合物。噁嗪化合物可单独使用一种化合物,还可以并用两种以上的化合物。噁嗪化合物的含量相对于聚酰胺酸或其衍生物的总量而言,优选为0.1wt%~50wt%,更优选为1wt%~40wt%,进一步更优选为1wt%~20wt%。Moreover, the liquid crystal alignment agent of this invention may further contain an oxazine compound from a viewpoint of the long-term stability of the electrical characteristic of a liquid crystal display element, for example. As the oxazine compound, one kind of compound may be used alone, or two or more kinds of compounds may be used in combination. The content of the oxazine compound is preferably 0.1 wt % to 50 wt %, more preferably 1 wt % to 40 wt %, and even more preferably 1 wt % to 20 wt %, based on the total amount of the polyamic acid or its derivatives.
噁嗪化合物优选为可溶于溶解聚酰胺酸或其衍生物的溶剂中、而且具有开环聚合性的噁嗪化合物。The oxazine compound is preferably an oxazine compound that is soluble in a solvent in which the polyamic acid or its derivative is dissolved and that has ring-opening polymerizability.
而且,噁嗪化合物中的噁嗪结构数并无特别的限定。Furthermore, the number of oxazine structures in the oxazine compound is not particularly limited.
噁嗪化合物已经有各种结构。本发明中所用的噁嗪化合物的结构并无特别的限定,可例示苯并噁嗪或萘并噁嗪等具有包含缩合多环芳香族基的芳香族基的噁嗪化合物。Oxazine compounds have various structures. The structure of the oxazine compound used in the present invention is not particularly limited, and examples thereof include oxazine compounds having an aromatic group including a condensed polycyclic aromatic group, such as benzoxazine or naphthoxazine.
噁嗪化合物的例子是下述式(a)~式(f)所表示的化合物。另外,在下述式中,关于朝向环中心而表示的键,是表示与构成环且可键结取代基的任意碳键结。Examples of oxazine compounds are compounds represented by the following formulas (a) to (f). In addition, in the following formulae, the bond shown toward the center of the ring means a bond to any carbon constituting the ring and to which a substituent may be bonded.
在式(a)~式(c)中,R1及R2为碳数为1~30的有机基。In formulas (a) to (c), R 1 and R 2 are organic groups having 1 to 30 carbon atoms.
在式(a)~式(f)中,R3~R6为氢或碳数为1~6的烃基。In formula (a) to formula (f), R 3 to R 6 are hydrogen or a hydrocarbon group having 1 to 6 carbons.
在式(c)、式(d)及式(f)中,X为单键、-O-、-S-、-S-S-、-SO2-、-CO-、-CONH-、-NHCO-、-C(CH3)2-、-C(CF3)2-、-(CH2)m-、-O-(CH2)m-O-、-S-(CH2)m-S-。此处,m是1~6的整数。In formula (c), formula (d) and formula (f), X is a single bond, -O-, -S-, -SS-, -SO 2 -, -CO-, -CONH-, -NHCO- , -C(CH 3 ) 2 -, -C(CF 3 ) 2 -, -(CH 2 ) m -, -O-(CH 2 ) m -O-, -S-(CH 2 ) m -S- . Here, m is an integer of 1-6.
而且,在式(e)及式(f)中,Y独立为单键、-O-、-S-、-CO-、-C(CH3)2-、-C(CF3)2-或碳数为1~3的亚烷基。Moreover, in formula (e) and formula (f), Y is independently a single bond, -O-, -S-, -CO-, -C(CH 3 ) 2 -, -C(CF 3 ) 2 - or An alkylene group having 1 to 3 carbon atoms.
而且,噁嗪化合物中包含于侧链具有噁嗪结构的寡聚物或聚合物、于主链中具有噁嗪结构的寡聚物或聚合物。Furthermore, the oxazine compound includes oligomers or polymers having an oxazine structure in the side chain, and oligomers or polymers having an oxazine structure in the main chain.
式(a)所表示的噁嗪化合物可例示以下的化合物。The following compounds can be illustrated as an oxazine compound represented by formula (a).
于式中,R1优选为碳数为1~30的烷基,更优选为碳数为1~20的烷基。In the formula, R 1 is preferably an alkyl group with 1 to 30 carbons, more preferably an alkyl group with 1 to 20 carbons.
式(b)所表示的噁嗪化合物可例示以下的化合物。The following compounds can be illustrated as an oxazine compound represented by formula (b).
于式中,R1优选为碳数为1~30的烷基,更优选为碳数为1~20的烷基。In the formula, R 1 is preferably an alkyl group with 1 to 30 carbons, more preferably an alkyl group with 1 to 20 carbons.
式(c)所表示的噁嗪化合物可列举下述式(c′)所表示的噁嗪化合物。Examples of the oxazine compound represented by the formula (c) include oxazine compounds represented by the following formula (c').
在式(c′)中,R1及R2为碳数为1~30的有机基、R3~R6为氢或碳数为1~6的烃基,X为单键、-CH2-、-C(CH3)2-、-CO-、-O-、-SO2-或C(CF3)2-。式(c′)所表示的噁嗪化合物的具体例是以下的化合物。In formula (c'), R 1 and R 2 are organic groups with 1 to 30 carbons, R 3 to R 6 are hydrogen or hydrocarbon groups with 1 to 6 carbons, X is a single bond, -CH 2 - , -C(CH 3 ) 2 -, -CO-, -O-, -SO 2 - or C(CF 3 ) 2 -. Specific examples of the oxazine compound represented by the formula (c') are the following compounds.
于式中,R1优选为碳数为1~30的烷基,更优选为碳数为1~20的烷基。In the formula, R 1 is preferably an alkyl group with 1 to 30 carbons, more preferably an alkyl group with 1 to 20 carbons.
式(d)所表示的噁嗪化合物的具体例是以下的化合物。Specific examples of the oxazine compound represented by formula (d) are the following compounds.
式(e)所表示的噁嗪化合物的具体例是以下的化合物。Specific examples of the oxazine compound represented by formula (e) are the following compounds.
式(f)所表示的噁嗪化合物的具体例是以下的化合物。Specific examples of the oxazine compound represented by formula (f) are the following compounds.
这些化合物中优选的是式(b-1)、式(c-1)、式(c-3)、式(c-5)、式(c-7)、式(c-9)、式(d-1)~式(d-6)、式(e-3)、式(e-4)、及式(f-2)~式(f-4)所表示的噁嗪化合物。Preferred among these compounds are formula (b-1), formula (c-1), formula (c-3), formula (c-5), formula (c-7), formula (c-9), formula ( Oxazine compounds represented by d-1) to formula (d-6), formula (e-3), formula (e-4), and formula (f-2) to formula (f-4).
所述噁嗪化合物可参照国际公开第2004/009708号说明书、日本专利特开平11-12258号公报、日本专利特开2004-352670号公报中记载的方法而制造。The oxazine compound can be produced by referring to the methods described in International Publication No. 2004/009708, Japanese Patent Laid-Open No. 11-12258, and Japanese Patent Laid-Open No. 2004-352670.
例如,式(a)所表示的噁嗪化合物可通过使酚化合物与伯胺和醛反应而获得(参照国际公开第2004/009708号说明书)。For example, an oxazine compound represented by formula (a) can be obtained by reacting a phenolic compound with a primary amine and an aldehyde (see International Publication No. 2004/009708).
而且,式(b)所表示的噁嗪化合物可以通过将伯胺缓缓加入至甲醛中的方法进行反应后,再通过添加具有萘酚系羟基的化合物而进行反应而获得(参照国际公开第2004/009708号说明书)。Moreover, the oxazine compound represented by the formula (b) can be obtained by adding a compound having a naphthol-based hydroxyl group and reacting after the primary amine is slowly added to formaldehyde (refer to International Publication No. 2004 /009708 instructions).
而且,式(c)所表示的噁嗪化合物可以通过如下方式而获得:在有机溶剂中,在脂肪族仲胺、脂肪族叔胺或碱性含氮杂环化合物的存在下,使酚化合物1摩尔、相对于1个该酚性羟基至少为2倍摩尔的醛、及等摩尔的伯胺进行反应(参照国际公开第2004/009708号说明书及日本专利特开平11-12258号公报)。Moreover, the oxazine compound represented by the formula (c) can be obtained by making the phenolic compound 1 Mole, at least 2-fold mole of aldehyde with respect to one phenolic hydroxyl group, and equimolar primary amine are reacted (see International Publication No. 2004/009708 specification and Japanese Patent Application Laid-Open No. 11-12258).
而且,式(d)~式(f)所表示的噁嗪化合物可以通过如下方式而获得:在正丁醇中、90℃以上的温度下,使4,4′-二胺基二苯甲烷等具有多个苯环和与所述苯环键结的有机基的二胺、福尔马林等醛、以及苯酚进行脱水缩合反应(参照日本专利特开2004-352670号公报)。Moreover, the oxazine compounds represented by formulas (d) to (f) can be obtained by making 4,4'-diaminodiphenylmethane, etc. Diamine having a plurality of benzene rings and organic groups bonded to the benzene rings, aldehydes such as formalin, and phenol undergo dehydration condensation reaction (see JP-A-2004-352670).
而且,例如自液晶显示元件的电气特性的长期稳定性的观点考虑,本发明的液晶配向剂还可以进一步含有噁唑啉化合物。所谓噁唑啉化合物,是指具有噁唑啉结构的化合物。噁唑啉化合物可单独使用一种化合物,也可以并用两种以上的化合物。噁唑啉化合物的含量相对于聚酰胺酸或其衍生物的总量而言,优选为0.1wt%~50wt%,更优选为1wt%~40wt%,进一步更优选为1wt%~20wt%。或者在将噁唑啉化合物中的噁唑啉结构换算为噁唑啉时,优选所述噁唑啉化合物的含量相对于所述聚酰胺酸或其衍生物而言为0.1wt%~40wt%。Moreover, the liquid crystal alignment agent of this invention may further contain an oxazoline compound from a viewpoint of the long-term stability of the electrical characteristic of a liquid crystal display element, for example. The term "oxazoline compound" refers to a compound having an oxazoline structure. As the oxazoline compound, one kind of compound may be used alone, or two or more kinds of compounds may be used in combination. The content of the oxazoline compound is preferably 0.1 wt % to 50 wt %, more preferably 1 wt % to 40 wt %, and even more preferably 1 wt % to 20 wt %, based on the total amount of the polyamic acid or its derivatives. Alternatively, when the oxazoline structure in the oxazoline compound is converted into oxazoline, the content of the oxazoline compound is preferably 0.1 wt% to 40 wt% relative to the polyamic acid or its derivative.
噁唑啉化合物可以在一个化合物中具有一个噁唑啉结构,但优选具有两个以上。而且噁唑啉化合物可以是在侧链具有噁唑啉环状结构的均聚物,也可以是共聚物。在侧链具有噁唑啉结构的聚合物可以是在侧链具有噁唑啉结构的单体的均聚物,也可以是在侧链具有噁唑啉结构的单体和不具噁唑啉结构的单体的共聚物。在侧链具有噁唑啉结构的共聚物可以是在侧链具有噁唑啉结构的两种以上的单体的共聚物,也可以是在侧链具有噁唑啉结构的两种以上单体和不具噁唑啉结构的单体的共聚物。An oxazoline compound may have one oxazoline structure in one compound, but preferably has two or more. Furthermore, the oxazoline compound may be a homopolymer or a copolymer having an oxazoline ring structure in a side chain. The polymer that has oxazoline structure in side chain can be the homopolymer of the monomer that has oxazoline structure in side chain, also can be the monomer that has oxazoline structure in side chain and does not have oxazoline structure monomeric copolymers. The copolymer that has oxazoline structure in side chain can be the copolymer of two or more monomers that have oxazoline structure in side chain, also can be the monomer that has more than two kinds of oxazoline structures in side chain and A copolymer of monomers without an oxazoline structure.
噁唑啉结构优选为噁唑啉结构中的氧和氮的一者或两者以可与聚酰胺酸的羰基反应的形式存在于噁唑啉化合物中的结构。The oxazoline structure is preferably a structure in which one or both of oxygen and nitrogen in the oxazoline structure exists in the oxazoline compound in a form that can react with the carbonyl group of the polyamic acid.
噁唑啉化合物的具体例是2,2′-双(2-噁唑啉)、1,2,4-三-(2-噁唑啉基-2)-苯、4-呋喃-2-基亚甲基-2-苯基-4H-噁唑-5-酮、1,4-双(4,5-二氢-2-噁唑基)苯、1,3-双(4,5-二氢-2-噁唑基)苯、2,3-双(4-异丙烯基-2-噁唑啉-2-基)丁烷、2,2′-双-4-苄基-2-噁唑啉、2,6-双(异丙基-2-噁唑啉-2-基)吡啶、2,2′-异亚丙基双(4-第三丁基-2-噁唑啉)、2,2′-异亚丙基双(4-苯基-2-噁唑啉)、2,2′-亚甲基双(4-第三丁基-2-噁唑啉)、及2,2′-亚甲基双(4-苯基-2-噁唑啉)。除这些化合物以外,还可以例示如EPOCROS(商品名、日本触媒株式会社制造)之类的具有噁唑基的聚合物或寡聚物。Specific examples of oxazoline compounds are 2,2'-bis(2-oxazoline), 1,2,4-tris-(2-oxazolinyl-2)-benzene, 4-furan-2-yl Methylene-2-phenyl-4H-oxazol-5-one, 1,4-bis(4,5-dihydro-2-oxazolyl)benzene, 1,3-bis(4,5-bis Hydrogen-2-oxazolyl)benzene, 2,3-bis(4-isopropenyl-2-oxazolin-2-yl)butane, 2,2'-bis-4-benzyl-2-oxa Azoline, 2,6-bis(isopropyl-2-oxazolin-2-yl)pyridine, 2,2'-isopropylidene bis(4-tert-butyl-2-oxazoline), 2,2'-isopropylidene bis(4-phenyl-2-oxazoline), 2,2'-methylene bis(4-tert-butyl-2-oxazoline), and 2, 2'-methylenebis(4-phenyl-2-oxazoline). In addition to these compounds, polymers or oligomers having an oxazole group such as EPOCROS (trade name, manufactured by Nippon Shokubai Co., Ltd.) can also be exemplified.
而且,例如自液晶显示元件的电气特性的长期稳定性的观点考虑,本发明的液晶配向剂还可以进一步含有环氧化合物。环氧化合物可单独使用一种化合物,也可以并用两种以上化合物。环氧化合物的含量相对于聚酰胺酸或其衍生物的总量而言,优选为0.1wt%~50wt%,更优选为1wt%~40wt%,进一步更优选为1wt%~20wt%。Moreover, the liquid crystal alignment agent of this invention may further contain an epoxy compound from a viewpoint of the long-term stability of the electrical characteristic of a liquid crystal display element, for example. One kind of epoxy compound may be used alone, or two or more kinds of compounds may be used in combination. The content of the epoxy compound is preferably 0.1 wt % to 50 wt %, more preferably 1 wt % to 40 wt %, and even more preferably 1 wt % to 20 wt %, based on the total amount of the polyamic acid or its derivatives.
环氧化合物可例示缩水甘油醚、缩水甘油酯、缩水甘油胺、含有环氧基的丙烯酸系树脂、缩水甘油基酰胺、缩水甘油基异三聚氰酸酯、链状脂肪族型环氧化合物、及环状脂肪族型环氧化合物。另外,所谓环氧化合物是表示具有环氧基的化合物,环氧树脂表示具有环氧基的树脂。Examples of the epoxy compound include glycidyl ether, glycidyl ester, glycidyl amine, epoxy group-containing acrylic resin, glycidyl amide, glycidyl isocyanurate, chain aliphatic epoxy compound, and cycloaliphatic epoxy compounds. In addition, an epoxy compound means a compound which has an epoxy group, and an epoxy resin means a resin which has an epoxy group.
缩水甘油醚的具体例是双酚A型环氧化合物、双酚F型环氧化合物、双酚S型环氧化合物、双酚型环氧化合物、氢化双酚-A型环氧化合物、氢化双酚-F型环氧化合物、氢化双酚-S型环氧化合物、氢化双酚型环氧化合物、溴化双酚-A型环氧化合物、溴化双酚-F型环氧化合物、酚系酚醛清漆型环氧化合物、甲酚清漆型环氧化合物、溴化酚系酚醛清漆型环氧化合物、溴化甲酚清漆型环氧化合物、双酚A酚醛清漆型环氧化合物、含有萘骨架的环氧化合物、芳香族聚缩水甘油醚化合物、二环戊二烯苯酚型环氧化合物、脂环族二缩水甘油醚化合物、脂肪族聚缩水甘油醚化合物、多硫化物型二缩水甘油醚化合物、及联苯二酚型环氧化合物。Specific examples of glycidyl ethers are bisphenol A type epoxy compounds, bisphenol F type epoxy compounds, bisphenol S type epoxy compounds, bisphenol type epoxy compounds, hydrogenated bisphenol-A type epoxy compounds, hydrogenated bisphenol Phenol-F type epoxy compound, hydrogenated bisphenol-S type epoxy compound, hydrogenated bisphenol type epoxy compound, brominated bisphenol-A type epoxy compound, brominated bisphenol-F type epoxy compound, phenolic Novolak-type epoxy compounds, cresol-type epoxy compounds, brominated phenol-based novolak-type epoxy compounds, brominated cresol-type epoxy compounds, bisphenol A novolak-type epoxy compounds, naphthalene skeleton-containing Epoxy compounds, aromatic polyglycidyl ether compounds, dicyclopentadiene phenol type epoxy compounds, alicyclic diglycidyl ether compounds, aliphatic polyglycidyl ether compounds, polysulfide type diglycidyl ether compounds, And biphenol type epoxy compounds.
缩水甘油酯可例示二缩水甘油酯化合物及缩水甘油酯环氧化合物。Examples of glycidyl esters include diglycidyl ester compounds and glycidyl ester epoxy compounds.
缩水甘油胺可例示聚缩水甘油胺化合物。As glycidylamine, polyglycidylamine compounds can be exemplified.
含有环氧基的丙烯酸系化合物可例示具有环氧乙烷基的单体的均聚物及共聚物。Examples of the epoxy group-containing acrylic compound include homopolymers and copolymers of monomers having an oxiranyl group.
缩水甘油基酰胺基可例示缩水甘油基酰胺型环氧化合物。Glycidyl amide type epoxy compound can be illustrated as a glycidyl amide group.
链状脂肪族型环氧化合物可例示将烯化合物的碳-碳双键氧化而所得的含有环氧基的化合物。As a chain aliphatic epoxy compound, the compound containing an epoxy group obtained by oxidizing the carbon-carbon double bond of an alkene compound can be illustrated.
环状脂肪族型环氧化合物可例示将环烯化合物的碳-碳双键氧化而所得的含有环氧基的化合物。As a cycloaliphatic epoxy compound, the compound containing an epoxy group obtained by oxidizing the carbon-carbon double bond of a cycloalkene compound can be illustrated.
双酚A型环氧化合物的具体例是828、1001、1002、1003、1004、1007、1010(均为Japan Epoxy Resins Co.,Ltd(现:可作为三菱化学株式会社的jER系列产品而获得/下同)制造)、Epotohto YD-128(东都化成株式会社制造)、DER-331、DER-332、DER-324(均为The Dow Chemical Company制造)、Epiclon 840、Epiclon 850、Epiclon 1050(均为DIC株式会社制造)、EPOMIK R-140、EPOMIK R-301、及EPOMIK R-304(均为三井化学株式会社制造)。Specific examples of bisphenol A-type epoxy compounds are 828, 1001, 1002, 1003, 1004, 1007, and 1010 (all of which are Japan Epoxy Resins Co., Ltd (now: available as jER series products of Mitsubishi Chemical Corporation/ The same below), Epotohto YD-128 (manufactured by Dongdu Chemical Co., Ltd.), DER-331, DER-332, DER-324 (all manufactured by The Dow Chemical Company), Epiclon 840, Epiclon 850, Epiclon 1050 (all manufactured by DIC Corporation), EPOMIK R-140, EPOMIK R-301, and EPOMIK R-304 (all manufactured by Mitsui Chemicals, Ltd.).
双酚F型环氧化合物的具体例是806、807、4004P(均为Japan Epoxy Resins Co.,Ltd制造)、Epotohto YDF-170、Epotohto YDF-175S、Epotohto YDF-2001(均为东都化成株式会社制造)、DER-354(The Dow Chemical Company制造)、Epiclon 830、及Epiclon 835(均为DIC株式会社制造)。Specific examples of bisphenol F type epoxy compounds are 806, 807, 4004P (all manufactured by Japan Epoxy Resins Co., Ltd), Epotohto YDF-170, Epotohto YDF-175S, Epotohto YDF-2001 (all manufactured by Tohto Chemical Co., Ltd. company), DER-354 (manufactured by The Dow Chemical Company), Epiclon 830, and Epiclon 835 (all manufactured by DIC Corporation).
双酚型环氧化合物的具体例是2,2-双(4-羟基苯基)-1,1,1,3,3,3-六氟丙烷的环氧化物。A specific example of the bisphenol type epoxy compound is the epoxide of 2,2-bis(4-hydroxyphenyl)-1,1,1,3,3,3-hexafluoropropane.
氢化双酚-A型环氧化合物的具体例是Sun Tohto ST-3000(东都化成株式会社制造)、Ricaresin HBE-100(新日本理化株式会社制造)、及DENACOL EX-252(Nagase chemteX Corporation制造)。Specific examples of hydrogenated bisphenol-A type epoxy compounds are Sun Tohto ST-3000 (manufactured by Tohto Kasei Co., Ltd.), Ricaresin HBE-100 (manufactured by New Japan Physical and Chemical Co., Ltd.), and DENACOL EX-252 (manufactured by Nagase ChemteX Corporation) ).
氢化双酚型环氧化合物的具体例是氢化2,2-双(4-羟基苯基)-1,1,1,3,3,3-六氟丙烷的环氧化物。A specific example of the hydrogenated bisphenol type epoxy compound is the epoxide of hydrogenated 2,2-bis(4-hydroxyphenyl)-1,1,1,3,3,3-hexafluoropropane.
溴化双酚-A型环氧化合物的具体例是5050、5051(均为Japan Epoxy Resins Co.,Ltd制造)、Epotohto YDB-360、Epotohto YDB-400(均为东都化成株式会社制造)、DER-530、DER-538(均为The Dow Chemical Company制造)、Epiclon 152、及Epiclon 153(均为DIC株式会社制造)。Specific examples of brominated bisphenol-A type epoxy compounds are 5050, 5051 (all manufactured by Japan Epoxy Resins Co., Ltd), Epotohto YDB-360, Epotohto YDB-400 (all manufactured by Tohto Chemical Co., Ltd.), DER-530, DER-538 (all manufactured by The Dow Chemical Company), Epiclon 152, and Epiclon 153 (all manufactured by DIC Corporation).
酚系酚醛清漆型环氧化合物的具体例是152、154(均为Japan Epoxy Resins Co.,Ltd制造)、YDPN-638(东都化成株式会社制造)、DEN431、DEN438(均为The Dow Chemical Company制造)、Epiclon N-770(DIC株式会社制造)、EPPN-201、及EPPN-202(均为日本化药株式会社制造)。Specific examples of the phenolic novolak type epoxy compound are 152, 154 (all manufactured by Japan Epoxy Resins Co., Ltd), YDPN-638 (manufactured by Tohto Chemical Co., Ltd.), DEN431, DEN438 (all manufactured by The Dow Chemical Company manufactured), Epiclon N-770 (manufactured by DIC Corporation), EPPN-201, and EPPN-202 (all manufactured by Nippon Kayaku Co., Ltd.).
甲酚清漆型环氧化合物的具体例是180S75(Japan Epoxy Resins Co.,Ltd制造)、YDCN-701、YDCN-702(均为东都化成株式会社制造)、Epiclon N-665、Epiclon N-695(均为DIC株式会社制造)、EOCN-102S、EOCN-103S、EOCN-104S、EOCN-1020、EOCN-1025、及EOCN-1027(均为日本化药株式会社制造)。Specific examples of the cresol novolac type epoxy compound are 180S75 (manufactured by Japan Epoxy Resins Co., Ltd), YDCN-701, YDCN-702 (both manufactured by Tohto Kasei Co., Ltd.), Epiclon N-665, Epiclon N-695 (all manufactured by DIC Corporation), EOCN-102S, EOCN-103S, EOCN-104S, EOCN-1020, EOCN-1025, and EOCN-1027 (all manufactured by Nippon Kayaku Co., Ltd.).
双酚A酚醛清漆型环氧化合物的具体例是157S70(Japan Epoxy Resins Co.,Ltd制造)、及Epiclon N-880(DIC株式会社制造)。Specific examples of the bisphenol A novolak-type epoxy compound are 157S70 (manufactured by Japan Epoxy Resins Co., Ltd.), and Epiclon N-880 (manufactured by DIC Corporation).
含有萘骨架的环氧化合物的具体例是Epiclon HP-4032、Epiclon HP-4700、Epiclon HP-4770(均为DIC株式会社制造)、及NC-7000(日本化药株式会社制造)。Specific examples of epoxy compounds containing a naphthalene skeleton are Epiclon HP-4032, Epiclon HP-4700, Epiclon HP-4770 (all manufactured by DIC Corporation), and NC-7000 (manufactured by Nippon Kayaku Co., Ltd.).
芳香族聚缩水甘油醚化合物的具体例是对苯二酚二缩水甘油醚(下述式E101)、邻苯二酚二缩水甘油醚(下述式E102)间苯二酚二缩水甘油醚(下述式E103)、三(4-缩水甘油氧基苯基)甲烷(下述式E105)、1031S、1032H60(均为Japan Epoxy Resins Co.,Ltd制造)、TACTIX-742(The Dow Chemical Company制造)、DENACOL EX-201(Nagase chemteX Corporation制造)、DPPN-503、DPPN-502H、DPPN-501H、NC6000(均为日本化药株式会社制造)、Techmore VG3101L(三井化学株式会社制造)、下述式E106所表示的化合物、及下述式E107所表示的化合物。Specific examples of the aromatic polyglycidyl ether compound are hydroquinone diglycidyl ether (the following formula E101), catechol diglycidyl ether (the following formula E102) and resorcinol diglycidyl ether (the following formula E102) Formula E103), tris(4-glycidyloxyphenyl)methane (formula E105 below), 1031S, 1032H60 (both manufactured by Japan Epoxy Resins Co., Ltd), TACTIX-742 (manufactured by The Dow Chemical Company) , DENACOL EX-201 (manufactured by Nagase ChemteX Corporation), DPPN-503, DPPN-502H, DPPN-501H, NC6000 (all manufactured by Nippon Kayaku Co., Ltd.), Techmore VG3101L (manufactured by Mitsui Chemicals Corporation), the following formula E106 The compound represented by and the compound represented by the following formula E107.
二环戊二烯苯酚型环氧化合物的具体例是TACTIX-556(The Dow Chemical Company制造)、及Epiclon HP-7200(DIC株式会社制造)。Specific examples of dicyclopentadiene phenol type epoxy compounds are TACTIX-556 (manufactured by The Dow Chemical Company) and Epiclon HP-7200 (manufactured by DIC Corporation).
脂环族二缩水甘油醚化合物的具体例是环己烷二甲醇二缩水甘油醚化合物、及Ricaresin DME-100(新日本理化株式会社制造)。Specific examples of the alicyclic diglycidyl ether compound are cyclohexanedimethanol diglycidyl ether compound and Ricaresin DME-100 (manufactured by Shin Nippon Chemical Co., Ltd.).
脂肪族聚缩水甘油醚化合物的具体例是乙二醇二缩水甘油醚(下述式E108)、二乙二醇二缩水甘油醚(下述式E109)、聚乙二醇二缩水甘油醚、丙二醇二缩水甘油醚(下述式E110)、三丙二醇二缩水甘油醚(下述式E111)、聚丙二醇二缩水甘油醚、新戊二醇二缩水甘油醚(下述式E112)、1,4-丁二醇二缩水甘油醚(下述式E113)、1,6-己二醇二缩水甘油醚(下述式E114)、二溴新戊二醇二缩水甘油醚(下述式E115)、DENACOL EX-810、DENACOL EX-851、DENACOL EX-8301、DENACOL EX-911、DENACOL EX-920、DENACOL EX-931、DENACOL EX-211、DENACOL EX-212、DENACOL EX-313(均为Nagase chemteX Corporation制造)、DD-503(ADEKA株式会社制造)、Ricaresin W-100(新日本理化株式会社制造)、1,3,5,6-四缩水甘油基-2,4-己二醇(下述式E116)、甘油聚缩水甘油醚、山梨糖醇聚缩水甘油醚、三羟甲基丙烷聚缩水甘油醚、季戊四醇聚缩水甘油醚、DENACOL EX-313、DENACOL EX-611、DENACOL EX-321、及DENACOL EX-411(均为Nagase chemteX Corporation制造)。Specific examples of aliphatic polyglycidyl ether compounds are ethylene glycol diglycidyl ether (the following formula E108), diethylene glycol diglycidyl ether (the following formula E109), polyethylene glycol diglycidyl ether, propylene glycol Diglycidyl ether (the following formula E110), tripropylene glycol diglycidyl ether (the following formula E111), polypropylene glycol diglycidyl ether, neopentyl glycol diglycidyl ether (the following formula E112), 1,4- Butanediol diglycidyl ether (the following formula E113), 1,6-hexanediol diglycidyl ether (the following formula E114), dibromoneopentyl glycol diglycidyl ether (the following formula E115), DENACOL EX-810, DENACOL EX-851, DENACOL EX-8301, DENACOL EX-911, DENACOL EX-920, DENACOL EX-931, DENACOL EX-211, DENACOL EX-212, DENACOL EX-313 (all manufactured by Nagase chemteX Corporation ), DD-503 (manufactured by ADEKA Co., Ltd.), Ricaresin W-100 (manufactured by Nippon Chemical Co., Ltd.), 1,3,5,6-tetraglycidyl-2,4-hexanediol (the following formula E116 ), glycerol polyglycidyl ether, sorbitol polyglycidyl ether, trimethylolpropane polyglycidyl ether, pentaerythritol polyglycidyl ether, DENACOL EX-313, DENACOL EX-611, DENACOL EX-321, and DENACOL EX -411 (both manufactured by Nagase ChemteX Corporation).
多硫化物型二缩水甘油醚化合物的具体例是FLDP-50及FLDP-60(均为Toray Thiokol Co.,Ltd.制造)。Specific examples of polysulfide-type diglycidyl ether compounds are FLDP-50 and FLDP-60 (both manufactured by Toray Thiokol Co., Ltd.).
联苯二酚型环氧化合物的具体例是YX-4000、YL-6121H(均为Japan Epoxy Resins Co.,Ltd制造)、NC-3000P、及NC-3000S(均为日本化药株式会社制造)。Specific examples of biphenol type epoxy compounds are YX-4000, YL-6121H (all manufactured by Japan Epoxy Resins Co., Ltd), NC-3000P, and NC-3000S (all manufactured by Nippon Kayaku Co., Ltd.) .
二缩水甘油酯化合物的具体例是对苯二甲酸二缩水甘油基酯(下述式117)、邻苯二甲酸二缩水甘油基酯(下述式E118)、邻苯二甲酸双(2-甲基环氧乙烷基甲基)酯(下述式E119)、下述式E121所表示的化合物、下述式E122所表示的化合物、及下述式E123所表示的化合物。Specific examples of diglycidyl ester compounds are diglycidyl terephthalate (formula 117 below), diglycidyl phthalate (formula E118 below), bis(2-methyl phthalate), Oxiranylmethyl) ester (the following formula E119), a compound represented by the following formula E121, a compound represented by the following formula E122, and a compound represented by the following formula E123.
缩水甘油酯环氧化合物的具体例是871、872(均为Japan Epoxy Resins Co.,Ltd制造)、Epiclon 200、Epiclon 400(均为DIC株式会社制造)、DENACOL EX-711、及DENACOL EX-721(均为Nagase chemteX Corporation制造)。Specific examples of glycidyl ester epoxy compounds are 871, 872 (both manufactured by Japan Epoxy Resins Co., Ltd), Epiclon 200, Epiclon 400 (both manufactured by DIC Corporation), DENACOL EX-711, and DENACOL EX-721 (both manufactured by Nagase ChemteX Corporation).
聚缩水甘油胺化合物的具体例是N,N-二缩水甘油苯胺(下述式E124)、N,N-二缩水甘油基-邻甲苯胺(下述式E125)、N,N-二缩水甘油基-间甲苯胺(下述式E126)、N,N-二缩水甘油基-2,4,6-三溴苯胺(下述式E127)、3-(N,N-二缩水甘油基)胺基丙基三甲氧基硅烷(下述式E128)、N,N,O-三缩水甘油基-对胺基苯酚(下述式E129)、N,N,O-三缩水甘油基-间胺基苯酚(下述式E130)、N,N,N′,N′-四缩水甘油基-间苯二甲胺(TETRAD-X(Mitsubishi Gas Chemical Company制造)、下述式E132)、1,3-双(N,N-二缩水甘油基胺基甲基)环己烷(TETRAD-C(Mitsubishi Gas Chemical Company制造)、下述式E133)、1,4-双(N,N-二缩水甘油基胺基甲基)环己烷(下述式E134)、1,3-双(N,N-二缩水甘油基胺基)环己烷(下述式E135)、1,4-双(N,N-二缩水甘油基胺基)环己烷(下述式E136)、1,3-双(N,N-二缩水甘油基胺基)苯(下述式E137)、1,4-双(N,N-二缩水甘油基胺基)苯(下述式E138)、2,6-双(N,N-二缩水甘油基胺基甲基)双环[2.2.1]庚烷(下述式E139)、N,N,N′,N′-四缩水甘油基-4,4′-二胺基二环己甲烷(下述式E140)、2,2′-二甲基-(N,N,N′,N′-四缩水甘油基)-4,4′-二胺基联苯(下述式E141)、N,N,N′,N′-四缩水甘油基-4,4′-二胺基二苯基醚(下述式E142)、1,3,5-三(4-(N,N-二缩水甘油基)胺基苯氧基)苯(下述式E143)、2,4,4′-三(N,N-二缩水甘油基胺基)二苯醚(下述式E144)、三(4-(N,N-二缩水甘油基)胺基苯基)甲烷(下述式E145)、3,4,3′,4′-四(N,N-二缩水甘油基胺基)联苯(下述式E146)、3,4,3′,4′-四(N,N-二缩水甘油基胺基)二苯醚(下述式E147)、下述式E148所表示的化合物、及下述式E149所表示的化合物。Specific examples of polyglycidylamine compounds are N,N-diglycidylaniline (formula E124 below), N,N-diglycidyl-o-toluidine (formula E125 below), N,N-diglycidylaniline Base-m-toluidine (the following formula E126), N,N-diglycidyl-2,4,6-tribromoaniline (the following formula E127), 3-(N,N-diglycidyl)amine Propyltrimethoxysilane (formula E128 below), N,N,O-triglycidyl-p-aminophenol (formula E129 below), N,N,O-triglycidyl-m-amino Phenol (the following formula E130), N, N, N', N'-tetraglycidyl-m-xylylenediamine (TETRAD-X (manufactured by Mitsubishi Gas Chemical Company), the following formula E132), 1,3- Bis(N,N-diglycidylaminomethyl)cyclohexane (TETRAD-C (manufactured by Mitsubishi Gas Chemical Company), following formula E133), 1,4-bis(N,N-diglycidyl Aminomethyl)cyclohexane (formula E134 below), 1,3-bis(N,N-diglycidylamino)cyclohexane (formula E135 below), 1,4-bis(N, N-diglycidylamino)cyclohexane (following formula E136), 1,3-bis(N,N-diglycidylamino)benzene (following formula E137), 1,4-bis( N,N-diglycidylamino)benzene (following formula E138), 2,6-bis(N,N-diglycidylaminomethyl)bicyclo[2.2.1]heptane (following formula E139), N, N, N', N'-tetraglycidyl-4,4'-diaminodicyclohexyl methane (following formula E140), 2,2'-dimethyl-(N,N , N', N'-tetraglycidyl)-4,4'-diaminobiphenyl (the following formula E141), N,N,N',N'-tetraglycidyl-4,4'- Diaminodiphenyl ether (following formula E142), 1,3,5-tris(4-(N,N-diglycidyl)aminophenoxy)benzene (following formula E143), 2, 4,4'-tris(N,N-diglycidylamino)diphenyl ether (formula E144 below), tris(4-(N,N-diglycidyl)aminophenyl)methane (below Formula E145), 3,4,3',4'-tetra(N,N-diglycidylamino)biphenyl (formula E146 below), 3,4,3',4'-tetra(N , N-diglycidylamino) diphenyl ether (the following formula E147), a compound represented by the following formula E148, and a compound represented by the following formula E149.
具有环氧乙烷基的单体的均聚物的具体例是聚(甲基丙烯酸缩水甘油酯)。具有环氧乙烷基的单体的共聚物的具体例是N-苯基马来酰亚胺-甲基丙烯酸缩水甘油酯共聚物、N-环己基马来酰亚胺-甲基丙烯酸缩水甘油酯共聚物、甲基丙烯酸苄酯-甲基丙烯酸缩水甘油酯共聚物、甲基丙烯酸丁酯-甲基丙烯酸缩水甘油酯共聚物、甲基丙烯酸-2-羟乙酯-甲基丙烯酸缩水甘油酯共聚物、甲基丙烯酸(3-乙基-3-环氧丙基)甲酯-甲基丙烯酸缩水甘油酯共聚物、及苯乙烯-甲基丙烯酸缩水甘油酯共聚物。A specific example of a homopolymer of a monomer having an oxirane group is poly(glycidyl methacrylate). Specific examples of copolymers of monomers having an oxirane group are N-phenylmaleimide-glycidyl methacrylate copolymer, N-cyclohexylmaleimide-glycidyl methacrylate Ester copolymer, benzyl methacrylate-glycidyl methacrylate copolymer, butyl methacrylate-glycidyl methacrylate copolymer, 2-hydroxyethyl methacrylate-glycidyl methacrylate Copolymer, (3-ethyl-3-epoxypropyl)methyl methacrylate-glycidyl methacrylate copolymer, and styrene-glycidyl methacrylate copolymer.
具有环氧乙烷基的单体的具体例是(甲基)丙烯酸缩水甘油酯、(甲基)丙烯酸-3,4-环氧基环己酯、及(甲基)丙烯酸甲基缩水甘油酯。Specific examples of monomers having an oxiranyl group are glycidyl (meth)acrylate, 3,4-epoxycyclohexyl (meth)acrylate, and methylglycidyl (meth)acrylate .
具有环氧乙烷基的单体的共聚物中的所述具有环氧乙烷基的单体以外的其他单体可例示:(甲基)丙烯酸、(甲基)丙烯酸甲酯、(甲基)丙烯酸乙酯、(甲基)丙烯酸异丙酯、(甲基)丙烯酸丁酯、(甲基)丙烯酸异丁酯、(甲基)丙烯酸第三丁酯、(甲基)丙烯酸环己酯、(甲基)丙烯酸苄酯、(甲基)丙烯酸-2-羟乙酯、(甲基)丙烯酸-2-羟丙酯、苯乙烯、甲基苯乙烯、氯甲基苯乙烯、(甲基)丙烯酸(3-乙基-3-环氧丙基)甲酯、N-环己基马来酰亚胺、及N-苯基马来酰亚胺。Examples of other monomers other than the monomer having an oxirane group in the copolymer of monomers having an oxirane group include: (meth)acrylic acid, methyl (meth)acrylate, (methyl) ) ethyl acrylate, isopropyl (meth)acrylate, butyl (meth)acrylate, isobutyl (meth)acrylate, tertiary butyl (meth)acrylate, cyclohexyl (meth)acrylate, Benzyl (meth)acrylate, 2-hydroxyethyl (meth)acrylate, 2-hydroxypropyl (meth)acrylate, styrene, methylstyrene, chloromethylstyrene, (methyl) (3-Ethyl-3-epoxypropyl)methyl acrylate, N-cyclohexylmaleimide, and N-phenylmaleimide.
缩水甘油基异三聚氰酸酯的具体例是1,3,5-三缩水甘油基-1,3,5-三嗪-2,4,6-(1H,3H,5H)-三酮(下述式E150)、1,3-二缩水甘油基-5-烯丙基-1,3,5-三嗪-2,4,6-(1H,3H,5H)-三酮(下述式E151)、及缩水甘油基异三聚氰酸酯型环氧树脂。A specific example of glycidyl isocyanurate is 1,3,5-triglycidyl-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione ( The following formula E150), 1,3-diglycidyl-5-allyl-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione (the following formula E151), and glycidyl isocyanurate epoxy resin.
链状脂肪族型环氧化合物的具体例是环氧化聚丁二烯、及Epolead PB3600(DAICEL CHEMICAL INDUSTRIES,LTD.制造)。Specific examples of chain aliphatic epoxy compounds are epoxidized polybutadiene and Epolead PB3600 (manufactured by DAICEL CHEMICAL INDUSTRIES, LTD.).
环状脂肪族型环氧化合物的具体例是2-甲基-3,4-环氧环己基甲基-2′-甲基-3′,4′-环氧基环己基羧酸酯(下述式E153)、2,3-环氧环戊烷-2′,3′-环氧环戊烷醚(下述式E154)、ε-己内酯改性3,4-环氧环己基甲基-3′,4′-环氧环己烷羧酸酯、1,2:8,9-二环氧柠檬烯(Celloxide 3000(DAICEL CHEMICAL INDUSTRIES,LTD.制造)、下述式E155)、下述式E156所表示的化合物、CY-175、CY-177、CY-179(均为The Ciba-Geigy Chemical Corp.制造(可自Huntsman Japan K.K.获得))、EHPD-3150(DAICEL CHEMICAL INDUSTRIES,LTD.制造)、及环状脂肪族型环氧树脂。A specific example of cycloaliphatic epoxy compound is 2-methyl-3,4-epoxycyclohexylmethyl-2'-methyl-3',4'-epoxycyclohexylcarboxylate (hereinafter Formula E153), 2,3-epoxycyclopentane-2', 3'-epoxycyclopentane ether (the following formula E154), ε-caprolactone modified 3,4-epoxycyclohexyl methyl -3',4'-epoxycyclohexane carboxylate, 1,2:8,9-diepoxylimonene (Celloxide 3000 (manufactured by DAICEL CHEMICAL INDUSTRIES, LTD.), the following formula E155), the following Compound represented by formula E156, CY-175, CY-177, CY-179 (all manufactured by The Ciba-Geigy Chemical Corp. (available from Huntsman Japan K.K.)), EHPD-3150 (manufactured by DAICEL CHEMICAL INDUSTRIES, LTD. ), and cycloaliphatic epoxy resins.
而且,例如本发明的液晶配向剂还可以进一步含有各种添加剂。各种添加剂的例子是聚酰胺酸及其衍生物以外的高分子化合物、及低分子化合物,可根据各自的目的而选择使用。Furthermore, for example, the liquid crystal alignment agent of the present invention may further contain various additives. Examples of various additives are high-molecular compounds and low-molecular compounds other than polyamic acid and its derivatives, which can be selected and used according to the respective purposes.
高分子化合物可例示在有机溶剂中为可溶性的高分子化合物。通过将此种高分子化合物添加于本发明的液晶配向剂中,可以提高液晶显示元件的电压保持率,减低离子密度,且提高耐光性和耐热性,制造可靠性高的液晶显示元件。该高分子化合物的具体例是例如聚酰胺、聚氨酯、聚脲、聚酯、聚环氧化物、聚酯多元醇、有机硅改性聚氨酯、及有机硅改性聚酯。As a polymer compound, a polymer compound which is soluble in an organic solvent can be illustrated. By adding such a polymer compound to the liquid crystal alignment agent of the present invention, the voltage retention rate of the liquid crystal display element can be increased, the ion density can be reduced, and the light resistance and heat resistance can be improved to manufacture a highly reliable liquid crystal display element. Specific examples of the polymer compound include, for example, polyamide, polyurethane, polyurea, polyester, polyepoxide, polyester polyol, silicone-modified polyurethane, and silicone-modified polyester.
至于低分子化合物,1)当期望提高涂布性时可例示用来实现相关目的的表面活性剂、2)当必须提高抗静电时可例示抗静电剂、3)当期望提高与基板的密着性或耐摩擦性时可例示硅烷偶联剂(silane coupling agent)或鈦系偶联剂、或者4)当于低温下进行酰亚胺化的情况下可例示酰亚胺化触媒。As for the low-molecular compound, 1) when it is desired to improve the coatability, a surfactant for the purpose can be exemplified, 2) when it is necessary to improve antistatic, an antistatic agent can be exemplified, 3) when it is desired to improve the adhesion to the substrate Or a silane coupling agent or a titanium-based coupling agent can be exemplified for friction resistance, or 4) an imidization catalyst can be exemplified when imidization is performed at a low temperature.
硅烷偶联剂的具体例是乙烯基三甲氧基硅烷、乙烯基三乙氧基硅烷、N-(2-胺基乙基)-3-胺基丙基甲基二甲氧基硅烷、N-(2-胺基乙基)-3-胺基丙基甲基三甲氧基硅烷、对胺基苯基三甲氧基硅烷、对胺基苯基三乙氧基硅烷、间胺基苯基三甲氧基硅烷、间胺基苯基三乙氧基硅烷、3-胺基丙基三甲氧基硅烷、3-胺基丙基三乙氧基硅烷、3-缩水甘油氧基丙基三甲氧基硅烷、3-缩水甘油氧基丙基甲基二甲氧基硅烷、2-(3,4-环氧基环己基)乙基三甲氧基硅烷、3-氯丙基甲基二甲氧基硅烷、3-氯丙基三甲氧基硅烷、3-甲基丙烯酰氧基丙基三甲氧基硅烷、3-巯基丙基三甲氧基硅烷、N-(1,3-二甲基亚丁基)-3-(三乙氧基硅烷基)-1-丙基胺、及N,N′-双[3-(三甲氧基硅烷基)丙基]乙二胺。Specific examples of silane coupling agents are vinyltrimethoxysilane, vinyltriethoxysilane, N-(2-aminoethyl)-3-aminopropylmethyldimethoxysilane, N- (2-aminoethyl)-3-aminopropylmethyltrimethoxysilane, p-aminophenyltrimethoxysilane, p-aminophenyltriethoxysilane, m-aminophenyltrimethoxysilane silane, m-aminophenyltriethoxysilane, 3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, 3-glycidyloxypropyltrimethoxysilane, 3-glycidyloxypropylmethyldimethoxysilane, 2-(3,4-epoxycyclohexyl)ethyltrimethoxysilane, 3-chloropropylmethyldimethoxysilane, 3 -Chloropropyltrimethoxysilane, 3-methacryloxypropyltrimethoxysilane, 3-mercaptopropyltrimethoxysilane, N-(1,3-dimethylbutylene)-3- (triethoxysilyl)-1-propylamine, and N,N'-bis[3-(trimethoxysilyl)propyl]ethylenediamine.
酰亚胺化触媒的具体例可列举:三甲胺、三乙胺、三丙胺、三丁胺等脂肪族胺类;N,N-二甲基苯胺、N,N-二乙基苯胺、经甲基取代的苯胺、经羟基取代的苯胺等芳香族胺类;吡啶、经甲基取代的吡啶、经羟基取代的吡啶、喹啉、经甲基取代的喹啉、经羟基取代的喹啉、异喹啉、经甲基取代的异喹啉、经羟基取代的异喹啉、咪唑、经甲基取代的咪唑、经羟基取代的咪唑等环式胺类。酰亚胺化触媒优选为选自N,N-二甲基苯胺、邻羟基苯胺、间羟基苯胺、对羟基苯胺、邻羟基吡啶、间羟基吡啶、对羟基吡啶、及异喹啉的一种或两种以上。Specific examples of imidization catalysts include: aliphatic amines such as trimethylamine, triethylamine, tripropylamine, and tributylamine; N, N-dimethylaniline, N, N-diethylaniline, methyl Aromatic amines such as base substituted aniline, hydroxy substituted aniline; pyridine, methyl substituted pyridine, hydroxy substituted pyridine, quinoline, methyl substituted quinoline, hydroxy substituted quinoline, iso Cyclic amines such as quinoline, methyl-substituted isoquinoline, hydroxyl-substituted isoquinoline, imidazole, methyl-substituted imidazole, and hydroxyl-substituted imidazole. The imidization catalyst is preferably selected from N,N-dimethylaniline, o-hydroxyaniline, m-hydroxyaniline, p-hydroxyaniline, o-hydroxypyridine, m-hydroxypyridine, p-hydroxypyridine, and isoquinoline or Two or more.
硅烷偶联剂的添加量通常为聚酰胺酸或其衍生物的总重量的0.1wt%~50wt%,优选为0.1wt%~30wt%。The amount of the silane coupling agent added is usually 0.1 wt % to 50 wt %, preferably 0.1 wt % to 30 wt %, based on the total weight of the polyamic acid or its derivatives.
酰亚胺化触媒的添加量相对于聚酰胺酸或其衍生物的羰基通常为0.01当量~5当量,优选为0.05当量~3当量。The addition amount of an imidation catalyst is 0.01 equivalent - 5 equivalents normally with respect to the carbonyl group of a polyamic acid or its derivative|guide_body, Preferably it is 0.05 equivalent - 3 equivalents.
其他添加剂的添加量根据其用途而有所不同,通常为聚酰胺酸或其衍生物的总重量的0.1wt%~50wt%,优选为0.1wt%~30wt%。The addition amount of other additives varies according to the use thereof, and is usually 0.1 wt % to 50 wt %, preferably 0.1 wt % to 30 wt %, based on the total weight of the polyamic acid or its derivatives.
而且,例如本发明的液晶配向剂还可以在不损及本发明的效果的范围(优选为所述聚酰胺酸或其衍生物的总量的20wt%以内)进一步含有丙烯酸聚合物、丙烯酸酯聚合物、以及四羧酸二酐、二羧酸或其衍生物与二胺的反应生成物即聚酰胺酰亚胺等其他聚合物成分。Moreover, for example, the liquid crystal alignment agent of the present invention may further contain acrylic polymer, acrylate polymer and other polymer components such as polyamideimide, which is a reaction product of tetracarboxylic dianhydride, dicarboxylic acid or its derivatives, and diamine.
而且,例如自调整液晶配向剂的涂布性或者所述聚酰胺酸或其衍生物的浓度的观点考虑,本发明的液晶配向剂还可以进一步含有溶剂。溶剂如果是具有溶解高分子成分的能力的溶剂,则可以无特别限制地应用。溶剂广泛包干在聚酰胺酸、可溶性聚酰亚胺等高分子成分的制造步骤或用途方面通常使用的溶剂,可根据使用目的而适宜选择。溶剂可以是一种,也可以将两种以上制成混合溶剂而使用。Furthermore, the liquid crystal alignment agent of the present invention may further contain a solvent, for example, from the viewpoint of adjusting the coatability of the liquid crystal alignment agent or the concentration of the polyamic acid or its derivative. The solvent can be used without any particular limitation as long as it has the ability to dissolve the polymer component. The solvent is widely used in the production process or application of polymer components such as polyamic acid and soluble polyimide, and can be appropriately selected according to the purpose of use. One kind of solvent may be used, or two or more kinds may be used as a mixed solvent.
溶剂可大致分为聚酰胺酸或其衍生物的母液、以及以改善涂布性为目的的其他溶剂。Solvents can be roughly classified into mother liquors of polyamic acid or derivatives thereof, and other solvents for the purpose of improving coatability.
在聚酰胺酸或其衍生物的母液中使用的是非质子性极性有机溶剂,其具体例是N-甲基-2-吡咯烷酮、二甲基咪唑啉酮、N-甲基己内酰胺、N-甲基丙酰胺、N,N-二甲基乙酰胺、二甲基亚砜、N,N-二甲基甲酰胺、N,N-二乙基甲酰胺、二乙基乙酰胺、γ-丁内酯等内酯。Aprotic polar organic solvents are used in the mother liquor of polyamic acid or its derivatives, and its specific examples are N-methyl-2-pyrrolidone, dimethylimidazolinone, N-methylcaprolactam, N-methyl Nyl propionamide, N,N-dimethylacetamide, dimethylsulfoxide, N,N-dimethylformamide, N,N-diethylformamide, diethylacetamide, γ-butyrol Esters and other lactones.
以改善涂布性等为目的的其他溶剂可例示:乳酸烷基酯、3-甲基-3-甲氧基丁醇、萘满、异佛尔酮、乙二醇单丁醚等乙二醇单烷基醚、二乙二醇单乙醚等二乙二醇单烷基醚、乙二醇单烷基酯或乙酸苯酯、三乙二醇单烷基醚、丙二醇单甲醚、丙二醇单丁醚等丙二醇单烷基醚、丙二酸二乙酯等丙二酸二烷基酯、二丙二醇单甲醚等二丙二醇单烷基醚、这些化合物的乙酸酯类等酯化合物。Examples of other solvents for the purpose of improving coatability, etc. include ethylene glycol such as alkyl lactate, 3-methyl-3-methoxybutanol, tetralin, isophorone, and ethylene glycol monobutyl ether. Monoalkyl ether, diethylene glycol monoethyl ether and other diethylene glycol monoalkyl ether, ethylene glycol monoalkyl ester or phenyl acetate, triethylene glycol monoalkyl ether, propylene glycol monomethyl ether, propylene glycol monobutyl Propylene glycol monoalkyl ethers such as ethers, dialkyl malonates such as diethyl malonate, dipropylene glycol monoalkyl ethers such as dipropylene glycol monomethyl ether, and ester compounds such as acetates of these compounds.
在这些溶剂中,特别优选N-甲基-2-吡咯烷酮、二甲基咪唑啉酮、γ-丁内酯、乙二醇单丁醚、二乙二醇单乙醚、丙二醇单丁醚、丙二醇单甲醚、及二丙二醇单甲醚。Among these solvents, N-methyl-2-pyrrolidone, dimethylimidazolinone, γ-butyrolactone, ethylene glycol monobutyl ether, diethylene glycol monoethyl ether, propylene glycol monobutyl ether, propylene glycol monobutyl ether, and propylene glycol monobutyl ether are particularly preferred. Methyl ether, and dipropylene glycol monomethyl ether.
本发明中的液晶配向剂是可用溶剂将包含通常所述聚酰胺酸或其衍生物的高分子成分稀释而以溶液的形态供给实际应用。此时高分子成分的浓度并无特别的限定,优选为0.1wt%~40wt%。于将该液晶配向剂涂布于基板上时,有时需要为了调整膜厚而将所含有的高分子成分预先用溶剂加以稀释的操作。此时,自将液晶配向剂的粘度调整为适于将溶剂容易地混合于液晶配向剂中的粘度的观点考虑,优选所述高分子成分的浓度为40wt%以下。The liquid crystal alignment agent in the present invention can be used in the form of a solution by diluting the polymer component containing the general polyamic acid or its derivatives with a solvent. At this time, the concentration of the polymer component is not particularly limited, but is preferably 0.1 wt% to 40 wt%. When coating this liquid crystal alignment agent on a board|substrate, in order to adjust a film thickness, the operation of diluting the polymer component contained beforehand with a solvent may be required. At this time, from the viewpoint of adjusting the viscosity of the liquid crystal alignment agent to a viscosity suitable for easily mixing the solvent in the liquid crystal alignment agent, the concentration of the polymer component is preferably 40 wt % or less.
还存在根据液晶配向剂的涂布方法而调整液晶配向剂中的所述高分子成分的浓度的情况。液晶配向剂的涂布方法为旋涂法或印刷法时,为了良好地保持膜厚,多数情况下使所述高分子成分的浓度通常为10wt%以下。也可以用其他涂布方法、例如浸渍法或喷墨法进一步降低浓度。另一方面,如果高分子成分的浓度为0.1wt%以上,则所得的液晶配向膜的膜厚容易变得最适宜。因此,所述高分子成分的浓度在通常的旋涂法或印刷法等中为0.1wt%以上,优选为0.5wt%~10wt%。然而,也可以根据液晶配向剂的涂布方法而以更低的浓度而使用。The density|concentration of the said polymer component in a liquid crystal alignment agent may be adjusted according to the coating method of a liquid crystal alignment agent. When the coating method of the liquid crystal alignment agent is a spin coating method or a printing method, in order to maintain a good film thickness, the concentration of the polymer component is usually 10 wt % or less in many cases. It is also possible to further reduce the concentration by other coating methods, such as dipping or inkjet methods. On the other hand, when the density|concentration of a polymer component is 0.1 wt% or more, the film thickness of the obtained liquid crystal alignment film becomes easy to become optimum. Therefore, the concentration of the polymer component is 0.1 wt % or more, preferably 0.5 wt % to 10 wt %, in a typical spin coating method, printing method, or the like. However, depending on the coating method of the liquid crystal alignment agent, it may be used at a lower concentration.
另外,在液晶配向膜的制作中使用的情况下,本发明的液晶配向剂的粘度可以根据形成该液晶配向剂的膜的手段或方法而决定。例如,在使用印刷机而形成液晶配向剂的膜的情况下,自获得充分的膜厚的观点考虑,优选为5mPa□s以上、且自抑制印刷不均的观点考虑优选为100mPa□s以下,更优选为10mPa□s~80mPa□s。在利用旋涂来涂布液晶配向剂而形成液晶配向剂的膜的情况下,自同样的观点考虑,优选为5mPa□s~200mPa□s,更优选为10mPa□s~100mPa□s。液晶配向剂的粘度可以通过利用溶剂进行稀释或者伴随着搅拌的熟化而降低。Moreover, when it is used for preparation of a liquid crystal alignment film, the viscosity of the liquid crystal alignment agent of this invention can be determined by the means or method of forming the film of this liquid crystal alignment agent. For example, when using a printing machine to form a film of a liquid crystal alignment agent, from the viewpoint of obtaining a sufficient film thickness, it is preferably 5 mPa s or more, and from the viewpoint of suppressing printing unevenness, it is preferably 100 mPa s or less. More preferably, it is 10 mPa□s to 80 mPa□s. When applying a liquid crystal alignment agent by spin coating to form a film of the liquid crystal alignment agent, from the same viewpoint, it is preferably 5 mPa□s to 200 mPa□s, more preferably 10 mPa□s to 100 mPa□s. The viscosity of the liquid crystal alignment agent can be reduced by diluting with a solvent or aging with stirring.
本发明的液晶配向剂可以是含有一种聚酰胺酸或其衍生物的形态,也可以是混合了两种以上聚酰胺酸或其衍生物的所谓聚合物共混物(polymer blend)的形态。将聚合物共混物形态的液晶配向剂设为含有聚酰胺酸或其衍生物A和聚酰胺酸或其衍生物B的组成物时,可例示A、B任意一者或两者中包含源自式(Q)所表示的四羧酸二酐的结构单元和源自式(V-2)所表示的具有侧链结构的二胺的结构单元的态样。然而,在假设利用聚合物共混物法使具有此种侧链结构的聚酰胺酸或其衍生物偏析于配向膜的上层的情况下,偏析于下层的聚酰胺酸或其衍生物中无需具有侧链结构。因此,通常成为A、B的任意一者、偏析于上层的聚酰胺酸或其衍生物包含源自式(Q)所表示的四羧酸二酐的结构单元和原子式(V-2)所表示的具有侧链结构的二胺的结构单元,另一者使用由不包含侧链结构的二胺所构成的聚酰胺酸或其衍生物的态样。另一者的聚酰胺酸或其衍生物中包含源自式(Q)所表示的四羧酸二酐的结构单元也无妨。The liquid crystal alignment agent of the present invention may be in the form of a polyamic acid or its derivatives, or in the form of a so-called polymer blend in which two or more polyamic acids or its derivatives are mixed. When the liquid crystal alignment agent in the form of a polymer blend is made into a composition containing polyamic acid or its derivative A and polyamic acid or its derivative B, the source contained in any one of A and B or both can be exemplified. Aspects of a structural unit derived from a tetracarboxylic dianhydride represented by formula (Q) and a structural unit derived from a diamine having a side chain structure represented by formula (V-2). However, assuming that the polyamic acid or its derivative having such a side chain structure is segregated in the upper layer of the alignment film by the polymer blend method, the polyamic acid or its derivative segregated in the lower layer does not need to have side chain structure. Therefore, the polyamic acid or its derivatives which usually become any one of A and B and segregate in the upper layer include structural units derived from tetracarboxylic dianhydride represented by formula (Q) and atomic formula (V-2). The structural unit which has the diamine of a side chain structure is shown, and the aspect which uses the polyamic acid which consists of diamine which does not contain a side chain structure, or its derivative is used for the other. It does not matter if the structural unit derived from the tetracarboxylic dianhydride represented by formula (Q) is contained in the other polyamic acid or its derivative|guide_body.
在共混三种以上聚酰胺酸或其衍生物的情况下,源自式(Q)所表示的四羧酸二酐的结构单元和源自式(V-2)所表示的具有侧链结构的二胺的结构单元,可以在混合的聚酰胺酸或其衍生物的仅一种中含有,也可以在两种聚酰胺酸或其衍生物中含有,还可以在所有的聚酰胺酸或其衍生物中含有,然而如上所述,通常成为仅仅在偏析于最上部的聚酰胺酸或其衍生物中包含源自式(Q)所表示的四羧酸二酐的结构单元和源自式(V-2)所表示的具有侧链结构的二胺的结构单元的态样。在此情况下,在其余两种聚酰胺酸或其衍生物中包含源自式(Q)所表示的四羧酸二酐的结构单元也无妨。In the case of blending three or more polyamic acids or derivatives thereof, the structural unit derived from the tetracarboxylic dianhydride represented by the formula (Q) and the compound having a side chain structure represented by the formula (V-2) The structural unit of the diamine can be contained in only one of the mixed polyamic acids or derivatives thereof, can also be contained in two kinds of polyamic acids or derivatives thereof, or can be contained in all polyamic acids or derivatives thereof. Contained in the derivative, however as mentioned above, usually only in the polyamic acid or its derivative that segregates in the uppermost part, contain the structural unit derived from the tetracarboxylic dianhydride represented by formula (Q) and the structural unit derived from the formula ( The aspect of the structural unit of the diamine which has a side chain structure represented by V-2). In this case, it does not matter if the structural unit derived from the tetracarboxylic dianhydride represented by formula (Q) is included in the remaining two polyamic acids or derivatives thereof.
本发明的液晶配向膜是通过对上述本发明的液晶配向剂的涂膜进行加热而形成的膜。本发明的液晶配向膜可以利用由液晶配向剂制作液晶配向膜的通常方法而获得。例如本发明的液晶配向膜可以通过如下步骤而获得:形成本发明的液晶配向剂的涂膜的步骤、对其进行加热而煅烧的步骤。关于本发明的液晶配向膜,还可以视需要对通过所述煅烧步骤而获得的膜进行摩擦处理。The liquid crystal alignment film of the present invention is a film formed by heating the above-mentioned coating film of the liquid crystal alignment agent of the present invention. The liquid crystal alignment film of the present invention can be obtained by a common method for producing a liquid crystal alignment film from a liquid crystal alignment agent. For example, the liquid crystal alignment film of the present invention can be obtained through the steps of forming a coating film of the liquid crystal alignment agent of the present invention and heating and calcining it. Regarding the liquid crystal alignment film of the present invention, the film obtained through the calcination step may also be subjected to rubbing treatment if necessary.
涂膜可与通常的液晶配向膜的制作同样地将本发明的液晶配向剂涂布于液晶显示元件的基板上而形成。所述基板可列举亦可设置ITO(Indium Tin Oxide)电极等电极或彩色滤光片等的玻璃制基板。The coating film can be formed by applying the liquid crystal alignment agent of the present invention on a substrate of a liquid crystal display element in the same manner as preparation of a normal liquid crystal alignment film. The substrate may be a glass substrate on which electrodes such as ITO (Indium Tin Oxide) electrodes or color filters may be provided.
将液晶配向剂涂布于基板上的方法通常已知有旋涂法、印刷法、浸渍法、滴下法、喷墨法等。这些方法也可以同样地适用于本发明中。As a method of coating a liquid crystal alignment agent on a substrate, generally known methods include spin coating, printing, dipping, dropping, and inkjet. These methods can also be similarly applied to the present invention.
所述涂膜的煅烧可以在所述聚酰胺酸或其衍生物呈现脱水、闭环反应所必需的条件下进行。所述涂膜的煅烧通常已知有在烘箱或红外炉中进行加热处理的方法、在加热板上进行加热处理的方法等。这些方法也可以同样地适用于本发明中。通常优选在150℃~300℃左右的温度下进行1分钟~3小时。Calcination of the coating film can be carried out under conditions necessary for the polyamic acid or its derivatives to exhibit dehydration and ring-closure reactions. Calcination of the above coating film generally includes a method of heat treatment in an oven or an infrared furnace, a method of heat treatment on a hot plate, and the like. These methods can also be similarly applied to the present invention. Usually, it is preferable to carry out at a temperature of about 150°C to 300°C for 1 minute to 3 hours.
摩擦处理可以与通常的用于液晶配向膜的配向处理的摩擦处理同样地进行,如果是在本发明的液晶配向膜中获得充分的延迟的条件即可。特佳的条件是毛压入量为0.2mm~0.8mm、平台移动速度为5mm/sec~250mm/sec、辊旋转速度为500rpm~2,000rpm。液晶配向膜的配向处理方法除了摩擦法以外,通常已知光配向法或转印法等。在获得本发明的效果的范围内,也可以将这些其他配向处理方法替换为所述摩擦处理,也可以与摩擦处理并用。The rubbing treatment can be performed in the same manner as the rubbing treatment used for the alignment treatment of a general liquid crystal alignment film, as long as it is the condition for obtaining sufficient retardation in the liquid crystal alignment film of the present invention. Particularly preferable conditions are that the gross indentation is 0.2 mm to 0.8 mm, the table moving speed is 5 mm/sec to 250 mm/sec, and the roll rotation speed is 500 rpm to 2,000 rpm. As an alignment treatment method of a liquid crystal alignment film, a photo-alignment method, a transfer method, etc. are generally known besides a rubbing method. Within the scope of obtaining the effects of the present invention, these other alignment treatment methods may be replaced by the rubbing treatment, or may be used in combination with the rubbing treatment.
关于照射光而实施配向处理的光配向法,提出了光分解法、光异构化法、光二聚反应法、光交联法等大量的配向机理(例如参照液晶,第3卷,第4号,第262页,1999年;日本专利特开2005-275364号公报及日本专利特开平11-15001号公报)。在这些光配向法中,进行了并无由于分解生成物或添加剂而污染液晶组成物之虞的光二聚反应法及光异构化法的开发。Regarding the photo-alignment method of performing alignment treatment by irradiating light, a large number of alignment mechanisms such as photo-decomposition method, photo-isomerization method, photo-dimerization method, and photo-crosslinking method have been proposed (for example, refer to Liquid Crystal, Vol. 3, No. 4 , p. 262, 1999; Japanese Patent Laid-Open No. 2005-275364 and Japanese Patent Laid-Open No. 11-15001). Among these photo-alignment methods, development of a photo-dimerization method and a photo-isomerization method that do not contaminate the liquid crystal composition with decomposition products or additives has been carried out.
关于光二聚反应法,例如有以M.Schadt等人的Jpn.J.Appl.Phys.,31,2155(1992)或者日本专利第2608661号公报为首的介绍利用对聚乙烯肉桂酸酯或其衍生物照射直线偏光的紫外光而引起的光二聚反应的光配向膜的文献。而且,在日本专利特开平10-251513号公报中介绍了由包含在侧链具有肉桂酸酯基的聚酰亚胺的光配向性组成物而形成的液晶配向膜,在日本专利特开2002-069180号公报中提出了由在侧链具有经取代的肉桂酰基的聚酰胺酸所形成的液晶配向膜。Regarding the photodimerization reaction method, for example, the introduction of Jpn.J.Appl.Phys. by M.Schadt et al., 31, 2155 (1992) or Japanese Patent No. 2608661 uses polyvinyl cinnamate or its derivatives Documentation on the photo-alignment film of the photo-dimerization reaction caused by the irradiation of linearly polarized ultraviolet light. Moreover, in Japanese Patent Laying-Open No. 10-251513, a liquid crystal alignment film formed by a photoalignment composition comprising polyimide having a cinnamate group in a side chain is introduced, and in Japanese Patent Laid-Open 2002- Japanese Patent Publication No. 069180 proposes a liquid crystal alignment film comprising a polyamic acid having a substituted cinnamoyl group in a side chain.
另一方面,还揭示了利用偶氮基等的光异构化反应的光配向法。在日本专利特开2005-275364号公报等中记载了:对主链上包含偶氮基等的聚酰胺酸膜照射直线偏光的紫外光后进行加热酰亚胺化,则获得具有大的配向指数的液晶配向膜。On the other hand, a photoalignment method using a photoisomerization reaction of an azo group or the like is also disclosed. In Japanese Patent Application Laid-Open No. 2005-275364, etc., it is described that a polyamic acid film containing an azo group or the like on the main chain is irradiated with linearly polarized ultraviolet light and then imidized by heating to obtain a polyamic acid film having a large alignment index. liquid crystal alignment film.
本发明的液晶配向剂如上所述那样含有式(Q)所表示的四羧酸二酐、式(V-2)所表示的具有侧链结构的二胺或式(V-2)所表示的具有侧链结构的二胺和其他二胺的混合物与四羧酸二酐反应而所得的聚酰胺酸或其衍生物,涂布于基板上进行加热而产生脱水、闭环反应,从而成为聚酰亚胺。于对形成于基板上的聚酰亚胺膜照射直线偏光的紫外光,其后贴合两枚基板而制造的单元(cell)中封入液晶组成物,则可获得通过光配向的侧链而赋予液晶分子所期望的配向状态的液晶显示元件,其中所述聚酰亚胺膜是利用含有适宜使用侧链包含感光性基的二胺、例如式(V-11-1)~式(V-11-19)所表示的化合物作为式(V-2)所表示的二胺而制造的聚酰胺酸或其衍生物的液晶配向剂而形成于基板上的聚酰亚胺膜。此时,也可以并用包含式(V-11-1)~式(V-11-19)所表示的感光性基的二胺和具有除此以外的侧链结构的式(V-2)所表示的二胺。另外,包含式(V-11-1)~式(V-11-19)所表示的感光性基的二胺、具有除此以外的侧链结构的式(V-2)所表示的二胺中,还可以并用不含侧链结构的其他二胺。As mentioned above, the liquid crystal alignment agent of the present invention contains tetracarboxylic dianhydride represented by formula (Q), diamine having a side chain structure represented by formula (V-2), or diamine represented by formula (V-2). Polyamic acid or its derivatives obtained by reacting a mixture of diamines with side chain structures and other diamines with tetracarboxylic dianhydride, are coated on a substrate and heated to cause dehydration and ring closure reactions, thereby becoming polyimide amine. When the polyimide film formed on the substrate is irradiated with linearly polarized ultraviolet light, and then the two substrates are bonded together to manufacture a cell (cell), a liquid crystal composition can be obtained by enclosing a side chain endowed by photoalignment. A liquid crystal display element in the desired alignment state of liquid crystal molecules, wherein the polyimide film is made of a diamine containing a suitable side chain containing a photosensitive group, such as formula (V-11-1) to formula (V-11 The compound represented by -19) is a polyimide film formed on a substrate as a liquid crystal alignment agent of a polyamic acid or a derivative thereof produced as a diamine represented by formula (V-2). At this time, diamines containing photosensitive groups represented by formulas (V-11-1) to (V-11-19) and formulas (V-2) having other side chain structures may be used in combination. Represented diamine. In addition, diamines containing photosensitive groups represented by formulas (V-11-1) to (V-11-19), diamines represented by formula (V-2) having other side chain structures Among them, other diamines not having a side chain structure can also be used in combination.
而且,于对形成于基板上的聚酰胺酸或其衍生物的膜照射紫外光,继而进行加热酰亚胺化,其后将两枚基板贴合而制造的单元中封入液晶组成物,则可获得由于光配向的主链的影响而赋予液晶分子所期望的配向状态的液晶显示元件,其中所述聚酰胺酸或其衍生物的膜是利用含有聚酰胺酸或其衍生物的液晶配向剂而形成于基板上的聚酰胺酸或其衍生物的膜,所述聚酰胺酸或其衍生物是使式(V-2)所表示的二胺与作为其他二胺的具有感光性基的二胺、例如式(VI-11-1)~(VI-11-16)所表示的化合物的混合物与四羧酸二酐反应而获得的。Furthermore, by irradiating the film of polyamic acid or its derivatives formed on the substrate with ultraviolet light, followed by imidization by heating, and then encapsulating the liquid crystal composition in a cell manufactured by laminating two substrates together, it is possible Obtain a liquid crystal display element that gives liquid crystal molecules a desired alignment state due to the influence of the main chain of photoalignment, wherein the film of polyamic acid or its derivatives is formed by using a liquid crystal alignment agent containing polyamic acid or its derivatives A film of polyamic acid or a derivative thereof formed on a substrate, wherein the polyamic acid or its derivative is obtained by combining a diamine represented by formula (V-2) with a diamine having a photosensitive group as other diamine , For example, obtained by reacting a mixture of compounds represented by formulas (VI-11-1) to (VI-11-16) with tetracarboxylic dianhydride.
在具有如上所述那样使用含有在主链上包含感光性基的聚合物的液晶配向剂而制造的配向膜的液晶显示元件中,当欲表现出预定的预倾角的情况下,可以适宜选择如下的方法:在照射紫外光时自任意的角度对基板照射直线偏光的方法、或者组合了对基板自垂直方向照射直线偏光和自任意的角度无偏光照射的方法。在使用本发明的液晶配向剂而形成了液晶配向膜的液晶显示元件中,当欲使液晶分子表现出预倾角的情况下,可以对所述的聚酰胺酸或其衍生物的膜照射偏光的紫外光,也可以照射无偏光的紫外光。In a liquid crystal display element having an alignment film manufactured by using a liquid crystal alignment agent containing a polymer containing a photosensitive group in the main chain as described above, when it is desired to exhibit a predetermined pretilt angle, the following can be appropriately selected The method: the method of irradiating the substrate with linearly polarized light from an arbitrary angle when irradiating ultraviolet light, or the method of combining the method of irradiating the substrate with linearly polarized light from a vertical direction and non-polarized light from an arbitrary angle. In a liquid crystal display element in which a liquid crystal alignment film is formed by using the liquid crystal alignment agent of the present invention, when it is desired to make the liquid crystal molecules exhibit a pretilt angle, the film of the polyamic acid or its derivatives can be irradiated with polarized light. Ultraviolet light may also be irradiated with non-polarized ultraviolet light.
本发明的液晶配向膜可以利用除上述步骤以外还进一步包含其他步骤的方法而适宜地获得。此种其他步骤可列举:使所述涂膜干燥的步骤、或者用清洗液对摩擦处理前后的膜进行清洗的步骤等。The liquid crystal alignment film of the present invention can be suitably obtained by a method further comprising other steps in addition to the above steps. Such other steps include a step of drying the coating film, a step of washing the film before and after rubbing treatment with a cleaning solution, and the like.
干燥步骤与上述煅烧步骤同样地通常已知有在烘箱或红外炉中进行加热处理的方法、在加热板上进行加热处理的方法等。这些方法也可以同样地适用。干燥步骤优选在溶剂可蒸发的范围内的温度下实施,更优选在相对于煅烧步骤中的温度而言较低的温度下实施。In the drying step, a method of heat-treating in an oven or an infrared furnace, a method of heat-treating on a hot plate, etc. are generally known, similarly to the above-mentioned calcination step. These methods can be applied equally well. The drying step is preferably performed at a temperature within a range in which the solvent can evaporate, more preferably at a lower temperature than that in the calcining step.
配向处理前后的液晶配向膜的利用清洗液的清洗方法可列举:刷洗(brushing)、喷雾(jet spray)、蒸汽清洗或超声波清洗等。这些方法可单独进行,也可以并用。清洗液可使用纯水,或者甲醇、乙醇、异丙醇等各种醇类,苯、甲苯、二甲苯等芳香族烃类,二氯甲烷等卤素系溶剂,丙酮、丁酮等酮类,但并不限定于这些清洗液。当然,这些清洗液需使用经过充分纯化的杂质较少的清洗液。此种清洗方法还可以适用于形成本发明的液晶配向膜时的所述清洗步骤中。The method of cleaning the liquid crystal alignment film before and after the alignment treatment using a cleaning solution includes brushing, jet spray, steam cleaning, ultrasonic cleaning, and the like. These methods may be used alone or in combination. The cleaning solution can be pure water, or various alcohols such as methanol, ethanol, and isopropanol, aromatic hydrocarbons such as benzene, toluene, and xylene, halogen solvents such as methylene chloride, and ketones such as acetone and butanone. It is not limited to these cleaning solutions. Of course, these cleaning solutions need to use fully purified cleaning solutions with less impurities. This cleaning method can also be applied to the cleaning step when forming the liquid crystal alignment film of the present invention.
本发明的液晶配向膜的膜厚并无特别的限定,优选为10nm~300nm,更优选为30nm~150nm。本发明的液晶配向膜的膜厚可以使用轮廓仪(profilometer)或椭偏仪(ellipsometer)等公知的膜厚测定装置而进行测定。The film thickness of the liquid crystal alignment film of the present invention is not particularly limited, but is preferably 10 nm to 300 nm, more preferably 30 nm to 150 nm. The film thickness of the liquid crystal alignment film of this invention can be measured using well-known film thickness measuring apparatuses, such as a profilometer (profilometer) and an ellipsometer (ellipsometer).
本发明的液晶显示元件包含:一对基板、形成于这对基板之间的液晶层、对液晶层施加电压的电极、使液晶分子配向为预定方向的液晶配向膜。液晶配向膜使用上述的本发明的液晶配向膜。The liquid crystal display element of the present invention includes: a pair of substrates, a liquid crystal layer formed between the pair of substrates, electrodes for applying voltage to the liquid crystal layer, and a liquid crystal alignment film for aligning liquid crystal molecules in a predetermined direction. As the liquid crystal alignment film, the above-mentioned liquid crystal alignment film of the present invention is used.
基板可使用在本发明的液晶配向膜中所述的玻璃制基板,电极可以使用在液晶配向膜的说明中例示的形成在玻璃制基板上的ITO电极。The glass substrate described in the liquid crystal alignment film of the present invention can be used for the substrate, and the ITO electrode formed on the glass substrate exemplified in the description of the liquid crystal alignment film can be used for the electrode.
液晶层可以由在形成了液晶配向膜的面相互相对贴合而成的所述一对基板之间密封的液晶组成物而形成。具有利用本发明的垂直配向用液晶配向剂而制造的液晶配向膜的液晶显示元件中,优选使用介电各向异性为负的液晶组成物。The liquid crystal layer may be formed of a liquid crystal composition sealed between the pair of substrates in which surfaces on which the liquid crystal alignment film is formed are bonded to face each other. In a liquid crystal display element having a liquid crystal alignment film produced by using the liquid crystal alignment agent for vertical alignment of the present invention, it is preferable to use a liquid crystal composition having a negative dielectric anisotropy.
介电各向异性为负的优选的液晶组成物可列举:日本专利特开昭57-114532号公报、日本专利特开平2-4725号公报、日本专利特开平4-224885号公报、日本专利特开平8-40953号公报、日本专利特开平8-104869号公报、日本专利特开平10-168076号公报、日本专利特开平10-168453号公报、日本专利特开平10-236989号公报、日本专利特开平10-236990号公报、日本专利特开平10-236992号公报、日本专利特开平10-236993号公报、日本专利特开平10-236994号公报、日本专利特开平10-237000号公报、日本专利特开平10-237004号公报、日本专利特开平10-237024号公报、日本专利特开平10-237035号公报、日本专利特开平10-237075号公报、日本专利特开平10-237076号公报、日本专利特开平10-237448号公报(EP967261A1说明书)、日本专利特开平10-287874号公报、日本专利特开平10-287875号公报、日本专利特开平10-291945号公报、日本专利特开平11-029581号公报、日本专利特开平11-080049号公报、日本专利特开2000-256307公报、日本专利特开2001-019965公报、日本专利特开2001-072626公报、日本专利特开2001-192657公报等中揭示的液晶组成物。Preferred liquid crystal compositions with negative dielectric anisotropy include Japanese Patent Laid-Open No. 57-114532, Japanese Patent Laid-Open No. 2-4725, Japanese Patent Laid-Open No. 4-224885, and Japanese Patent Laid-Open No. 4-224885. Kokai No. 8-40953, Japanese Patent Kokai No. 8-104869, Japanese Patent Kokai No. 10-168076, Japanese Patent Kokai No. 10-168453, Japanese Patent Kokai No. 10-236989, Japanese Patent Kokai Unexamined Patent Publication No. 10-236990, Japanese Patent Laid-Open Publication No. 10-236992, Japanese Patent Laid-Open Publication No. 10-236993, Japanese Patent Laid-Open Publication No. 10-236994, Japanese Patent Laid-Open Publication No. 10-237000, Unexamined Patent Publication No. 10-237004, Japanese Patent Laid-Open Publication No. 10-237024, Japanese Patent Laid-Open Publication No. 10-237035, Japanese Patent Laid-Open Publication No. 10-237075, Japanese Patent Laid-Open Publication No. 10-237076, KOKAI Publication No. 10-237448 (EP967261A1 specification), Japanese Patent Application Publication No. 10-287874, Japanese Patent Application Publication No. 10-287875, Japanese Patent Application Publication No. 10-291945, Japanese Patent Application Publication No. 11-029581 , JP-A-11-080049, JP-2000-256307, JP-2001-019965, JP-2001-072626, JP-2001-192657, etc. liquid crystal composition.
具有由本发明的液晶配向剂而制造的液晶配向膜的液晶显示元件以TN方式或IPS方式进行驱动的情况下,液晶显示元件还可以使用介电各向异性为正的液晶组成物。介电各向异性为正的优选的液晶组成物可列举:日本专利第3086228号公报、日本专利第2635435号公报、日本专利特表平5-501735号公报、日本专利特开平8-157826号公报、日本专利特开平8-231960号公报、日本专利特开平9-241644号公报(EP885272A1说明书)、日本专利特开平9-302346号公报(EP806466A1说明书)、日本专利特开平8-199168号公报(EP722998A1说明书)、日本专利特开平9-235552号公报、日本专利特开平9-255956号公报、日本专利特开平9-241643号公报(EP885271A1说明书)、日本专利特开平10-204016号公报(EP844229A1说明书)、日本专利特开平10-204436号公报、日本专利特开平10-231482号公报、日本专利特开2000-087040公报、日本专利特开2001-48822公报等中揭示的液晶组成物。When the liquid crystal display element having the liquid crystal alignment film produced by the liquid crystal alignment agent of the present invention is driven by TN mode or IPS mode, the liquid crystal display element can also use a liquid crystal composition with positive dielectric anisotropy. Preferred liquid crystal compositions with positive dielectric anisotropy include: Japanese Patent No. 3086228, Japanese Patent No. 2635435, Japanese Patent Application Laid-Open No. 5-501735, and Japanese Patent Laid-Open No. 8-157826 , Japanese Patent Laid-Open Publication No. 8-231960, Japanese Patent Laid-Open Publication No. 9-241644 (EP885272A1 specification), Japanese Patent Laid-Open Publication No. 9-302346 (EP806466A1 specification), Japanese Patent Laid-Open Publication No. 8-199168 (EP722998A1 Instructions), Japanese Patent Laid-Open No. 9-235552, Japanese Patent Laid-Open No. 9-255956, Japanese Patent Laid-Open No. 9-241643 (EP885271A1 specification), Japanese Patent Laid-Open No. 10-204016 (EP844229A1 specification) , Japanese Patent Laid-Open No. 10-204436, Japanese Patent Laid-Open No. 10-231482, Japanese Patent Laid-Open No. 2000-087040, and Japanese Patent Laid-Open No. 2001-48822.
即使使用于所述介电各向异性为正或负的液晶组成物中添加一种以上光学活性化合物也都可以。One or more optically active compounds may be added to the liquid crystal composition having positive or negative dielectric anisotropy.
本发明的液晶显示元件可以通过如下方式而获得:于一对基板的至少一者上形成本发明的液晶配向膜,使所得的一对基板以液晶配向膜朝内的方式对向并以间隔物介隔,于形成在基板间的间隙封入液晶组成物而形成液晶层。在本发明的液晶显示元件的制造中还可以进一步视需要包含在基板上贴附偏光膜等的步骤。The liquid crystal display element of the present invention can be obtained by forming the liquid crystal alignment film of the present invention on at least one of a pair of substrates, making the resulting pair of substrates face each other with the liquid crystal alignment film facing inward and separating them with spacers. A liquid crystal composition is sealed in a gap formed between the substrates to form a liquid crystal layer. In the manufacture of the liquid crystal display element of the present invention, a step of sticking a polarizing film or the like on the substrate may be further included as necessary.
本发明的液晶显示元件是于基板表面在垂直方向上对液晶层施加电压的纵电场方式用液晶显示元件。纵电场方式用液晶显示元件需要表现出较大的预倾角,因此可适宜使用由本发明的液晶配向剂所形成的液晶配向膜,所述液晶配向剂含有使四羧酸二酐、式(V-2)所表示的具有侧链结构的二胺或含有其的二胺的混合物反应而获得的聚酰胺酸或其衍生物。The liquid crystal display element of the present invention is a liquid crystal display element for a vertical electric field system in which a voltage is applied to a liquid crystal layer in a direction perpendicular to a substrate surface. The liquid crystal display element used in the vertical electric field mode needs to show a larger pretilt angle, so the liquid crystal alignment film formed by the liquid crystal alignment agent of the present invention can be suitably used, and the liquid crystal alignment agent contains tetracarboxylic dianhydride, formula (V- 2) A polyamic acid obtained by reacting a diamine having a side chain structure or a mixture of diamines containing the same, or a derivative thereof.
由本发明的液晶配向剂而制造的液晶配向膜还可以用于以横电场方式的TN方式或IPS方式进行驱动的液晶显示元件中。在这种情况下,在TN方式或IPS方式中无需较大的预倾角,因此当使式(V-2)所表示的二胺和不具有侧链结构的二胺的混合物与四羧酸二酐反应时,可以通过适宜减少式(V-2)所表示的二胺的含量,而设定为适于TN方式或IPS方式的态样。The liquid crystal alignment film produced from the liquid crystal alignment agent of the present invention can also be used in liquid crystal display elements driven by the TN mode or IPS mode of the transverse electric field mode. In this case, there is no need for a larger pretilt angle in the TN mode or the IPS mode, so when the mixture of the diamine represented by the formula (V-2) and the diamine without a side chain structure is mixed with the diamine of the tetracarboxylic acid During the anhydride reaction, it is possible to set a mode suitable for the TN system or the IPS system by appropriately reducing the content of the diamine represented by the formula (V-2).
如上所述,将本发明的液晶配向剂作为原料而制作的液晶配向膜可以通过适宜选择作为其原料的聚合物,而适用于各种显示驱动方式的液晶显示元件中。As mentioned above, the liquid crystal alignment film prepared by using the liquid crystal alignment agent of the present invention as a raw material can be applied to liquid crystal display elements of various display driving methods by appropriately selecting the polymer as the raw material.
本发明的液晶显示元件还可以进一步具有上述构成要素以外的要素。作为此种其他构成要素,在本发明的液晶显示元件中还可以安装偏光板(偏光膜)、波片(wave plate)、光散射膜、驱动电路等在液晶显示元件中通常使用的构成要素。The liquid crystal display element of the present invention may further have elements other than the above-mentioned constituent elements. As such other constituent elements, constituent elements commonly used in liquid crystal display elements, such as polarizing plates (polarizing films), wave plates, light scattering films, and drive circuits, may be incorporated in the liquid crystal display element of the present invention.
[实例][example]
以下,通过实例对本发明加以说明,但本发明并不限定于这些实例。在实例中使用的化合物如下所示。Hereinafter, the present invention will be described by way of examples, but the present invention is not limited to these examples. Compounds used in Examples are shown below.
<四羧酸二酐><Tetracarboxylic dianhydride>
BPDA-H:二环己烷四羧酸二酐,式(Q),岩谷瓦斯株式会社制造BPDA-H: Dicyclohexanetetracarboxylic dianhydride, formula (Q), manufactured by Iwatani Gas Co., Ltd.
H-PMDA:环己烷四羧酸二酐,式(25)H-PMDA: cyclohexane tetracarboxylic dianhydride, formula (25)
CBDA:环丁烷四羧酸二酐,式(19)CBDA: cyclobutane tetracarboxylic dianhydride, formula (19)
BTDA:丁烷四羧酸二酐,式(23)BTDA: butane tetracarboxylic dianhydride, formula (23)
PSQ1:18,21-双(3-(2,5-二氧代四氢呋喃-3-基)丙基)-18,21-二甲基-1,3,5,7,9,11,13,15-八苯基-五环[10.5.1.25,13.17,11.19,15]十硅氧烷,式(S-1)PSQ1: 18,21-bis(3-(2,5-dioxotetrahydrofuran-3-yl)propyl)-18,21-dimethyl-1,3,5,7,9,11,13, 15-Octaphenyl-pentacyclo[10.5.1.25, 13.17, 11.19, 15] decasiloxane, formula (S-1)
<二胺><Diamine>
MBMA:4,4′-亚甲基双(3-甲基苯胺),式(VI-1-5)MBMA: 4,4'-methylenebis(3-methylaniline), formula (VI-1-5)
DDM:4,4′-二胺基二苯甲烷,式(VI-1-1)DDM: 4,4'-diaminodiphenylmethane, formula (VI-1-1)
5ChCh:5-{4-[4-(4-正戊基环己基)]环己基}苯基甲基-1,3-二胺基苯,在式(V-2-7)中Y2为链长5的烷基的二胺5ChCh: 5-{4-[4-(4-n-pentylcyclohexyl)]cyclohexyl}phenylmethyl-1,3-diaminobenzene, in formula (V-2-7) Y 2 is Alkyl diamines with chain length 5
16Ch::在式(V-2-2)中Y2为链长16的烷基的二胺16Ch:: In the formula (V-2-2), Y 2 is the diamine of the alkyl group with a chain length of 16
DABC:3,5-二胺基苄基肉桂酸酯,式(V-11-2)DABC: 3,5-diaminobenzyl cinnamate, formula (V-11-2)
PDAB:4,4′-二胺基偶氮苯,式(VI-11-11)PDAB: 4,4'-diaminoazobenzene, formula (VI-11-11)
OPDA:6-(2,5-二氧代-3-苯基-2,5-二氢-1H-吡咯-1-基)己基3,5-二胺基苯甲酸酯,式(V-11-19)OPDA: 6-(2,5-dioxo-3-phenyl-2,5-dihydro-1H-pyrrol-1-yl)hexyl 3,5-diaminobenzoate, formula (V- 11-19)
<添加剂><additive>
BANI-M:双{4-(烯丙基双环[2.2.1]庚-5-烯-2,3-二羧基酰亚胺)苯基}甲烷BANI-M: bis{4-(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)phenyl}methane
HEA:N,N′-二羟基亚乙基双丙烯酰胺HEA: N,N'-dihydroxyethylenebisacrylamide
EHS:2-(3,4-环氧基环己基)乙基三甲氧基硅烷EHS: 2-(3,4-Epoxycyclohexyl)ethyltrimethoxysilane
GPS:3-缩水甘油氧基丙基三甲氧基硅烷GPS: 3-Glycidoxypropyltrimethoxysilane
<溶剂><solvent>
NMP:N-甲基-2-吡咯烷酮NMP: N-methyl-2-pyrrolidone
BC:丁基溶纤剂(乙二醇单丁醚)BC: Butyl cellosolve (ethylene glycol monobutyl ether)
<聚酰胺酸的合成><Synthesis of polyamic acid>
[合成例1][Synthesis Example 1]
于具有温度计、搅拌机、原料投入口及氮气导入口的100ml的四口烧瓶中装入5ChCh 0.285g、MBMA 1.341g及脱水NMP 30.0g,于干燥氮气流下进行搅拌。其次,添加BPDA-H 1.613g和BTDA 0.2610g使其反应30小时后,添加BC 16.5g,合成聚合物固形物浓度为7wt%的聚酰胺酸溶液PA1。当原料的反应中由于反应温度而造成温度上升的情况下,将反应温度抑制为约70℃以下而进行反应。0.285g of 5ChCh, 1.341g of MBMA and 30.0g of dehydrated NMP were charged into a 100ml four-neck flask equipped with a thermometer, a stirrer, a raw material inlet and a nitrogen inlet, and stirred under a dry nitrogen flow. Next, after adding 1.613g of BPDA-H and 0.2610g of BTDA to react for 30 hours, 16.5g of BC was added to synthesize a polyamic acid solution PA1 with a polymer solids concentration of 7wt%. When the temperature rises due to the reaction temperature during the reaction of the raw materials, the reaction is carried out while suppressing the reaction temperature to about 70° C. or lower.
聚酰胺酸的重均分子量是通过如下方式而求出的:用磷酸-DMF混合溶液(磷酸/DMF=0.6/100,重量比)对所得的聚酰胺酸进行稀释以使聚酰胺酸浓度成为约1wt%使用2695separation module□2414示差折射仪(Waters制造),将上述混合溶液作为展开剂而利用GPC法进行测定,进行聚苯乙烯换算。另外,管柱使用HSPgel RT MB-M(Waters制造),在管柱温度为40℃、流速为0.35mL/min的条件下进行测定。The weight-average molecular weight of polyamic acid is obtained by the following method: the obtained polyamic acid is diluted with phosphoric acid-DMF mixed solution (phosphoric acid/DMF=0.6/100, weight ratio) so that the polyamic acid concentration becomes about 1 wt% was measured by the GPC method using a 2695 separation module 2414 differential refractometer (manufactured by Waters) using the above-mentioned mixed solution as a developer, and it was calculated in terms of polystyrene. In addition, HSPgel RT MB-M (manufactured by Waters) was used as a column, and the measurement was performed under conditions of a column temperature of 40° C. and a flow rate of 0.35 mL/min.
[比较合成例1、比较合成例2][Comparative Synthesis Example 1, Comparative Synthesis Example 2]
以表1中所示的方式变更四羧酸二酐,除此以外基于合成例1而调制在单体中并不使用BPDA-H的聚合物固形物浓度为7wt%的聚酰胺酸溶液CP1及CP2。In addition to changing the tetracarboxylic dianhydride in the manner shown in Table 1, based on Synthesis Example 1, polyamic acid solutions CP1 and CP1 having a polymer solid content concentration of 7 wt% without using BPDA-H in the monomer were prepared. CP2.
[合成例2][Synthesis Example 2]
以表1中所示的方式变更四羧酸二酐及二胺,除此以外基于合成例1而调制于单体中进一步使用了具有倍半硅氧烷骨架的酸酐的聚合物固形物浓度为7wt%的聚酰胺酸溶液PA2。将合成例1、合成例2及比较例1、比较例2的聚酰胺酸溶液的单体组成和所得的聚合物的重均分子量汇总于表1中。In addition to changing the tetracarboxylic dianhydride and diamine as shown in Table 1, based on Synthesis Example 1, the solid content concentration of the polymer in which an acid anhydride having a silsesquioxane skeleton was further used in the monomer was prepared as follows: 7wt% polyamic acid solution PA2. Table 1 summarizes the monomer compositions of the polyamic acid solutions of Synthesis Example 1, Synthesis Example 2, and Comparative Example 1 and Comparative Example 2, and the weight average molecular weight of the obtained polymer.
表1Table 1
[实例1][instance 1]
将合成例1中合成的聚合物固形物浓度为7wt%的聚酰胺酸溶液,通过添加NMP/BC=1/1(重量比)的混合溶剂而稀释为聚合物固形物浓度为4wt%,制成液晶配向剂AL1。使用所得的液晶配向剂,如下所述地制作液晶显示元件。The polyamic acid solution that the polymer solids concentration synthesized in Synthesis Example 1 is 7wt% is diluted to the polymer solids concentration by adding a mixed solvent of NMP/BC=1/1 (weight ratio) and is 4wt%. into liquid crystal alignment agent AL1. Using the obtained liquid crystal alignment agent, a liquid crystal display element was produced as follows.
<VA型液晶显示元件的制作><Production of VA-type liquid crystal display element>
于一对附有ITO透明电极的基板上,利用旋涂法涂布所得的液晶配向剂AL1,于80℃下、于加热板上干燥90秒。其次,于设定为200℃的烘箱中加热煅烧60分钟,获得形成了液晶配向膜的基板。将形成了配向膜的面作为内侧,于其中一个基板上在周边以残留液晶注入孔的方式将环氧系接着剂涂布为带状,在另一个基板上散布4.25μm的间隙材料而进行贴合。于所得的单元中真空注入如下所示的液晶组成物,将注入孔用UV硬化型密封剂进行密封。最后,于110℃下进行30分钟的加热处理(各向同性处理),获得VA型液晶显示元件。On a pair of substrates with ITO transparent electrodes, the obtained liquid crystal alignment agent AL1 was coated by spin coating, and dried on a heating plate at 80° C. for 90 seconds. Next, heat and calcinate in an oven set at 200° C. for 60 minutes to obtain a substrate on which a liquid crystal alignment film is formed. With the surface on which the alignment film was formed as the inner side, an epoxy-based adhesive was applied in a strip shape on one of the substrates so that liquid crystal injection holes remained on the periphery, and a gap material of 4.25 μm was spread on the other substrate for bonding. combine. The liquid crystal composition shown below was vacuum injected into the obtained cell, and the injection hole was sealed with a UV curable sealant. Finally, heat processing (isotropy processing) was performed at 110 degreeC for 30 minutes, and the VA type liquid crystal display element was obtained.
[实例2、比较例1、比较例2][Example 2, Comparative Example 1, Comparative Example 2]
将合成例2及比较合成例1、比较合成例2中合成的聚合物固形物浓度为7wt%的聚酰胺酸溶液PA2、CP1及CP2,通过添加NMP/BC=1/1(重量比)的混合溶剂而稀释为聚合物固形物浓度为4wt%,制成液晶配向剂AL2、CA1及CA2。使用所得的液晶配向剂,基于实例1而制作液晶显示元件。The polyamic acid solution PA2, CP1 and CP2 of 7wt% by the polyamic acid solution PA2, CP1 and CP2 that synthetic polymer solids concentration is synthesized in synthetic example 2 and comparative synthetic example 1, comparative synthetic example 2, by adding NMP/BC=1/1 (weight ratio) Mix solvents and dilute to a polymer solid concentration of 4 wt%, to prepare liquid crystal alignment agents AL2, CA1 and CA2. Based on Example 1, a liquid crystal display element was fabricated using the obtained liquid crystal alignment agent.
[实例3~实例6][Example 3-Example 6]
于所述聚酰胺酸溶液PA1及PA2中,分别添加相当于聚合物重量30wt%的表2中所示的添加剂后,添加NMP/BC=1/1(重量比)的混合溶剂而稀释为聚合物固形物浓度为4wt%。使用稀释的液晶配向剂,基于实例1而制作液晶显示元件。In the polyamic acid solutions PA1 and PA2, after adding the additives shown in Table 2 corresponding to 30 wt% of the weight of the polymer, add a mixed solvent of NMP/BC=1/1 (weight ratio) to dilute to polymerize The solids concentration was 4 wt%. A liquid crystal display element was fabricated based on Example 1 by using a diluted liquid crystal alignment agent.
<VHR的测定><Measurement of VHR>
使用东阳特克尼卡株式会社(Toyo Corporation)制造的液晶物性评价装置6254型,测定VA型液晶显示元件的VHR。测定条件为栅宽60μsec、频率为0.3Hz、波高为±5V,测定温度为60℃。The VHR of the VA-type liquid crystal display element was measured using a liquid crystal physical property evaluation device Model 6254 manufactured by Toyo Corporation. The measurement conditions were a grid width of 60 µsec, a frequency of 0.3 Hz, a wave height of ±5 V, and a measurement temperature of 60°C.
<离子密度的测定><Measurement of ion density>
使用Toyo Corporation制造的液晶物性评价装置6254型,测定VA型液晶显示元件的离子密度。测定条件为频率为0.01Hz、电压为±10V,测定温度为60℃。The ion density of the VA-type liquid crystal display element was measured using a liquid crystal physical property evaluation device Model 6254 manufactured by Toyo Corporation. The measurement conditions were a frequency of 0.01 Hz, a voltage of ±10 V, and a measurement temperature of 60°C.
表2Table 2
如表2所示那样,在使用由液晶配向剂(所述液晶配向剂含有式(Q)所表示的四羧酸二酐与式(V-2)所表示的二胺反应而所得的聚酰胺酸)而所得的液晶配向膜的VA型液晶显示元件中,与使用其他四羧酸二酐的情况相比显示出极其高的VHR值。另外可知:通过并用如PSQ1之类的具有倍半硅氧烷骨架的酸酐,可实现进一步提高电压保持率以及减低离子密度。As shown in Table 2, when using a polyamide obtained by reacting a liquid crystal alignment agent (the liquid crystal alignment agent contains tetracarboxylic dianhydride represented by formula (Q) and diamine represented by formula (V-2) Acid) in the VA-type liquid crystal display element of the liquid crystal alignment film obtained, compared with the case of using other tetracarboxylic dianhydrides, it showed extremely high VHR value. In addition, it was found that by using together an acid anhydride having a silsesquioxane skeleton such as PSQ1, further improvement in voltage retention and reduction in ion density can be achieved.
<残留DC的评价><Evaluation of residual DC>
使用横河电机株式会社制造的FG110型信号发生器,对使用夹具而安装在90度配置了偏光板的尼康株式会社制造的偏光显微镜上的VA型液晶显示元件施加30Hz、3V的矩形波。于其上重叠3V的直流电压30分钟后,结束直流电压的重叠,然后利用连接在安捷伦科技(Agilent Technologies)制造的DSO3062型示波器上的浜松光电子株式会社制造的光电倍增管,检测液晶显示元件的透过光量。调节信号发生器的偏移以使在电压示波器上显示出的表示光量变化的波形变化变得最少,将该偏移电压作为闪变消去电压而记录下来。将该值的绝对值作为残留DC。残留DC越小则留下的残像越少而良好。Using a signal generator FG110 manufactured by Yokogawa Electric Corporation, a 30 Hz, 3 V rectangular wave was applied to a VA-type liquid crystal display element mounted on a polarizing microscope manufactured by Nikon Corporation with polarizing plates arranged at 90 degrees using a jig. After superimposing a DC voltage of 3 V on it for 30 minutes, the superimposition of the DC voltage was terminated, and then a photomultiplier tube manufactured by Hamamatsu Photon Electronics Co., Ltd. connected to a DSO3062 oscilloscope manufactured by Agilent Technologies was used to detect the liquid crystal display element. The amount of light transmitted. The offset of the signal generator was adjusted so that the change in the waveform indicating the change in light quantity displayed on the voltage oscilloscope becomes the least, and the offset voltage was recorded as the flicker elimination voltage. The absolute value of this value was taken as residual DC. The smaller the residual DC is, the less afterimages remain and are favorable.
对实例1~实例6、及比较例1、比较例2中制作的液晶显示元件进行残留DC的测定,于各元件间对比自直流电压重叠结束的时间点到1分钟后及30分钟后的闪变消去电压。将其结果示于表3中。The residual DC was measured for the liquid crystal display elements produced in Examples 1 to 6, and Comparative Example 1 and Comparative Example 2, and the flicker after 1 minute and 30 minutes after the DC voltage superimposition was completed were compared between each element. Change the voltage. The results are shown in Table 3.
表3table 3
如表3所示,可知:在使用由液晶配向剂(所述液晶配向剂含有式(Q)所表示的四羧酸二酐与式(V-2)所表示的二胺反应而所得的聚酰胺酸)而所得的液晶配向膜的VA型液晶显示元件中,残留DC的减低显著。As shown in Table 3, it can be seen that: when using a liquid crystal alignment agent (the liquid crystal alignment agent contains tetracarboxylic dianhydride represented by formula (Q) and diamine represented by formula (V-2) Amic acid) in the VA-type liquid crystal display element of the obtained liquid crystal alignment film, the reduction of residual DC is remarkable.
<形成光配向液晶配向剂的聚酰胺酸的合成><Synthesis of Polyamic Acid Forming Photoalignment Liquid Crystal Alignment Agent>
[合成例3~合成例6、比较合成例3~比较合成例5][Synthesis Example 3 to Synthesis Example 6, Comparative Synthesis Example 3 to Comparative Synthesis Example 5]
在使用了截留紫外线的荧光灯的黄室(yellow room)内进行合成,除此以外基于合成例1的方法,调制浓度为7wt%的光配向用聚酰胺酸溶液PA3~PA6及CP3~CP5。另外,合成例6的聚酰胺酸PA6的原料中并不包含式(V-2)所表示的具有侧链结构的二胺,其是如后所述那样用以与聚酰胺酸PA3~PA5及CP3~CP5共混而使用的聚酰胺酸溶液。将合成例3~合成例6及比较合成例3~比较合成例5的溶液组成和重均分子量的测定结果汇总于表4中。Except that the synthesis was carried out in a yellow room using fluorescent lamps that cut off ultraviolet rays, polyamic acid solutions PA3-PA6 and CP3-CP5 for photoalignment with a concentration of 7 wt% were prepared based on the method of Synthesis Example 1. In addition, the raw material of polyamic acid PA6 of Synthesis Example 6 does not contain the diamine having a side chain structure represented by formula (V-2), which is used to combine polyamic acid PA3 to PA5 and polyamic acid PA5 as described later. Polyamic acid solution for blending CP3-CP5. Table 4 summarizes the measurement results of the solution composition and weight average molecular weight of Synthesis Example 3 to Synthesis Example 6 and Comparative Synthesis Example 3 to Comparative Synthesis Example 5.
表4Table 4
[实例7~实例9][Example 7-Example 9]
将合成例3中合成的聚合物固形物浓度为7wt%的聚酰胺酸溶液PA3、合成例6中合成的聚合物固形物浓度为7wt%的聚酰胺酸溶液PA6以重量比20/80(前者/后者)进行混合,其次添加NMP/BC=1/1(重量比)的混合溶剂而将其稀释为聚合物固形物浓度为4wt%,从而制成液晶配向剂AL7。基于该方法,以表5中所示的组成比调制AL8、AL9及CA3~CA5。The polyamic acid solution PA3 that is 7wt% the polyamic acid solution PA3 that is the polyamic acid solution PA3 of 7wt% the polymer solid content concentration that is synthesized in the synthetic example 3, the polyamic acid solution PA6 that the polymer solid content concentration that is synthesized in the synthetic example 6 is 7wt% with weight ratio 20/80 (the former /the latter) were mixed, followed by adding a mixed solvent of NMP/BC=1/1 (weight ratio) to dilute it so that the polymer solids concentration was 4wt%, thereby preparing liquid crystal alignment agent AL7. Based on this method, AL8, AL9, and CA3 to CA5 were modulated at the composition ratios shown in Table 5.
[实例10~实例13][Example 10-Example 13]
将所述聚酰胺酸溶液以表5所示的组成比加以混合,分别添加相当于合计聚合物重量的30wt%的添加剂。其次添加NMP/BC=1/1(重量比)的混合溶剂而将其稀释为聚合物固形物浓度为4wt%,调制液晶配向剂AL10~AL13。The polyamic acid solution was mixed at the composition ratio shown in Table 5, and additives corresponding to 30 wt% of the total polymer weight were added respectively. Next, a mixed solvent of NMP/BC=1/1 (weight ratio) was added to dilute it to a polymer solid concentration of 4 wt%, to prepare liquid crystal alignment agents AL10˜AL13.
表5table 5
[实例14][Example 14]
<光配向VA型液晶显示元件的制作><Production of photo-alignment VA-type liquid crystal display element>
于一对附有ITO透明电极的基板上,利用旋涂法涂布所得的液晶配向剂AL7,于80℃下、于加热板上干燥90秒。其次,于设定为210℃的烘箱中进行15分钟的加热处理,形成膜厚约100nm的聚酰亚胺膜。其次,自基板的法线倾斜约40°的方向,使用紫外线照射装置(ML-501C/B)(所述紫外线照射装置使用了Ushio Inc.制造超高压水银灯(USH-500BY1)),介隔偏光板而照射直线偏光(365nm,能量约为200mJ/cm2),获得形成了液晶配向膜的基板。将形成了配向膜的面作为内侧,在其中一个基板上在周边以残留液晶注入孔的方式将环氧系接着剂涂布为带状,在另一个基板上散布4.25μm的间隙材料而进行贴合。于所得的单元中真空注入如下所示的液晶组成物,将注入孔用UV硬化型密封剂进行密封。最后,于110℃下进行30分钟的加热处理(各向同性处理),获得光配向VA型液晶显示元件。On a pair of substrates with ITO transparent electrodes, the obtained liquid crystal alignment agent AL7 was coated by spin coating, and dried on a heating plate at 80° C. for 90 seconds. Next, heat processing was performed for 15 minutes in an oven set at 210° C. to form a polyimide film having a film thickness of about 100 nm. Next, in a direction inclined about 40° from the normal line of the substrate, using an ultraviolet irradiation device (ML-501C/B) (the ultraviolet irradiation device uses an ultra-high pressure mercury lamp (USH-500BY1) manufactured by Ushio Inc.), through polarized light The plate was irradiated with linearly polarized light (365 nm, energy about 200 mJ/cm 2 ), to obtain a substrate on which a liquid crystal alignment film was formed. With the surface on which the alignment film was formed as the inner side, an epoxy-based adhesive was applied in a strip shape on one of the substrates so that liquid crystal injection holes remained on the periphery, and a 4.25 μm gap material was spread on the other substrate and pasted. combine. The liquid crystal composition shown below was vacuum injected into the obtained cell, and the injection hole was sealed with a UV curable sealant. Finally, heat treatment (isotropic treatment) was performed at 110° C. for 30 minutes to obtain a photoalignment VA-type liquid crystal display element.
[实例15~20及比较例6~8][Examples 15-20 and Comparative Examples 6-8]
使用液晶配向剂AL8~AL13及CA3~CA5,基于实例14而制作光配向VA型液晶显示元件。Using liquid crystal alignment agents AL8-AL13 and CA3-CA5, based on Example 14, a photo-aligned VA-type liquid crystal display element was produced.
<VHR的长时间热可靠性的评价><Evaluation of long-term thermal reliability of VHR>
对实例14~实例20及比较例6~比较例8中制作的光配向VA型液晶显示元件,以如下的方式进行VHR的长时间热可靠性的评价。For the photoalignment VA-type liquid crystal display elements produced in Examples 14 to 20 and Comparative Examples 6 to 8, the long-term thermal reliability of VHR was evaluated in the following manner.
<VHR的测定><Measurement of VHR>
以与实例1中所使用的相同的装置进行VA型液晶显示装置的VHR的测定。测定条件为栅宽60μsec、频率为30Hz、波高为±1V,测定温度为60℃。The VHR of the VA-type liquid crystal display device was measured with the same device as that used in Example 1. The measurement conditions were a grid width of 60 µsec, a frequency of 30 Hz, a wave height of ±1 V, and a measurement temperature of 60°C.
<VHR的长时间热可靠性的计算><Calculation of long-term thermal reliability of VHR>
关于实例14~实例20及比较例6~比较例8中制作的液晶显示元件,将元件制作后24小时以内所测定的VHR值作为VHR(初始)。而且将VHR测定后的液晶显示元件于保持为100℃的烘箱中保持100小时后,以上述的条件测定的VHR值作为VHR(100小时)。由所得的2个VHR,依照以下之式计算VHR降低率。可以说这个值越小则VHR的长时间热可靠性越良好。将结果示于表6中。About the liquid crystal display element produced in Example 14-Example 20 and Comparative Example 6-Comparative Example 8, the VHR value measured within 24 hours after element production was made VHR (initial). And the liquid crystal display element after VHR measurement was hold|maintained in the oven maintained at 100 degreeC for 100 hours, and the VHR value measured on the said conditions was made into VHR (100 hours). From the obtained two VHRs, the VHR decrease rate was calculated according to the following formula. It can be said that the smaller this value is, the better the long-term thermal reliability of the VHR is. The results are shown in Table 6.
VHR降低率=[{VHR(初始)-VHR(100小时)}×100]/VHR(初始)VHR reduction rate = [{VHR(initial)-VHR(100 hours)}×100]/VHR(initial)
表6Table 6
如表6所示,以使用由液晶配向剂(所述液晶配向剂含有包含BPDA-H的聚酰胺酸)而所得的液晶配向膜的液晶显示元件,可以起到与使用由液晶配向剂(所述液晶配向剂含有包含单环的H-PMDA的聚酰胺酸)而所得的液晶配向膜的液晶显示元件相比而言VHR的初始特性和VHR长期热可靠性更高的效果。As shown in Table 6, the liquid crystal display element using the liquid crystal alignment film obtained by the liquid crystal alignment agent (the liquid crystal alignment agent contains polyamic acid containing BPDA-H) can play the same role as the use of the liquid crystal alignment agent (the Compared with the liquid crystal display element of the obtained liquid crystal alignment film containing the liquid crystal alignment agent containing polyamic acid containing monocyclic H-PMDA, the initial characteristics of VHR and the effect of VHR long-term thermal reliability are higher.
<残留DC的评价><Evaluation of residual DC>
对实例14~实例20及比较例6~比较例8中所制作的液晶显示元件,基于实例1而进行残留DC测定的评价。将其结果示于表7。Based on Example 1, the evaluation of residual DC measurement was performed about the liquid crystal display element produced in Example 14-Example 20 and Comparative Example 6-Comparative Example 8. The results are shown in Table 7.
表7Table 7
如表7所示,可知:在使用由液晶配向剂(所述液晶配向剂含有式(Q)所表示的四羧酸二酐与式(V-2)所表示的二胺反应而所得的聚酰胺酸)而所得的光配向型液晶配向膜的光配向VA型液晶显示元件中,残留DC也显著减低。As shown in Table 7, it can be seen that when using a liquid crystal alignment agent (the liquid crystal alignment agent contains tetracarboxylic dianhydride represented by formula (Q) and diamine represented by formula (V-2) Amic acid) and the obtained photo-alignment type liquid crystal alignment film in the photo-alignment VA-type liquid crystal display element, the residual DC is also significantly reduced.
以上所述,仅是本发明的较佳实施例而已,并非对本发明作任何形式上的限制,虽然本发明已以较佳实施例揭露如上,然而并非用以限定本发明,任何熟悉本专业的技术人员,在不脱离本发明技术方案范围内,当可利用上述揭示的结构及技术内容作出些许的更动或修饰为等同变化的等效实施例,但是凡是未脱离本发明技术方案的内容,依据本发明的技术实质对以上实施例所作的任何简单修改、等同变化与修饰,均仍属于本发明技术方案的范围内。The above description is only a preferred embodiment of the present invention, and does not limit the present invention in any form. Although the present invention has been disclosed as above with preferred embodiments, it is not intended to limit the present invention. Anyone familiar with this field Those skilled in the art, without departing from the scope of the technical solution of the present invention, may use the structure and technical content disclosed above to make some changes or modifications to equivalent embodiments with equivalent changes, but any content that does not depart from the technical solution of the present invention, Any simple modifications, equivalent changes and modifications made to the above embodiments according to the technical essence of the present invention still fall within the scope of the technical solutions of the present invention.
Claims (11)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009-213057 | 2009-09-15 | ||
JP2009213057 | 2009-09-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102020995A true CN102020995A (en) | 2011-04-20 |
Family
ID=43862784
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010102811883A Pending CN102020995A (en) | 2009-09-15 | 2010-09-10 | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP5556482B2 (en) |
KR (1) | KR20110030333A (en) |
CN (1) | CN102020995A (en) |
TW (1) | TW201109368A (en) |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102206495A (en) * | 2010-03-30 | 2011-10-05 | 智索株式会社 | Liquid crystal aligning agent, liquid crystal alignment layer and liquid crystal display device |
CN102952552A (en) * | 2011-08-23 | 2013-03-06 | 奇美实业股份有限公司 | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element |
CN103048725A (en) * | 2012-12-25 | 2013-04-17 | 深超光电(深圳)有限公司 | Polarizer and method for manufacturing polarizer |
CN103387833A (en) * | 2012-05-09 | 2013-11-13 | 捷恩智株式会社 | Liquid crystal alignment agent for photo alignment, liquid crystal alignment layer for photo alignment, and liquid crystal display element |
CN103842408A (en) * | 2011-08-18 | 2014-06-04 | 东丽株式会社 | Polyamic acid resin composition, polyimide resin composition, polyimide oxazole resin composition, and flexible substrate containing same |
CN104059675A (en) * | 2013-03-19 | 2014-09-24 | Jsr株式会社 | Liquid Crystal Aligning Agent, Liquid Crystal Alignment Film, Liquid Crystal Display Device, Polymer And Compound |
CN104321695A (en) * | 2012-04-24 | 2015-01-28 | 捷恩智株式会社 | Liquid-crystal-orienting agent for forming liquid-crystal-oriented film for photoalignment, liquid-crystal-oriented film, and liquid-crystal display element using liquid-crystal-oriented film |
CN104718491A (en) * | 2012-10-09 | 2015-06-17 | 日产化学工业株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
CN104892657A (en) * | 2014-03-07 | 2015-09-09 | 达兴材料股份有限公司 | Siloxane trianhydride, polymer, liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element |
CN104927880A (en) * | 2014-03-18 | 2015-09-23 | Jsr株式会社 | Compound, polymer, liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display device, |
TWI586639B (en) * | 2012-04-26 | 2017-06-11 | Nissan Chemical Ind Ltd | Diamine, polymer, liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element |
CN107090300A (en) * | 2016-02-18 | 2017-08-25 | 捷恩智株式会社 | To form the aligning agent for liquid crystal of liquid crystal orientation film, liquid crystal orientation film and use its liquid crystal display cells |
CN105452948B (en) * | 2013-07-30 | 2018-11-13 | 夏普株式会社 | The manufacturing method of liquid crystal display device |
TWI644948B (en) * | 2016-02-26 | 2018-12-21 | 奇美實業股份有限公司 | Liquid crystal alignment agent and uses thereof |
TWI644947B (en) * | 2016-02-05 | 2018-12-21 | 奇美實業股份有限公司 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
CN110366698A (en) * | 2016-12-28 | 2019-10-22 | 日产化学株式会社 | Aligning agent for liquid crystal, liquid crystal orientation film and liquid crystal indicate element |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5831674B2 (en) * | 2010-02-03 | 2015-12-09 | Jsr株式会社 | Liquid crystal alignment agent |
WO2014178406A1 (en) * | 2013-05-01 | 2014-11-06 | 日産化学工業株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
JP6582609B2 (en) * | 2014-06-26 | 2019-10-02 | 三菱ケミカル株式会社 | Polyimide precursor composition |
JP6627595B2 (en) * | 2015-06-11 | 2020-01-08 | Jnc株式会社 | Liquid crystal alignment agent for forming liquid crystal alignment film for photo alignment, liquid crystal alignment film, and liquid crystal display device using the same |
JP6733142B2 (en) * | 2015-09-18 | 2020-07-29 | 日産化学株式会社 | Resin composition for thin film formation |
JP2019128411A (en) | 2018-01-23 | 2019-08-01 | シャープ株式会社 | Substrate with alignment film, and liquid crystal display device |
TWI719278B (en) * | 2018-01-26 | 2021-02-21 | 達興材料股份有限公司 | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device |
TWI717889B (en) * | 2019-11-05 | 2021-02-01 | 達興材料股份有限公司 | Alignment agent, diamine compound, alignment film and liquid crystal display device |
KR20230134517A (en) * | 2021-01-18 | 2023-09-21 | 닛산 가가쿠 가부시키가이샤 | Alignment film forming material, alignment film, and polymer dispersed liquid crystal device |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000214467A (en) * | 1999-01-26 | 2000-08-04 | Hitachi Chem Co Ltd | Composition for liquid crystal alignment film for low voltage driven liquid crystal panel, liquid crystal alignment film for low voltage driven liquid crystal panel, substrate to hold liquid crystal and liquid crystal display element |
JP2001089426A (en) * | 1999-09-14 | 2001-04-03 | Fuji Photo Film Co Ltd | New acetylene compound |
CN1762978A (en) * | 2004-10-05 | 2006-04-26 | Jsr株式会社 | Novel diamine compound,polymer and liquid crystal tropism agent |
JP2007248637A (en) * | 2006-03-14 | 2007-09-27 | National Institute For Materials Science | Liquid crystal alignment film, liquid crystal alignment agent, and liquid crystal display element |
US20070232780A1 (en) * | 2006-03-16 | 2007-10-04 | Chisso Corporation | Photo-alignment film and liquid crystal display element |
CN101470303A (en) * | 2007-12-26 | 2009-07-01 | 智索株式会社 | Liquid crystal tropism agent, liquid crystal tropism film and liquid crystal display element |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3050477B2 (en) * | 1994-01-14 | 2000-06-12 | 日立化成工業株式会社 | Liquid crystal alignment film |
JPH08328005A (en) * | 1995-05-26 | 1996-12-13 | Hitachi Chem Co Ltd | Liquid crystal oriented film, treatment of liquid crystal oriented film, liquid crystal holding substrate, liquid crystal display element, production of liquid crystal display element and material for liquid crystal oriented film |
JPH1039312A (en) * | 1996-07-24 | 1998-02-13 | Hitachi Chem Co Ltd | Liquid crystal orienting film, liquid crystal holding substrate with the same, liquid crystal display device and material for liquid crystal orienting film |
-
2010
- 2010-08-02 JP JP2010173557A patent/JP5556482B2/en not_active Expired - Fee Related
- 2010-09-09 KR KR1020100088361A patent/KR20110030333A/en not_active Withdrawn
- 2010-09-10 CN CN2010102811883A patent/CN102020995A/en active Pending
- 2010-09-14 TW TW099131045A patent/TW201109368A/en unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000214467A (en) * | 1999-01-26 | 2000-08-04 | Hitachi Chem Co Ltd | Composition for liquid crystal alignment film for low voltage driven liquid crystal panel, liquid crystal alignment film for low voltage driven liquid crystal panel, substrate to hold liquid crystal and liquid crystal display element |
JP2001089426A (en) * | 1999-09-14 | 2001-04-03 | Fuji Photo Film Co Ltd | New acetylene compound |
CN1762978A (en) * | 2004-10-05 | 2006-04-26 | Jsr株式会社 | Novel diamine compound,polymer and liquid crystal tropism agent |
JP2007248637A (en) * | 2006-03-14 | 2007-09-27 | National Institute For Materials Science | Liquid crystal alignment film, liquid crystal alignment agent, and liquid crystal display element |
US20070232780A1 (en) * | 2006-03-16 | 2007-10-04 | Chisso Corporation | Photo-alignment film and liquid crystal display element |
CN101470303A (en) * | 2007-12-26 | 2009-07-01 | 智索株式会社 | Liquid crystal tropism agent, liquid crystal tropism film and liquid crystal display element |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102206495A (en) * | 2010-03-30 | 2011-10-05 | 智索株式会社 | Liquid crystal aligning agent, liquid crystal alignment layer and liquid crystal display device |
TWI570156B (en) * | 2011-08-18 | 2017-02-11 | Toray Industries | Polylysine resin composition, polyimine resin composition, polyimine carbazole resin composition, and flexible substrate containing the same |
CN103842408B (en) * | 2011-08-18 | 2016-09-21 | 东丽株式会社 | Polyamic acid resin composition, polyimide resin composition and polyimides azoles resin combination and containing their flexible base board |
CN103842408A (en) * | 2011-08-18 | 2014-06-04 | 东丽株式会社 | Polyamic acid resin composition, polyimide resin composition, polyimide oxazole resin composition, and flexible substrate containing same |
CN102952552A (en) * | 2011-08-23 | 2013-03-06 | 奇美实业股份有限公司 | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element |
CN104321695A (en) * | 2012-04-24 | 2015-01-28 | 捷恩智株式会社 | Liquid-crystal-orienting agent for forming liquid-crystal-oriented film for photoalignment, liquid-crystal-oriented film, and liquid-crystal display element using liquid-crystal-oriented film |
CN108034435A (en) * | 2012-04-24 | 2018-05-15 | 捷恩智株式会社 | Light orientation aligning agent for liquid crystal, light orientation liquid crystal orientation film, its forming method and LCD assembly |
CN108410476B (en) * | 2012-04-24 | 2021-10-08 | 捷恩智株式会社 | Liquid crystal aligning agent for photo-alignment, liquid crystal alignment film for photo-alignment, and liquid crystal display module |
CN108410476A (en) * | 2012-04-24 | 2018-08-17 | 捷恩智株式会社 | Light orientation aligning agent for liquid crystal, light orientation liquid crystal orientation film and LCD assembly |
CN104321695B (en) * | 2012-04-24 | 2018-05-01 | 捷恩智株式会社 | Light orientation aligning agent for liquid crystal, light orientation liquid crystal orientation film, its forming method and LCD assembly |
TWI586639B (en) * | 2012-04-26 | 2017-06-11 | Nissan Chemical Ind Ltd | Diamine, polymer, liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element |
CN103387833B (en) * | 2012-05-09 | 2016-08-24 | 捷恩智株式会社 | Form method and the liquid crystal display cells of light orientation liquid crystal orienting film |
CN103387833A (en) * | 2012-05-09 | 2013-11-13 | 捷恩智株式会社 | Liquid crystal alignment agent for photo alignment, liquid crystal alignment layer for photo alignment, and liquid crystal display element |
CN104718491A (en) * | 2012-10-09 | 2015-06-17 | 日产化学工业株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
CN103048725B (en) * | 2012-12-25 | 2016-05-18 | 深超光电(深圳)有限公司 | Polarizer and method for manufacturing the same |
CN103048725A (en) * | 2012-12-25 | 2013-04-17 | 深超光电(深圳)有限公司 | Polarizer and method for manufacturing polarizer |
CN104059675A (en) * | 2013-03-19 | 2014-09-24 | Jsr株式会社 | Liquid Crystal Aligning Agent, Liquid Crystal Alignment Film, Liquid Crystal Display Device, Polymer And Compound |
CN105452948B (en) * | 2013-07-30 | 2018-11-13 | 夏普株式会社 | The manufacturing method of liquid crystal display device |
CN104892657B (en) * | 2014-03-07 | 2017-11-28 | 达兴材料股份有限公司 | Siloxane trianhydride, polymer, liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element |
CN104892657A (en) * | 2014-03-07 | 2015-09-09 | 达兴材料股份有限公司 | Siloxane trianhydride, polymer, liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element |
CN104927880A (en) * | 2014-03-18 | 2015-09-23 | Jsr株式会社 | Compound, polymer, liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display device, |
CN104927880B (en) * | 2014-03-18 | 2018-11-30 | Jsr株式会社 | Compound, polymer, aligning agent for liquid crystal, liquid crystal orientation film and display element |
TWI644947B (en) * | 2016-02-05 | 2018-12-21 | 奇美實業股份有限公司 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
CN107090300A (en) * | 2016-02-18 | 2017-08-25 | 捷恩智株式会社 | To form the aligning agent for liquid crystal of liquid crystal orientation film, liquid crystal orientation film and use its liquid crystal display cells |
CN107090300B (en) * | 2016-02-18 | 2022-01-11 | 捷恩智株式会社 | Liquid crystal aligning agent for forming liquid crystal alignment film, and liquid crystal display element using same |
TWI644948B (en) * | 2016-02-26 | 2018-12-21 | 奇美實業股份有限公司 | Liquid crystal alignment agent and uses thereof |
CN110366698A (en) * | 2016-12-28 | 2019-10-22 | 日产化学株式会社 | Aligning agent for liquid crystal, liquid crystal orientation film and liquid crystal indicate element |
Also Published As
Publication number | Publication date |
---|---|
JP2011085901A (en) | 2011-04-28 |
TW201109368A (en) | 2011-03-16 |
JP5556482B2 (en) | 2014-07-23 |
KR20110030333A (en) | 2011-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5556482B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
CN101470303B (en) | Liquid crystal tropism agent, liquid crystal tropism film and liquid crystal display element | |
KR101901771B1 (en) | Liquid crystal alignment agents for photo-alignment, liquid crystal photo-alignment layers, and liquid crystal displays using the same | |
KR101526253B1 (en) | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | |
CN103387833B (en) | Form method and the liquid crystal display cells of light orientation liquid crystal orienting film | |
CN104058993B (en) | Photonasty diamines, polyamic acid or derivatives thereof, aligning agent for liquid crystal, liquid crystal orientation film and liquid crystal display cells | |
JP5130907B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
JP5482109B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
JP5434490B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
CN105694912B (en) | Liquid crystal aligning agent for photo-alignment, liquid crystal aligning film, and liquid crystal display element using the same | |
JP5569095B2 (en) | Diamine having diphenylamine structure at two positions in the molecule, polymer obtained by reacting this diamine, liquid crystal aligning agent containing this polymer, liquid crystal aligning film formed using this liquid crystal aligning agent, and this liquid crystal aligning film Liquid crystal display device having | |
CN104321695A (en) | Liquid-crystal-orienting agent for forming liquid-crystal-oriented film for photoalignment, liquid-crystal-oriented film, and liquid-crystal display element using liquid-crystal-oriented film | |
CN103374131A (en) | Polyamic acid or derivative thereof, liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element provided therewith | |
CN106244171A (en) | Light orientation aligning agent for liquid crystal, liquid crystal orientation film and use its liquid crystal display cells and lateral electric-field type liquid crystal display cells | |
JP5428643B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
JP5630139B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
JP2010102159A (en) | Liquid crystal aligning agent, liquid crystal alignment layer, and liquid crystal display element | |
JP2010102184A (en) | Liquid crystal aligning agent, liquid crystal alignment layer, and liquid crystal display element | |
CN107557023A (en) | To form the aligning agent for liquid crystal of light orientation liquid crystal orientation film, liquid crystal orientation film and use its liquid crystal display cells | |
KR101360832B1 (en) | Liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: JNC CORPORATION Free format text: FORMER OWNER: CHISSO CORPORATION Effective date: 20111014 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20111014 Address after: Japan Tokyo Chiyoda Otemachi two chome 2 No. 1 Applicant after: JNC Corporation Co-applicant after: Chisso Petrochemical Corporation Address before: Japan Osaka Osaka North Island in the three chome 3 No. 23 Applicant before: Chisso Corporation Co-applicant before: Chisso Petrochemical Corporation |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: Japan Tokyo Chiyoda Otemachi two chome 2 No. 1 Applicant after: JNC Corporation Co-applicant after: Chisso Petrochemical Corp. Address before: Japan Tokyo Chiyoda Otemachi two chome 2 No. 1 Applicant before: JNC Corporation Co-applicant before: Chisso Petrochemical Corporation |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110420 |